Annotation Detail for BCL2
Basic Information Top
| Gene Symbol: | BCL2 ( Bcl-2 ) |
|---|---|
| Gene Full Name: | B-cell CLL/lymphoma 2 |
| Band: | 18q21.33 |
| Quick Links | Entrez ID:596; OMIM: 151430; Uniprot ID:BCL2_HUMAN; ENSEMBL ID: ENSG00000171791; HGNC ID: 990 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa04141 | Protein processing in endoplasmic reticulum |
| hsa05145 | Toxoplasmosis |
| hsa05014 | Amyotrophic lateral sclerosis (ALS) |
| hsa04722 | Neurotrophin signaling pathway |
| hsa05222 | Small cell lung cancer |
| hsa05210 | Colorectal cancer |
| hsa05215 | Prostate cancer |
| hsa04510 | Focal adhesion |
| hsa04210 | Apoptosis |
| hsa05200 | Pathways in cancer |
| Pathway ID | Pathway Name |
|---|---|
| Apoptosis |
| Pathway ID | Pathway Name |
|---|---|
| 200171 | Validated targets of C-MYC transcriptional repression |
| 200130 | C-MYB transcription factor network |
| 200133 | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 200156 | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 200157 | EPO signaling pathway |
| 200158 | IL2 signaling events mediated by STAT5 |
| 200082 | IL2-mediated signaling events |
| 200099 | IL2 signaling events mediated by PI3K |
| 200076 | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 200148 | Caspase cascade in apoptosis |
| 200112 | RXR and RAR heterodimerization with other nuclear receptor |
| 200116 | ATF-2 transcription factor network |
| 200101 | Direct p53 effectors |
| 200100 | Ceramide signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| P00046 | Oxidative stress response |
| P00006 | Apoptosis signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| 500890 | BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members |
| 500261 | Activation of BAD and translocation to mitochondria |
| Desease ID | Desease Name |
|---|---|
| Cancers of haematopoietic and lymphoid tissues | |
| Cancers | |
| Viral infections | |
| Cancers of the digestive system | |
| H00005 | Chronic lymphocytic leukemia (CLL) |
| H00030 | Cervical cancer |
| H00018 | Gastric cancer |
| H00013 | Small cell lung cancer |
| H00028 | Choriocarcinoma |
| Head and neck cancers | |
| Infections caused by dsDNA viruses | |
| Cancers of the lung and pleura | |
| H00041 | Kaposi's sarcoma |
| H00054 | Nasopharyngeal cancer |
| Cancers of the breast and female genital organs |
| Desease ID | Desease Name |
|---|---|
| 1740 | Alzheimer's disease |
| 1751 | Schistosomiasis |
| 1763 | Keratosis |
| 1780 | Brain ischemia |
| 1781 | Rheumatoid arthritis |
| 1807 | Autoimmune disease |
| 1809 | HIV infection |
| 1832 | Congenital abnormality |
| 1838 | Lichen planus |
| 1850 | Herpes |
| 1853 | Eye cancer |
| 1861 | Epstein-Barr virus infection |
| 1870 | Drug abuse |
| 1878 | Ischemia |
| 1893 | Esotropia |
| 1930 | Graves' disease |
| 1934 | Cancer |
| 1946 | Thyroid gland disease |
| 1954 | Stroke |
| 1986 | Eating disorder |
| 1997 | Dental plaque |
| 2029 | Tuberculosis |
| 2060 | Glaucoma |
| 2074 | Asthma |
| 2124 | Autistic disorder |
| 2146 | Lupus erythematosus |
| 2171 | Celiac disease |
| Desease Name |
|---|
| follicular lymphoma to diffuse large-cell lymphoma |
| CANCER |
| follicular lymphoma |
| Carcinoma, Squamous Cell |
| leukemia/lymphoma, T-Cell |
| systemic lupus erythematosus |
| chronic obstructive pulmonary disease/COPD lung function |
| IMMUNE |
| Hodgkin's disease |
| Neoplasm Recurrence, Local |
| lung cancer |
| Lupus |
| leukemia |
| Oropharyngeal Neoplasms |
| No data |
| Desease Name |
|---|
| Leukemia/lymphoma, B-cell, 2 |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C028098 | 10-hydroxycamptothecin | BCL2 protein affects the susceptibility to 10-hydroxycamptothecin | affects response to substance | 16603448 |
| C478160 | (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane | (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane results in decreased expression of BCL2 protein | decreases expression | 15982805 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea results in decreased expression of BCL2 mRNA | decreases expression | 10567332 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 affects the expression of BCL2 protein | affects expression | 16912651 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15905586 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of BCL2 mRNA | decreases expression | 19933214 |
| C094859 | 2,2',3,3',4,6'-hexachlorobiphenyl | 2,2',3,3',4,6'-hexachlorobiphenyl results in decreased expression of BCL2 mRNA | decreases expression | 17445852 |
| C404910 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of BCL2 protein | increases expression | 15525693 |
| C446520 | 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone | 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone results in decreased expression of BCL2 | decreases expression | 16077967 |
| C044578 | 2,3,5,6-tetrachlorohydroquinone | 2,3,5,6-tetrachlorohydroquinone results in decreased expression of BCL2 protein | decreases expression | 11064002 |
| C486182 | 2,3-bis(4-hydroxyphenyl)-propionitrile | 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA | increases expression | 19264808 |
| C486182 | 2,3-bis(4-hydroxyphenyl)-propionitrile | 2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein | increases expression | 19264808 |
| C486182 | 2,3-bis(4-hydroxyphenyl)-propionitrile | ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein] | affects reaction|increases expression | 19264808 |
| C486182 | 2,3-bis(4-hydroxyphenyl)-propionitrile | ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA] | affects reaction|increases expression | 19264808 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of BCL2 protein | increases phosphorylation | 16018989 |
| C089946 | 2,4-thiazolidinedione | 2,4-thiazolidinedione results in decreased expression of BCL2 protein | decreases expression | 15916743 |
| C011269 | 2,5-hexanedione | 2,5-hexanedione results in increased expression of BCL2 protein | increases expression | 17492505 |
| C012177 | 2-aminofluorene | [2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 20452335 |
| C012177 | 2-aminofluorene | zerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 20452335 |
| C484327 | 2'-benzoyloxycinnamaldehyde | 2'-benzoyloxycinnamaldehyde results in decreased expression of BCL2 protein | decreases expression | 14660655 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17461445 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 17531121 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17531121 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in decreased expression of BCL2 mRNA | decreases expression | 12208782 |
| C518368 | (2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide | (2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide results in decreased expression of BCL2 | decreases expression | 17352252 |
| C049826 | 2-methoxyacetaldehyde | 2-methoxyacetaldehyde promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] | increases expression|increases reaction | 10221278 |
| C022830 | 2-methoxyestradiol | 2-methoxyestradiol results in decreased expression of BCL2 | decreases expression | 16011306 |
| C500959 | 2-selenium-bridged beta-cyclodextrin | 2-selenium-bridged beta-cyclodextrin affects the expression of BCL2 protein | affects expression | 15843033 |
| C524063 | 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one | 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [[F3 protein co-treated with F7 protein] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 18325115 |
| C482492 | 3,4,5,4'-tetramethoxystilbene | 3,4,5,4'-tetramethoxystilbene affects the expression of and affects the phosphorylation of BCL2 protein | affects expression|affects phosphorylation | 15668717 |
| C482492 | 3,4,5,4'-tetramethoxystilbene | 3,4,5,4'-tetramethoxystilbene affects the expression of BCL2 mRNA | affects expression | 15668717 |
| C506282 | 3,5-dimethoxy-4'-hydroxystilbene | [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| C506282 | 3,5-dimethoxy-4'-hydroxystilbene | [3,5-dimethoxy-4'-hydroxystilbene results in decreased phosphorylation of CREB1 protein] which results in decreased expression of BCL2 mRNA | decreases expression|decreases phosphorylation | 17135264 |
| C506282 | 3,5-dimethoxy-4'-hydroxystilbene | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 17135264 |
| C090937 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 19481069 |
| C090937 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in decreased expression of BCL2 protein | decreases expression | 19481069 |
| C090937 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 17135264 |
| C090937 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Quercetin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 17135264 |
| C017906 | 3-dinitrobenzene | 3-dinitrobenzene results in increased expression of BCL2 mRNA | increases expression | 16025311 |
| C002385 | 3-morpholino-sydnonimine | 3-morpholino-sydnonimine results in decreased expression of BCL2 protein | decreases expression | 12880480 |
| C002385 | 3-morpholino-sydnonimine | Selegiline inhibits the reaction [3-morpholino-sydnonimine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12880480 |
| C496751 | 4-(1H-imidazol-1-yl)retinoic acid | 4-(1H-imidazol-1-yl)retinoic acid results in decreased expression of BCL2 protein | decreases expression | 17145897 |
| C038864 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of BCL2 | decreases expression | 16909596 |
| C038864 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of BCL2 protein | decreases expression | 16109544 |
| C486184 | 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol | 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of BCL2 mRNA | increases expression | 19264808 |
| C486184 | 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol | 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of BCL2 protein | increases expression | 19264808 |
| C486184 | 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol | ESR2 protein affects the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of BCL2 mRNA] | affects reaction|increases expression | 19264808 |
| C405354 | 4,5,6,7-tetrabromobenzotriazole | [4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16489027 |
| C016601 | 4-hydroxytamoxifen | 4-hydroxytamoxifen results in decreased expression of BCL2 mRNA | decreases expression | 19698761 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA | increases expression | 16835749 16582591 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein | increases expression | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16835749 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18508827 |
| C041594 | 4-nonylphenol | 4-nonylphenol results in increased expression of BCL2 mRNA | increases expression | 15461258 |
| C503119 | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased phosphorylation of BCL2 protein | increases phosphorylation | 16179969 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| C031477 | 7-hydroxycoumarin | 7-hydroxycoumarin results in decreased expression of BCL2 protein | decreases expression | 15964220 |
| C501332 | ABT-737 | ABT-737 inhibits the reaction [BAX protein binds to BCL2 protein] | affects binding|decreases reaction | 17097560 |
| C501332 | ABT-737 | ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein] | affects binding|decreases reaction | 17097560 |
| C501332 | ABT-737 | BCL2 protein modified form results in decreased susceptibility to ABT-737 | decreases response to substance | 17097560 |
| C501332 | ABT-737 | [PD 98059 results in decreased phosphorylation of BCL2 protein] which results in increased susceptibility to ABT-737 | decreases phosphorylation|increases response to substance | 17097560 |
| C501332 | ABT-737 | ABT-737 binds to BCL2 protein | affects binding | 17097560 |
| D000079 | Acetaldehyde | Acetaldehyde results in decreased expression of BCL2 mRNA | decreases expression | 16814256 |
| D000079 | Acetaldehyde | ADIPOQ protein inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 16814256 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of BCL2 protein | decreases expression | 18467506 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of BCL2 mRNA | increases expression | 12540782 |
| D000082 | Acetaminophen | KITL protein inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18467506 |
| D000082 | Acetaminophen | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 12540782 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 19265712 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19265712 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17542780 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein] | affects cotreatment|decreases expression|decreases reaction | 19082730 |
| D017255 | Acitretin | Acitretin results in decreased expression of BCL2 protein | decreases expression | 16196285 16109552 |
| D000181 | Acrylonitrile | Acrylonitrile results in decreased expression of BCL2 protein | decreases expression | 16173056 |
| C000188 | alachlor | alachlor results in increased expression of BCL2 protein | increases expression | 10545406 |
| C000188 | alachlor | BCL2 protein results in decreased susceptibility to alachlor | decreases response to substance | 12730627 |
| C000188 | alachlor | fulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein] | decreases reaction|increases expression | 10545406 |
| C000188 | alachlor | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor] | decreases reaction|decreases response to substance | 12730627 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of BCL2 | decreases expression | 16909596 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of BCL2 protein | decreases expression | 12189556 16109544 17077328 |
| C103303 | alitretinoin | BCL2 protein results in decreased susceptibility to alitretinoin | decreases response to substance | 12189556 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased expression of BCL2 mRNA | decreases expression | 16048438 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16005924 |
| C010845 | aluminum chloride | aluminum chloride results in decreased expression of BCL2 mRNA | decreases expression | 17096939 |
| C010845 | aluminum chloride | aluminum chloride results in decreased expression of BCL2 protein | decreases expression | 17096939 |
| C067527 | aluminum maltolate | aluminum maltolate results in decreased expression of BCL2 mRNA | decreases expression | 15537749 |
| C067527 | aluminum maltolate | aluminum maltolate results in decreased expression of BCL2 protein | decreases expression | 11382389 |
| D004999 | Amifostine | [Amifostine co-treated with Doxorubicin] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15985719 |
| D006710 | Homocysteine | Homocysteine results in decreased expression of BCL2 protein | decreases expression | 16757814 |
| D006710 | Homocysteine | Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16757814 |
| D017311 | Amlodipine | Amlodipine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17234320 |
| D017311 | Amlodipine | Amlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19698708 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of BCL2 mRNA | affects expression | 16483693 |
| D000661 | Amphetamine | Amphetamine results in decreased expression of BCL2 protein | decreases expression | 15731293 |
| D000677 | Amsacrine | BCL2 protein results in decreased susceptibility to Amsacrine | decreases response to substance | 10920913 |
| C416531 | AN 215 | AN 215 analog results in decreased expression of BCL2 | decreases expression | 16003723 |
| D000968 | Antimycin A | BCL2 protein results in decreased susceptibility to Antimycin A | decreases response to substance | 12730627 |
| D000968 | Antimycin A | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A] | decreases reaction|decreases response to substance | 12730627 |
| D047310 | Apigenin | Apigenin results in decreased expression of BCL2 protein | decreases expression | 15486995 |
| D047310 | Apigenin | BCL2 protein results in decreased susceptibility to Apigenin | decreases response to substance | 15486995 |
| C061640 | arjunolic acid | arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 19682444 |
| C028617 | aroclor 1248 | aroclor 1248 results in decreased expression of BCL2 protein | decreases expression | 16263226 |
| D001151 | Arsenic | Arsenic results in increased expression of BCL2 protein | increases expression | 12899209 |
| C006632 | arsenic trioxide | arsenic trioxide affects the expression of BCL2 protein | affects expression | 16867262 16010437 18357729 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with bortezomib] results in decreased expression of BCL2 | affects cotreatment|decreases expression | 20471514 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with PML protein] results in decreased expression of BCL2 | affects cotreatment|decreases expression | 20377131 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 20416161 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BCL2 mRNA | decreases expression | 20458559 11775218 16904648 15622746 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BCL2 protein | decreases expression | 19695276 16818652 12490120 12845720 19489279 11780464 11135700 20435036 11775218 16105982 18349030 11589617 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of BCL2 mRNA | increases expression | 16966277 |
| C006632 | arsenic trioxide | BCL2 protein inhibits the reaction [arsenic trioxide results in decreased expression of MYC mRNA] | decreases expression|decreases reaction | 11775218 |
| C006632 | arsenic trioxide | BCL2 protein results in decreased susceptibility to arsenic trioxide | decreases response to substance | 16007134 16904648 11775218 |
| C006632 | arsenic trioxide | SB 203580 promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 16818652 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BCL2 protein | decreases expression | 12609071 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BCL2 protein | decreases expression | 19260322 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of BCL2 mRNA | increases expression | 17487067 |
| C006632 | arsenic trioxide | pifithrin inhibits the reaction [arsenic trioxide results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 17487067 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BCL2 mRNA | decreases expression | 19379560 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BCL2 protein | decreases expression | 19379560 |
| C015001 | arsenite | arsenite results in decreased expression of BCL2 mRNA alternative form | decreases expression | 20083129 |
| C015001 | arsenite | arsenite results in decreased expression of BCL2 protein | decreases expression | 20083129 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of BCL2 mRNA | increases expression | 12909582 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17166419 |
| D001241 | Aspirin | Aspirin results in decreased expression of BCL2 protein | decreases expression | 12490308 |
| D016589 | Astemizole | Astemizole results in decreased expression of BCL2 mRNA | decreases expression | 20221588 |
| D001374 | Azacitidine | Azacitidine results in decreased expression of BCL2 mRNA | decreases expression | 15547111 |
| D001374 | Azacitidine | Azacitidine results in decreased expression of BCL2 protein | decreases expression | 15547111 |
| D001374 | Azacitidine | pifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 15547111 |
| D001374 | Azacitidine | pifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15547111 |
| D001388 | Aziridines | Aziridines analog results in decreased expression of BCL2 protein | decreases expression | 15174162 |
| C012765 | bakuchiol | bakuchiol results in decreased expression of BCL2 protein | decreases expression | 17292878 |
| C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16407826 |
| C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [RNF34 protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407826 |
| D001514 | Bee Venoms | Bee Venoms results in decreased expression of BCL2 protein | decreases expression | 15922390 |
| D001542 | Benomyl | Benomyl inhibits the reaction [BCL2 protein binds to BAX protein] | affects binding|decreases reaction | 16903866 |
| D001542 | Benomyl | Benomyl results in increased phosphorylation of BCL2 protein | increases phosphorylation | 16903866 |
| D001554 | Benzene | Benzene results in decreased expression of BCL2 mRNA | decreases expression | 18724895 |
| D001554 | Benzene | Benzene results in increased expression of BCL2 protein | increases expression | 20850422 |
| D001554 | Benzene | Benzene affects the expression of BCL2 mRNA | affects expression | 11896287 |
| D001554 | Benzene | TRP53 protein affects the reaction [Benzene results in increased expression of BCL2 mRNA] | affects reaction|increases expression | 11896287 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 21295105 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with Nitrogen Oxides] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 16041517 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of BCL2 mRNA | decreases expression | 11782367 20498004 20064835 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of BCL2 protein | increases expression | 20850422 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of BCL2 protein | increases expression | 9395224 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of BCL2 mRNA | increases expression | 18973830 |
| D001564 | Benzo(a)pyrene | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 18973830 |
| D001564 | Benzo(a)pyrene | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 18973830 |
| D001564 | Benzo(a)pyrene | theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 18973830 |
| D001599 | Berberine | Berberine results in decreased expression of BCL2 protein | decreases expression | 16505103 |
| C033363 | beta-1,3-glucan | beta-1,3-glucan results in increased expression of BCL2 mRNA | increases expression | 17690738 |
| C033363 | beta-1,3-glucan | [resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 17690738 |
| C026609 | beta-solamarine | beta-solamarine results in decreased expression of BCL2 protein | decreases expression | 17619073 |
| C053541 | bicalutamide | bicalutamide results in increased expression of BCL2 | increases expression | 11845989 |
| C006780 | bisphenol A | bisphenol A results in increased expression of BCL2 mRNA | increases expression | 15461258 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BCL2 mRNA | decreases expression | 11906184 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BCL2 protein | decreases expression | 11906184 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BCL2 | decreases expression | 16909604 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of BCL2 mRNA | decreases expression | 17553608 |
| C400082 | bortezomib | [arsenic trioxide co-treated with bortezomib] results in decreased expression of BCL2 | affects cotreatment|decreases expression | 20471514 |
| C400082 | bortezomib | bortezomib results in decreased expression of BCL2 mRNA | decreases expression | 16022909 |
| C400082 | bortezomib | bortezomib results in decreased expression of BCL2 protein | decreases expression | 16022909 |
| C400082 | bortezomib | [geldanamycin co-treated with bortezomib] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15781649 |
| C023623 | brassinolide | brassinolide results in decreased expression of BCL2 protein | decreases expression | 17557751 |
| D002038 | Bungarotoxins | Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16835749 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in decreased expression of BCL2 mRNA | decreases expression | 17989939 |
| D019328 | Buthionine Sulfoximine | Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 17989939 |
| D020122 | tert-Butylhydroperoxide | Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15288519 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of BCL2 protein | decreases expression | 15288519 17419000 12782109 |
| D020122 | tert-Butylhydroperoxide | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15569404 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of BCL2 protein | decreases expression | 15569404 |
| D002166 | Camptothecin | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 19481069 |
| D002166 | Camptothecin | Camptothecin results in decreased expression of BCL2 protein | decreases expression | 19481069 10692111 |
| D002193 | Cantharidin | Cantharidin results in decreased expression of BCL2 protein | decreases expression | 16117893 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of BCL2 protein | decreases expression | 17505005 18405923 18991268 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of BCL2 protein | decreases expression | 17306913 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of BCL2 mRNA | increases expression | 18719996 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of BCL2 protein | increases expression | 18719996 |
| D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 18156304 |
| D002251 | Carbon Tetrachloride | [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 16426832 |
| D002251 | Carbon Tetrachloride | puerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16426832 |
| C111238 | carboxycinnamic acid bishydroxamide | carboxycinnamic acid bishydroxamide results in decreased expression of BCL2 protein | decreases expression | 15897598 |
| D002330 | Carmustine | [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16187019 |
| C043211 | carvedilol | carvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 15380674 |
| D002392 | Catechin | Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D002392 | Catechin | Catechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18611398 |
| D002392 | Catechin | Catechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18611398 |
| C095591 | chan su | chan su results in decreased expression of BCL2 protein | decreases expression | 16012733 |
| C016299 | chelerythrine | chelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]] | decreases expression|decreases reaction | 12690470 |
| D048271 | Chitosan | [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18567086 |
| D002699 | Chlorambucil | Chlorambucil results in decreased expression of BCL2 protein | decreases expression | 11699414 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 mRNA | decreases expression | 16322545 |
| C000474 | cholestane-3,5,6-triol | cholestane-3,5,6-triol results in increased expression of BCL2 mRNA | increases expression | 16039982 |
| C000474 | cholestane-3,5,6-triol | Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16039982 |
| D002784 | Cholesterol | Cholesterol analog results in decreased expression of BCL2 mRNA | decreases expression | 19477266 |
| C043561 | chrysin | BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein] | decreases expression|decreases reaction | 16215670 |
| C043561 | chrysin | BCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16215670 |
| C043561 | chrysin | BCL2 protein inhibits the reaction [chrysin results in increased cleavage of and results in increased activity of CASP3 protein] | decreases reaction|increases activity|increases cleavage | 16215670 |
| C043561 | chrysin | BCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein] | decreases reaction|increases degradation | 16215670 |
| C043561 | chrysin | BCL2 protein results in decreased susceptibility to chrysin | decreases response to substance | 16215670 |
| C045645 | cilostazol | cilostazol affects the expression of BCL2 protein | affects expression | 15978173 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde analog results in decreased expression of BCL2 protein | decreases expression | 17510524 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of BCL2 protein | decreases expression | 15964311 15566391 |
| C012843 | cinnamic aldehyde | Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15566391 |
| D002939 | Ciprofloxacin | [Etoposide co-treated with Ciprofloxacin] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 12063570 |
| D019343 | Citric Acid | [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16624386 |
| D003024 | Clozapine | Clozapine results in increased expression of BCL2 mRNA | increases expression | 15126120 |
| D003024 | Clozapine | Clozapine results in increased expression of BCL2 protein | increases expression | 15126120 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of BCL2 protein | increases expression | 16827160 |
| D003042 | Cocaine | Cocaine affects the expression of BCL2 mRNA | affects expression | 15681117 |
| D003300 | Copper | Copper results in decreased expression of BCL2 mRNA | decreases expression | 16962711 |
| D003300 | Copper | Copper results in decreased expression of BCL2 protein | decreases expression | 16962711 |
| C030123 | coumarin | coumarin results in decreased expression of BCL2 protein | decreases expression | 15964220 |
| D003474 | Curcumin | Curcumin analog results in decreased expression of BCL2 mRNA | decreases expression | 17671737 19250217 |
| D003474 | Curcumin | [Curcumin co-treated with Isoflavones] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18640131 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Paclitaxel results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16243823 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16219905 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 17640567 |
| D003474 | Curcumin | Curcumin results in decreased expression of BCL2 mRNA | decreases expression | 17671742 19235267 17332930 17596214 17671737 19250217 |
| D003474 | Curcumin | Curcumin results in decreased expression of BCL2 protein | decreases expression | 12497104 17332930 18593936 16023083 19372569 17096185 18226269 17671742 19235267 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]] | decreases reaction|increases expression | 17640567 |
| D003474 | Curcumin | TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 18226269 |
| D003474 | Curcumin | [Curcumin co-treated with gemcitabine] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 17440100 |
| D003474 | Curcumin | Curcumin results in decreased expression of BCL2 protein | decreases expression | 18829502 |
| D003474 | Curcumin | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 17531121 |
| D003474 | Curcumin | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17531121 |
| D003474 | Curcumin | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15569404 |
| D003474 | Curcumin | Curcumin results in decreased expression of BCL2 mRNA | decreases expression | 17531121 |
| D003474 | Curcumin | Curcumin results in decreased expression of BCL2 protein | decreases expression | 17531121 |
| D003474 | Curcumin | Curcumin results in decreased expression of BCL2 | decreases expression | 18462866 |
| D003484 | Cyanamide | [Ethanol co-treated with Cyanamide] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 12003908 |
| D003520 | Cyclophosphamide | BCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP3 protein] | decreases reaction|increases activity | 11723234 |
| D003520 | Cyclophosphamide | BCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP9 protein] | decreases reaction|increases activity | 11723234 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of BCL2 mRNA | increases expression | 14503796 |
| D003520 | Cyclophosphamide | [Doxorubicin co-treated with Cyclophosphamide] affects the expression of BCL2 mRNA | affects cotreatment|affects expression | 16322899 |
| D016572 | Cyclosporine | Cyclosporine promotes the reaction [Paclitaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein] | decreases activity|increases phosphorylation|increases reaction | 12086014 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of BCL2 mRNA | decreases expression | 12086014 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of BCL2 protein | decreases expression | 12086014 |
| C017180 | decamethrin | decamethrin results in decreased expression of BCL2 protein | decreases expression | 12628584 |
| C017180 | decamethrin | decamethrin results in decreased expression of BCL2 protein | decreases expression | 10771154 |
| C017180 | decamethrin | decamethrin results in increased expression of BCL2 protein | increases expression | 10771154 |
| C014347 | decitabine | decitabine results in decreased expression of BCL2 protein | decreases expression | 18636160 |
| C107676 | deguelin | deguelin results in decreased expression of BCL2 mRNA | decreases expression | 19365708 |
| C107676 | deguelin | deguelin results in decreased expression of BCL2 protein | decreases expression | 19365708 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in increased expression of BCL2 protein | increases expression | 16407456 |
| D003687 | Dehydroepiandrosterone | Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| D003687 | Dehydroepiandrosterone | Dihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| D003687 | Dehydroepiandrosterone | Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| C509625 | dehydroepiandrosterone-bovine serum albumin | dehydroepiandrosterone-bovine serum albumin results in increased expression of BCL2 protein | increases expression | 16407456 |
| C509625 | dehydroepiandrosterone-bovine serum albumin | Pertussis Toxin inhibits the reaction [dehydroepiandrosterone-bovine serum albumin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| D019314 | Dehydroepiandrosterone Sulfate | Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein | increases expression | 16407456 |
| D019314 | Dehydroepiandrosterone Sulfate | Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| C017185 | delphinidin | delphinidin results in decreased expression of BCL2 protein | decreases expression | 15740068 |
| C075597 | Dendroaspis natriuretic peptide | Dendroaspis natriuretic peptide results in decreased expression of BCL2 protein | decreases expression | 15803858 |
| D003840 | Deoxycholic Acid | BCL2 protein results in decreased susceptibility to Deoxycholic Acid | decreases response to substance | 12507930 |
| C007262 | deoxynivalenol | Ascorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17166419 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of BCL2 protein | decreases expression | 17166419 |
| D003907 | Dexamethasone | [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15867202 |
| D003907 | Dexamethasone | [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15867202 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of BCL2 mRNA | decreases expression | 16644695 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of BCL2 protein | decreases expression | 16644695 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 16644695 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16644695 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| C028009 | diallyl disulfide | diallyl disulfide results in decreased expression of BCL2 protein | decreases expression | 16052692 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of BCL2 protein | decreases expression | 17513609 |
| D016190 | Carboplatin | Carboplatin results in decreased expression of BCL2 mRNA | decreases expression | 15996812 15576332 17404015 |
| D016190 | Carboplatin | Carboplatin results in decreased expression of BCL2 protein | decreases expression | 15996812 |
| C061481 | dibenzoylmethane | dibenzoylmethane inhibits the reaction [ESR1 protein binds to BCL2 enhancer] | affects binding|decreases reaction | 16051634 |
| C061481 | dibenzoylmethane | dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16051634 |
| D002945 | Cisplatin | BCL2 protein inhibits the reaction [Cisplatin affects the localization of BAX protein] | affects localization|decreases reaction | 16009487 |
| D002945 | Cisplatin | BCL2 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 16009487 |
| D002945 | Cisplatin | BCL2 protein results in decreased susceptibility to [Cisplatin co-treated with Etoposide] | affects cotreatment|decreases response to substance | 15917659 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of BCL2 mRNA | decreases expression | 17404015 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of BCL2 protein | decreases expression | 14512787 |
| D002945 | Cisplatin | Cisplatin results in increased expression of BCL2 protein | increases expression | 17619073 |
| D002945 | Cisplatin | [Quercetin results in increased susceptibility to Cisplatin] which results in decreased expression of BCL2 protein | decreases expression|increases response to substance | 16619537 |
| D002945 | Cisplatin | BCL2 protein affects the susceptibility to Cisplatin | affects response to substance | 15746559 |
| D002945 | Cisplatin | BCL2 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 15315938 |
| D002945 | Cisplatin | chelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]] | decreases expression|decreases reaction | 12690470 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of BCL2 protein | decreases expression | 12690470 |
| D002945 | Cisplatin | sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12690470 |
| D002945 | Cisplatin | uranyl acetate inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12690470 |
| C499970 | dideoxypetrosynol A | dideoxypetrosynol A results in decreased expression of BCL2 protein | decreases expression | 15547680 |
| D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 18313992 |
| D004026 | Dieldrin | BCL2 protein inhibits the reaction [Dieldrin results in increased activity of CASP3 protein] | decreases reaction|increases activity | 15183012 15033812 |
| D004026 | Dieldrin | BCL2 protein inhibits the reaction [Dieldrin results in increased activity of PRKCD protein] | decreases reaction|increases activity | 15033812 |
| D004026 | Dieldrin | BCL2 protein results in decreased susceptibility to Dieldrin | decreases response to substance | 15183012 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of BCL2 mRNA | increases expression | 15923092 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of BCL2 protein | increases expression | 15923092 9395224 |
| D004052 | Diethylnitrosamine | [2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 20452335 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein | affects cotreatment|affects expression | 11915028 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 21295105 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of BCL2 protein | increases expression | 19073162 |
| D004052 | Diethylnitrosamine | IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein] | affects cotreatment|affects expression|affects reaction | 11915028 |
| D004052 | Diethylnitrosamine | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] | decreases reaction|increases expression | 19073162 |
| D004052 | Diethylnitrosamine | zerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 20452335 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of BCL2 mRNA | decreases expression | 15545218 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of BCL2 mRNA | increases expression | 17943652 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of BCL2 protein | decreases expression | 17009535 |
| D002117 | Calcitriol | [Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15955619 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of BCL2 mRNA | decreases expression | 15955619 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of BCL2 protein | decreases expression | 12479363 |
| C444299 | diindolylmethane | diindolylmethane analog results in decreased expression of BCL2 protein | decreases expression | 16051428 |
| D019813 | 1,2-Dimethylhydrazine | 1,2-Dimethylhydrazine results in increased expression of BCL2 protein | increases expression | 15309441 |
| D019813 | 1,2-Dimethylhydrazine | olive oil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15309441 |
| C018522 | dimethyl-N-acetylmuramyl-alanylglutamate | dimethyl-N-acetylmuramyl-alanylglutamate results in decreased expression of BCL2 protein | decreases expression | 16806111 |
| C018522 | dimethyl-N-acetylmuramyl-alanylglutamate | gypenoside inhibits the reaction [dimethyl-N-acetylmuramyl-alanylglutamate results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16806111 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of BCL2 protein | decreases expression | 14659978 |
| D004128 | Dimethylnitrosamine | Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 14659978 |
| D004128 | Dimethylnitrosamine | pyrrolidino-4-iodotamoxifen inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 14659978 |
| D004144 | Diosgenin | Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16331273 |
| D004144 | Diosgenin | Diosgenin results in decreased expression of BCL2 protein | decreases expression | 16331273 |
| D004280 | Dobutamine | Dobutamine results in decreased expression of BCL2 protein | decreases expression | 15052282 |
| C067311 | docetaxel | [zoledronic acid co-treated with docetaxel] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 19103299 |
| D004281 | Docosahexaenoic Acids | [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 19015929 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased expression of BCL2 | decreases expression | 19116882 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased expression of BCL2 protein | decreases expression | 11090257 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [Paraquat results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12714668 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased expression of BCL2 protein | increases expression | 12714668 |
| D004298 | Dopamine | Dopamine results in decreased expression of BCL2 protein | decreases expression | 17603292 |
| D004298 | Dopamine | resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17603292 |
| D004317 | Doxorubicin | Acetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17542780 |
| D004317 | Doxorubicin | [Amifostine co-treated with Doxorubicin] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15985719 |
| D004317 | Doxorubicin | BCL2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16450387 17541305 16322301 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of BCL2 mRNA | affects expression | 16705698 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with Cyclophosphamide] affects the expression of BCL2 mRNA | affects cotreatment|affects expression | 16322899 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein] | increases phosphorylation|increases reaction | 16168113 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BCL2 mRNA | decreases expression | 16001973 18560228 17404015 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BCL2 protein | decreases expression | 17959036 16890185 11779855 17542780 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of BCL2 mRNA | increases expression | 19757172 15939500 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of BCL2 protein | increases expression | 15571967 |
| D004317 | Doxorubicin | [F3 protein affects the expression of BCL2 protein] which affects the susceptibility to Doxorubicin | affects expression|affects response to substance | 18325115 |
| D004317 | Doxorubicin | [[F3 protein co-treated with F7 protein] results in increased expression of BCL2 protein] which results in decreased susceptibility to Doxorubicin | affects cotreatment|decreases response to substance|increases expression | 18325115 |
| D004317 | Doxorubicin | GSTA1 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16890185 |
| D004317 | Doxorubicin | IFNA1 protein promotes the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 17959036 |
| D004317 | Doxorubicin | Morphine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17542780 |
| D004317 | Doxorubicin | pluronic block copolymer p85 inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 15939500 |
| D004317 | Doxorubicin | Sirolimus inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15571967 |
| D004317 | Doxorubicin | Tamoxifen promotes the reaction [Doxorubicin results in increased expression of BCL2 mRNA] | increases expression|increases reaction | 19757172 |
| D004317 | Doxorubicin | BDKRB1 protein affects the reaction [Doxorubicin results in decreased expression of BCL2 protein] | affects reaction|decreases expression | 18627295 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BCL2 protein | decreases expression | 18627295 17673183 15811867 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of BCL2 mRNA | increases expression | 15505089 |
| D004317 | Doxorubicin | Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17673183 |
| D004317 | Doxorubicin | sildenafil inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15811867 |
| D004317 | Doxorubicin | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 19789217 |
| D004317 | Doxorubicin | Amlodipine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17234320 |
| D004317 | Doxorubicin | carvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 15380674 |
| D004317 | Doxorubicin | Catechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18611398 |
| D004317 | Doxorubicin | Catechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18611398 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BCL2 mRNA | decreases expression | 18400355 18611398 15380674 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BCL2 protein | decreases expression | 18611398 17234320 17924179 18632596 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of BCL2 protein | increases expression | 17520333 |
| D004317 | Doxorubicin | EPO protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17924179 |
| D004317 | Doxorubicin | GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18400355 |
| D004317 | Doxorubicin | Ginkgo biloba extract 761 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18632596 |
| D004317 | Doxorubicin | Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18611398 |
| D004317 | Doxorubicin | Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18611398 |
| D004317 | Doxorubicin | TNF protein affects the reaction [GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]] | affects reaction|decreases expression|decreases reaction | 18400355 |
| D004317 | Doxorubicin | Withanolides inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 17520333 |
| D004318 | Doxycycline | Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17673183 |
| C060327 | dracorhodin | dracorhodin analog results in decreased expression of BCL2 protein | decreases expression | 15684474 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal promotes the reaction [Zidovudine results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 17696246 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in decreased expression of BCL2 protein | decreases expression | 19295228 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased expression of BCL2 protein | increases expression | 15998571 |
| C004934 | eleostearic acid | eleostearic acid results in decreased expression of BCL2 protein | decreases expression | 15961301 |
| C034192 | ellipticine | ellipticine results in decreased expression of BCL2 protein | decreases expression | 16027529 |
| D004726 | Endosulfan | Endosulfan results in increased expression of BCL2 protein | increases expression | 10821422 |
| C062669 | epicatechin gallate | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 18973830 |
| D015251 | Epirubicin | Epirubicin results in increased expression of BCL2 mRNA | increases expression | 14503796 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate affects the expression of BCL2 protein | affects expression | 15975156 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12672908 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of BCL2 protein | decreases expression | 20149610 15657356 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 18973830 |
| D034261 | Epothilones | BCL2 protein results in decreased susceptibility to Epothilones | decreases response to substance | 12517783 |
| D034261 | Epothilones | BCL2 protein results in decreased susceptibility to [flavopiridol co-treated with Epothilones] | affects cotreatment|decreases response to substance | 12517783 |
| D004918 | Erythromycin Estolate | Erythromycin Estolate results in increased expression of BCL2 mRNA | increases expression | 12883083 |
| D004958 | Estradiol | ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] | decreases reaction|increases expression | 20305694 |
| D004958 | Estradiol | ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] | decreases reaction|increases expression | 20305694 |
| D004958 | Estradiol | dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16051634 |
| D004958 | Estradiol | ESR1 protein affects the reaction [Estradiol results in increased expression of BCL2 mRNA] | affects reaction|increases expression | 19264808 |
| D004958 | Estradiol | ESR1 protein affects the reaction [Estradiol results in increased expression of BCL2 protein] | affects reaction|increases expression | 19264808 |
| D004958 | Estradiol | ESR2 protein affects the reaction [Estradiol results in increased expression of BCL2 mRNA] | affects reaction|increases expression | 19264808 |
| D004958 | Estradiol | Estradiol affects the expression of BCL2 mRNA | affects expression | 11896290 |
| D004958 | Estradiol | Estradiol results in increased expression of BCL2 mRNA | increases expression | 19698761 19264808 16051634 15897899 |
| D004958 | Estradiol | Estradiol results in increased expression of BCL2 protein | increases expression | 19264808 10545406 15870704 20305694 |
| D004958 | Estradiol | Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 15897899 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15870704 10545406 20305694 |
| D004958 | Estradiol | Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16051634 |
| D004958 | Estradiol | Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein] | decreases reaction|increases expression | 20305694 |
| D004958 | Estradiol | YC137 inhibits the reaction [ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]] | decreases reaction|increases expression | 20305694 |
| D004958 | Estradiol | YC137 inhibits the reaction [ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]] | decreases reaction|increases expression | 20305694 |
| D004958 | Estradiol | Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 14659978 |
| D004961 | Estramustine | Estramustine results in increased phosphorylation of BCL2 protein | increases phosphorylation | 11763419 |
| D004967 | Estrogens | Estrogens results in increased expression of BCL2 protein | increases expression | 16007339 |
| D004967 | Estrogens | Estrogens inhibits the reaction [Glucocorticoids results in decreased expression of BCL2] | decreases expression|decreases reaction | 16007339 |
| D004966 | Estrogens, Conjugated (USP) | [Progesterone co-treated with Estrogens, Conjugated (USP)] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 15779298 |
| D000431 | Ethanol | Ethanol affects the localization of BCL2 protein | affects localization | 16035105 |
| D000431 | Ethanol | Ethanol affects the reaction [BAX protein binds to BCL2 protein] | affects binding|affects reaction | 16035105 |
| D000431 | Ethanol | [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 16426832 |
| D000431 | Ethanol | [Ethanol co-treated with Cyanamide] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 12003908 |
| D000431 | Ethanol | Ethanol results in decreased expression of BCL2 mRNA | decreases expression | 15353170 |
| D000431 | Ethanol | puerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16426832 |
| D004996 | Ethidium | Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 15897899 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of BCL2 protein | increases expression | 12857939 |
| C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate results in decreased activity of BCL2 protein | decreases activity | 15634644 |
| D017308 | Etodolac | Etodolac results in decreased expression of BCL2 mRNA | decreases expression | 16046235 16104877 |
| D017308 | Etodolac | Etodolac results in decreased expression of BCL2 protein | decreases expression | 16046235 16104877 |
| D005047 | Etoposide | BCL2 protein results in decreased susceptibility to [Cisplatin co-treated with Etoposide] | affects cotreatment|decreases response to substance | 15917659 |
| D005047 | Etoposide | [Etoposide co-treated with Ciprofloxacin] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 12063570 |
| D005047 | Etoposide | BCL2 protein affects the reaction [[Etoposide results in increased activity of GSK3B protein] which results in increased activity of CASP3 protein] | affects reaction|increases activity | 19408126 |
| D005047 | Etoposide | Etoposide results in decreased expression of BCL2 mRNA | decreases expression | 19408126 |
| D005047 | Etoposide | Etoposide results in decreased expression of BCL2 protein | decreases expression | 19408126 |
| D005047 | Etoposide | [G(M3) Ganglioside results in increased expression of BCL2 protein] which results in decreased susceptibility to Etoposide | decreases response to substance|increases expression | 16571667 |
| D005047 | Etoposide | Lithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 19408126 |
| D005047 | Etoposide | Lithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19408126 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15710601 |
| C049347 | fasudil | fasudil results in increased expression of BCL2 protein | increases expression | 17761835 |
| D005278 | Fenitrothion | Fenitrothion results in increased expression of BCL2 | increases expression | 21137095 |
| C008169 | ferric oxide, saccharated | ferric oxide, saccharated results in decreased expression of BCL2 protein | decreases expression | 16957011 |
| C421458 | ferric-sorbitol-citrate | ferric-sorbitol-citrate results in decreased expression of BCL2 | decreases expression | 17257079 |
| D047309 | Flavones | Flavones results in increased expression of BCL2 protein | increases expression | 15998571 |
| C077990 | flavopiridol | BCL2 protein mutant form inhibits the reaction [flavopiridol affects the localization of CYCS protein] | affects localization|decreases reaction | 12170773 |
| C077990 | flavopiridol | BCL2 protein mutant form inhibits the reaction [flavopiridol results in increased activity of CASP3 protein] | decreases reaction|increases activity | 12170773 |
| C077990 | flavopiridol | BCL2 protein mutant form inhibits the reaction [flavopiridol results in increased activity of CASP9 protein] | decreases reaction|increases activity | 12170773 |
| C077990 | flavopiridol | BCL2 protein mutant form inhibits the reaction [flavopiridol results in increased cleavage of BID protein] | decreases reaction|increases cleavage | 12170773 |
| C077990 | flavopiridol | BCL2 protein mutant form inhibits the reaction [flavopiridol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 12170773 |
| C077990 | flavopiridol | BCL2 protein mutant form results in decreased susceptibility to flavopiridol | decreases response to substance | 12170773 |
| C077990 | flavopiridol | BCL2 protein results in decreased susceptibility to flavopiridol | decreases response to substance | 12517783 |
| C077990 | flavopiridol | BCL2 protein results in decreased susceptibility to [flavopiridol co-treated with Epothilones] | affects cotreatment|decreases response to substance | 12517783 |
| C077990 | flavopiridol | [flavopiridol co-treated with gemcitabine] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15770523 |
| C077990 | flavopiridol | flavopiridol results in decreased expression of BCL2 mRNA | decreases expression | 15972445 |
| D015073 | 2-Acetylaminofluorene | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein | affects cotreatment|affects expression | 11915028 |
| D015073 | 2-Acetylaminofluorene | IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein] | affects cotreatment|affects expression|affects reaction | 11915028 |
| D005472 | Fluorouracil | BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16407826 |
| D005472 | Fluorouracil | BCL2 protein affects the susceptibility to Fluorouracil | affects response to substance | 16412276 15177426 16332177 18949393 16603448 |
| D005472 | Fluorouracil | BCL2 protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 17439414 |
| D005472 | Fluorouracil | [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 19015929 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 16391804 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16391804 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 16407826 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 16596200 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 19084572 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of BCL2 mRNA | decreases expression | 16557594 17589894 17287894 15996812 16929163 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of BCL2 protein | decreases expression | 17589894 18161298 16929163 15996812 18205257 16557594 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of BCL2 mRNA | increases expression | 14503796 |
| D005472 | Fluorouracil | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 16929163 |
| D005472 | Fluorouracil | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16929163 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18567086 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of BCL2 protein | decreases expression | 18567086 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of BCL2 mRNA | increases expression | 16888818 |
| D005473 | Fluoxetine | BCL2 protein results in decreased susceptibility to Fluoxetine | decreases response to substance | 16076491 |
| D005492 | Folic Acid | Folic Acid affects the expression of BCL2 mRNA | affects expression | 16611376 |
| D005492 | Folic Acid | PTHLH protein inhibits the reaction [Folic Acid results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16672315 |
| D005492 | Folic Acid | [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 18156304 |
| D005492 | Folic Acid | Folic Acid affects the expression of BCL2 protein | affects expression | 16933212 |
| D005492 | Folic Acid | [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein | affects cotreatment|affects expression | 16933212 |
| C012629 | formoterol | formoterol results in decreased expression of BCL2 mRNA | decreases expression | 14687023 |
| C012629 | formoterol | formoterol results in decreased expression of BCL2 protein | decreases expression | 14687023 |
| C070081 | fulvestrant | ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] | decreases reaction|increases expression | 20305694 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein] | decreases reaction|increases expression | 10545406 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein] | decreases reaction|increases expression | 10545406 20305694 15870704 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of BCL2 protein] | decreases reaction|increases expression | 10545406 |
| C070081 | fulvestrant | YC137 inhibits the reaction [ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]] | decreases reaction|increases expression | 20305694 |
| D005665 | Furosemide | Furosemide affects the expression of BCL2 mRNA | affects expression | 17497460 |
| C052659 | gambogic acid | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 19084572 |
| C052659 | gambogic acid | gambogic acid results in decreased expression of BCL2 mRNA | decreases expression | 15968715 19084572 |
| C054597 | garcinol | garcinol results in decreased expression of BCL2 protein | decreases expression | 16052481 |
| C001277 | geldanamycin | [geldanamycin co-treated with bortezomib] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15781649 |
| C056507 | gemcitabine | [flavopiridol co-treated with gemcitabine] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15770523 |
| C056507 | gemcitabine | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 16929163 |
| C056507 | gemcitabine | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16929163 |
| C056507 | gemcitabine | [Curcumin co-treated with gemcitabine] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 17440100 |
| D019833 | Genistein | [Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15955619 |
| D019833 | Genistein | Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15288519 |
| D005839 | Gentamicins | BCL2 protein results in decreased susceptibility to Gentamicins | decreases response to substance | 19151550 |
| D005839 | Gentamicins | Amlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19698708 |
| D005839 | Gentamicins | Gentamicins results in decreased expression of BCL2 protein | decreases expression | 19698708 |
| D005839 | Gentamicins | Nifedipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19698708 |
| D005839 | Gentamicins | Nitrendipine promotes the reaction [Gentamicins results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 19698708 |
| C007845 | gingerol | gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18030663 |
| C007845 | gingerol | gingerol results in decreased expression of BCL2 mRNA | decreases expression | 19481070 |
| C007845 | gingerol | gingerol results in decreased expression of BCL2 protein | decreases expression | 18030663 19481070 |
| C007845 | gingerol | gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18030663 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18632596 |
| D005938 | Glucocorticoids | Glucocorticoids results in decreased expression of BCL2 protein | decreases expression | 15748212 |
| D005938 | Glucocorticoids | Estrogens inhibits the reaction [Glucocorticoids results in decreased expression of BCL2] | decreases expression|decreases reaction | 16007339 |
| D005938 | Glucocorticoids | Glucocorticoids results in decreased expression of BCL2 | decreases expression | 16007339 |
| D005947 | Glucose | Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D005947 | Glucose | epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D005947 | Glucose | Glucose results in increased degradation of and results in decreased expression of BCL2 protein | decreases expression|increases degradation | 19557821 |
| D005947 | Glucose | Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D005947 | Glucose | Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D005947 | Glucose | Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]] | decreases reaction|increases expression | 17640567 |
| D005978 | Glutathione | BCL2 protein results in decreased export of Glutathione | decreases export | 15561710 |
| D005679 | G(M3) Ganglioside | [G(M3) Ganglioside results in increased expression of BCL2 protein] which results in decreased susceptibility to Etoposide | decreases response to substance|increases expression | 16571667 |
| D017273 | Goserelin | Goserelin results in increased expression of BCL2 protein | increases expression | 16973256 |
| D006072 | Gossypol | Gossypol analog binds to BCL2 protein | affects binding | 16020667 |
| C511402 | Grape Seed Proanthocyanidins | Grape Seed Proanthocyanidins affects the expression of BCL2 | affects expression | 12587719 |
| C058858 | grifolin | grifolin results in decreased expression of BCL2 protein | decreases expression | 15949805 |
| C474918 | gypenoside | gypenoside inhibits the reaction [dimethyl-N-acetylmuramyl-alanylglutamate results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16806111 |
| D006533 | Heptachlor | Heptachlor results in increased expression of BCL2 protein | increases expression | 14678745 |
| C013015 | hesperetin | hesperetin affects the expression of BCL2 protein | affects expression | 15975156 |
| C014026 | hexamethylene bisacetamide | hexamethylene bisacetamide affects the expression of BCL2 | affects expression | 15543656 |
| D017313 | Fenretinide | [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16187019 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction BCL2 protein | decreases reaction | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16230421 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of BCL2 protein | decreases expression | 17159502 16187019 |
| C050426 | huperzine A | huperzine A affects the expression of BCL2 | affects expression | 15956816 |
| D006861 | Hydrogen Peroxide | BCL2 protein results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance | 9989825 |
| D006861 | Hydrogen Peroxide | epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12672908 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of BCL2 protein | decreases expression | 12672908 |
| D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12672908 |
| D006861 | Hydrogen Peroxide | BCL2 protein affects the susceptibility to Hydrogen Peroxide | affects response to substance | 15746559 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of BCL2 mRNA | affects expression | 17204550 17570061 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of BCL2 protein | affects expression | 17570061 17204550 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of BCL2 protein | increases expression | 16157298 |
| D006861 | Hydrogen Peroxide | Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] | affects expression|decreases reaction | 17570061 |
| D006861 | Hydrogen Peroxide | Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] | affects expression|decreases reaction | 17570061 |
| D006861 | Hydrogen Peroxide | Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] | affects expression|decreases reaction | 17570061 |
| D006861 | Hydrogen Peroxide | Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] | affects expression|decreases reaction | 17570061 |
| D006861 | Hydrogen Peroxide | [[pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide] which results in decreased expression of BCL2 protein | decreases expression|increases abundance|increases expression | 19361538 |
| D006861 | Hydrogen Peroxide | RLN2 protein affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] | affects expression|affects reaction | 17204550 |
| D006861 | Hydrogen Peroxide | RLN2 protein affects the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] | affects expression|affects reaction | 17204550 |
| C527042 | hydroxycamptothecinum | BCL2 protein results in decreased susceptibility to hydroxycamptothecinum | decreases response to substance | 17439414 |
| D016627 | Oxidopamine | Oxidopamine results in decreased expression of BCL2 protein | decreases expression | 16480889 |
| D016627 | Oxidopamine | Tea inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16480889 |
| C404743 | IDN 5109 | IDN 5109 results in decreased expression of BCL2 | decreases expression | 16391850 |
| D007069 | Ifosfamide | BCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein] | decreases reaction|increases activity | 11723234 |
| D007069 | Ifosfamide | BCL2 protein results in decreased susceptibility to Ifosfamide analog | decreases response to substance | 11723234 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in decreased expression of BCL2 | decreases expression | 16082211 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of BCL2 mRNA | decreases expression | 11721434 10785260 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of BCL2 protein | decreases expression | 18678619 10785260 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] | affects expression|decreases reaction | 17570061 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] | affects expression|decreases reaction | 17570061 |
| C506002 | ircinin-1 | ircinin-1 results in decreased expression of BCL2 mRNA | decreases expression | 16163705 |
| C506002 | ircinin-1 | ircinin-1 results in decreased expression of BCL2 protein | decreases expression | 16163705 |
| C051890 | irinotecan | BCL2 protein affects the susceptibility to irinotecan | affects response to substance | 18949393 |
| C051890 | irinotecan | [Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 16391804 |
| C051890 | irinotecan | [Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16391804 |
| D007501 | Iron | Iron results in decreased expression of BCL2 protein | decreases expression | 16957011 |
| D007529 | Isoflavones | [Curcumin co-treated with Isoflavones] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18640131 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of BCL2 protein | decreases expression | 15052282 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of BCL2 protein | decreases expression | 12791704 |
| C067713 | lactacystin | lactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] | decreases reaction|increases degradation|increases expression | 19361538 |
| C047781 | lamotrigine | lamotrigine results in increased expression of BCL2 mRNA | increases expression | 18719996 |
| C047781 | lamotrigine | lamotrigine results in increased expression of BCL2 protein | increases expression | 18719996 |
| C477361 | LAQ824 | BCL2 protein results in decreased susceptibility to LAQ824 | decreases response to substance | 16189296 |
| D001556 | Lindane | Lindane results in decreased expression of BCL2 protein | decreases expression | 14688026 |
| D001556 | Lindane | Lindane results in increased expression of BCL2 protein | increases expression | 14688026 |
| D044243 | Linoleic Acids, Conjugated | Linoleic Acids, Conjugated results in decreased expression of BCL2 protein | decreases expression | 15961301 |
| D044243 | Linoleic Acids, Conjugated | Linoleic Acids, Conjugated results in decreased expression of BCL2 protein | decreases expression | 20155912 |
| D008043 | Linseed Oil | Linseed Oil results in decreased expression of BCL2 mRNA | decreases expression | 19904759 |
| D008094 | Lithium | Lithium affects the expression of BCL2 mRNA | affects expression | 18835332 |
| D008094 | Lithium | Lithium inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19149911 |
| D008094 | Lithium | Lithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18976035 |
| D008094 | Lithium | Lithium results in increased expression of BCL2 mRNA | increases expression | 16288908 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of BCL2 mRNA | increases expression | 19101580 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of BCL2 protein | increases expression | 18830594 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 19408126 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19408126 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15090542 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| C015329 | lycopene | lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| C015329 | lycopene | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| C048341 | mafosfamide | BCL2 protein inhibits the reaction [mafosfamide results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 11723234 |
| C048341 | mafosfamide | BCL2 protein results in decreased susceptibility to mafosfamide | decreases response to substance | 11723234 |
| C005095 | malachite green | malachite green results in increased expression of and affects the localization of BCL2 protein | affects localization|increases expression | 10840942 |
| C065861 | malvidin | malvidin results in decreased expression of BCL2 protein | decreases expression | 15964118 |
| C013099 | mancozeb | alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16005924 |
| C013099 | mancozeb | mancozeb results in decreased expression of BCL2 protein | decreases expression | 16005924 |
| D008464 | Mecamylamine | Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16835749 |
| D008466 | Mechlorethamine | Mechlorethamine results in decreased expression of BCL2 protein | decreases expression | 16738803 |
| C100076 | mesoxalonitrile | BCL2 protein results in decreased susceptibility to mesoxalonitrile | decreases response to substance | 12730627 |
| C100076 | mesoxalonitrile | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to mesoxalonitrile] | decreases reaction|decreases response to substance | 12730627 |
| D009921 | Metaproterenol | Metaproterenol results in decreased expression of BCL2 protein | decreases expression | 15052282 |
| D008694 | Methamphetamine | Lithium inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19149911 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of BCL2 protein | decreases expression | 19149911 |
| D008694 | Methamphetamine | Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19149911 |
| C008390 | methional | BCL2 protein affects the susceptibility to methional | affects response to substance | 8611183 |
| D008731 | Methoxychlor | BCL2 protein results in decreased susceptibility to Methoxychlor | decreases response to substance | 16081520 14973267 |
| D008731 | Methoxychlor | Methoxychlor metabolite results in increased expression of BCL2 protein | increases expression | 15525693 |
| D008731 | Methoxychlor | Methoxychlor results in decreased expression of BCL2 mRNA | decreases expression | 16081520 |
| D008731 | Methoxychlor | Methoxychlor results in increased expression of BCL2 protein | increases expression | 15525693 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of BCL2 protein | decreases expression | 16019050 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in decreased expression of BCL2 protein | decreases expression | 16019050 |
| D008769 | Methylnitronitrosoguanidine | lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 16030430 |
| D008769 | Methylnitronitrosoguanidine | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| D008769 | Methylnitronitrosoguanidine | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of BCL2 mRNA | increases expression | 15240709 |
| D008770 | Methylnitrosourea | FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16011256 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in decreased expression of BCL2 protein | decreases expression | 16011256 16047940 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein | decreases expression | 12880480 |
| D015655 | 1-Methyl-4-phenylpyridinium | [1-Methyl-4-phenylpyridinium co-treated with Quercetin] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 19466539 |
| D015655 | 1-Methyl-4-phenylpyridinium | [1-Methyl-4-phenylpyridinium co-treated with resveratrol] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 19466539 |
| D008775 | Methylprednisolone | Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] | affects expression|decreases reaction | 17570061 |
| D008775 | Methylprednisolone | Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] | affects expression|decreases reaction | 17570061 |
| C008493 | methylselenic acid | methylselenic acid affects the expression of BCL2 protein | affects expression | 12017302 |
| D014290 | Metipranolol | Metipranolol inhibits the reaction [Zinc results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| D014290 | Metipranolol | Metipranolol inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| D008874 | Midazolam | Midazolam results in increased expression of BCL2 | increases expression | 17715682 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of BCL2 mRNA | decreases expression | 16009178 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of BCL2 protein | decreases expression | 16525653 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 16644695 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16644695 |
| D008911 | Minocycline | Minocycline results in increased expression of BCL2 mRNA | increases expression | 15004018 |
| D008911 | Minocycline | Minocycline results in increased expression of BCL2 protein | increases expression | 15004018 |
| D008911 | Minocycline | [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein | affects binding|increases expression | 15004018 |
| D008911 | Minocycline | [Minocycline results in increased expression of BCL2 protein] which binds to BAX protein | affects binding|increases expression | 15004018 |
| D008911 | Minocycline | [Minocycline results in increased expression of BCL2 protein] which binds to BID protein | affects binding|increases expression | 15004018 |
| D008911 | Minocycline | Sodium Azide inhibits the reaction [Minocycline results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15004018 |
| D016685 | Mitomycin | Mitomycin results in increased expression of BCL2 mRNA | increases expression | 19757172 |
| D016685 | Mitomycin | Mitomycin results in increased expression of BCL2 protein | increases expression | 15793875 |
| D016685 | Mitomycin | Tamoxifen promotes the reaction [Mitomycin results in increased expression of BCL2 mRNA] | increases expression|increases reaction | 19757172 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 mRNA | decreases expression | 12927354 |
| C091888 | monoisoamyl-2,3-dimercaptosuccinate | monoisoamyl-2,3-dimercaptosuccinate affects the expression of BCL2 mRNA | affects expression | 19615344 |
| C091888 | monoisoamyl-2,3-dimercaptosuccinate | monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 19615344 |
| D009020 | Morphine | Morphine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17542780 |
| D009020 | Morphine | Lithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18976035 |
| D009020 | Morphine | Morphine results in decreased expression of BCL2 mRNA | decreases expression | 18976035 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of BCL2 protein | decreases expression | 11428642 9665388 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of BCL2 protein | decreases expression | 9302645 |
| C040015 | myricetin | myricetin results in decreased expression of BCL2 protein | decreases expression | 15748703 |
| C040015 | myricetin | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15748703 |
| C514580 | N1-(2-aminophenyl)-N8-phenyloctanediamide | N1-(2-aminophenyl)-N8-phenyloctanediamide results in increased expression of BCL2 protein | increases expression | 17341627 |
| C482378 | N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate | N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate results in decreased expression of BCL2 protein | decreases expression | 16749867 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of BCL2 protein | decreases expression | 16025880 |
| C035605 | nabumetone | nabumetone results in decreased expression of BCL2 protein | decreases expression | 16019514 |
| C064769 | N-acetylsphingosine | BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 16215670 |
| C064769 | N-acetylsphingosine | BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein] | decreases reaction|increases activity|increases cleavage | 16215670 |
| C064769 | N-acetylsphingosine | BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein] | decreases reaction|increases degradation | 16215670 |
| D009270 | Naloxone | Naloxone results in increased expression of BCL2 protein | increases expression | 16004788 |
| D019810 | Sodium Azide | Sodium Azide inhibits the reaction [Minocycline results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15004018 |
| C031721 | naphthalene | naphthalene results in increased expression of BCL2 protein | increases expression | 14595851 |
| D009281 | Naphthalenes | Naphthalenes results in decreased expression of BCL2 protein | decreases expression | 17224139 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA | increases expression | 12883083 |
| C487679 | neuroprotectin D1 | neuroprotectin D1 results in increased expression of BCL2 protein | increases expression | 16077186 |
| C026385 | n-hexane | n-hexane metabolite results in increased expression of BCL2 protein | increases expression | 17492505 |
| D009534 | Niclosamide | Niclosamide inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 20215516 |
| D009543 | Nifedipine | Nifedipine results in increased expression of and affects the localization of BCL2 protein | affects localization|increases expression | 10695937 |
| D009543 | Nifedipine | Nifedipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19698708 |
| D009568 | Nitrendipine | Nitrendipine promotes the reaction [Gentamicins results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 19698708 |
| D009569 | Nitric Oxide | Nitric Oxide results in decreased expression of BCL2 protein | decreases expression | 15126337 |
| D009569 | Nitric Oxide | [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| D009569 | Nitric Oxide | Nitric Oxide affects the expression of BCL2 mRNA | affects expression | 17135264 |
| D009569 | Nitric Oxide | [Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| D009569 | Nitric Oxide | Nitric Oxide results in increased phosphorylation of and results in decreased activity of BCL2 protein | decreases activity|increases phosphorylation | 16039061 |
| D009589 | Nitrogen Oxides | [Benzo(a)pyrene co-treated with Nitrogen Oxides] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 16041517 |
| D005996 | Nitroglycerin | Nitroglycerin results in decreased expression of BCL2 protein | decreases expression | 17678976 |
| D009599 | Nitroprusside | Nitroprusside results in decreased expression of BCL2 protein | decreases expression | 15708893 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 mRNA | decreases expression | 17135264 |
| C081306 | N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide | N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide results in decreased expression of BCL2 protein | decreases expression | 15519653 |
| C008655 | N'-nitrosonornicotine | Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16835749 |
| C008655 | N'-nitrosonornicotine | N'-nitrosonornicotine results in increased expression of BCL2 mRNA | increases expression | 16835749 16582591 |
| D016912 | Levonorgestrel | Levonorgestrel results in decreased expression of BCL2 protein | decreases expression | 16019350 |
| C107010 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 12540782 |
| C408162 | oblimersen | [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15867202 |
| C408162 | oblimersen | [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15867202 |
| C408162 | oblimersen | oblimersen results in decreased expression of BCL2 protein | decreases expression | 11095261 |
| C076029 | olanzapine | olanzapine results in increased expression of BCL2 mRNA | increases expression | 15126120 |
| C076029 | olanzapine | olanzapine results in increased expression of BCL2 protein | increases expression | 15126120 |
| C042763 | olive oil | [olive oil co-treated with Sulindac] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15309441 |
| C042763 | olive oil | olive oil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15309441 |
| C042763 | olive oil | olive oil results in decreased expression of BCL2 protein | decreases expression | 15309441 |
| C016340 | o,p'-DDT | fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of BCL2 protein] | decreases reaction|increases expression | 10545406 |
| C016340 | o,p'-DDT | o,p'-DDT results in increased expression of BCL2 protein | increases expression | 10545406 |
| C011959 | oridonin | oridonin results in decreased expression of BCL2 protein | decreases expression | 16019488 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of BCL2 protein | decreases expression | 16024531 |
| C015407 | oxalomalic acid | oxalomalic acid results in decreased expression of BCL2 protein | decreases expression | 16785314 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of BCL2 mRNA | decreases expression | 11042672 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of BCL2 protein | decreases expression | 11042672 |
| D010100 | Oxygen | Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 11042672 |
| D010100 | Oxygen | Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 11042672 |
| D017239 | Paclitaxel | BCL2 mRNA results in decreased susceptibility to Paclitaxel | decreases response to substance | 16322897 |
| D017239 | Paclitaxel | BCL2 protein results in decreased susceptibility to Paclitaxel | decreases response to substance | 16275990 |
| D017239 | Paclitaxel | Curcumin inhibits the reaction [Paclitaxel results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16243823 |
| D017239 | Paclitaxel | Cyclosporine promotes the reaction [Paclitaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein] | decreases activity|increases phosphorylation|increases reaction | 12086014 |
| D017239 | Paclitaxel | Doxorubicin promotes the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein] | increases phosphorylation|increases reaction | 16168113 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of and affects the phosphorylation of BCL2 protein | affects phosphorylation|decreases expression | 10822281 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of BCL2 mRNA | decreases expression | 10822281 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of BCL2 protein | decreases expression | 10822281 |
| D017239 | Paclitaxel | Paclitaxel results in increased cleavage of BCL2 protein | increases cleavage | 10822281 |
| D017239 | Paclitaxel | Paclitaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein | decreases activity|increases phosphorylation | 12086014 |
| D017239 | Paclitaxel | Paclitaxel results in increased phosphorylation of BCL2 protein | increases phosphorylation | 16168113 |
| D017239 | Paclitaxel | [pifithrin co-treated with Paclitaxel] results in increased phosphorylation of BCL2 protein | affects cotreatment|increases phosphorylation | 18516295 |
| D019308 | Palmitic Acid | Palmitic Acid results in decreased expression of BCL2 | decreases expression | 15945276 |
| D019308 | Palmitic Acid | Palmitic Acid results in decreased expression of BCL2 | decreases expression | 15945276 |
| C019248 | pamidronate | pamidronate results in decreased expression of BCL2 protein | decreases expression | 10780527 |
| C482884 | panduratin A | panduratin A results in decreased expression of BCL2 protein | decreases expression | 16497706 |
| D010269 | Paraquat | GPX1 protein affects the reaction [Paraquat affects the expression of BCL2 mRNA] | affects expression|affects reaction | 12654481 |
| D010269 | Paraquat | Docosahexaenoic Acids inhibits the reaction [Paraquat results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12714668 |
| D010269 | Paraquat | Paraquat results in decreased expression of BCL2 protein | decreases expression | 12714668 |
| C002669 | parthenolide | [parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein | decreases activity|decreases expression | 20154269 |
| C002669 | parthenolide | [[parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Tamoxifen | decreases activity|decreases expression|increases response to substance | 20154269 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of BCL2 protein | increases expression | 20850422 |
| C408604 | PD 169316 | PD 169316 results in increased expression of BCL2 mRNA | increases expression | 14685156 |
| C093973 | PD 98059 | PD 98059 results in decreased phosphorylation of BCL2 protein | decreases phosphorylation | 17097560 |
| C093973 | PD 98059 | [PD 98059 results in decreased phosphorylation of BCL2 protein] which results in increased susceptibility to ABT-737 | decreases phosphorylation|increases response to substance | 17097560 |
| D010424 | Pentobarbital | Pentobarbital results in increased expression of BCL2 | increases expression | 17715682 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [dehydroepiandrosterone-bovine serum albumin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16407456 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased expression of BCL2 protein | decreases expression | 16054126 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of BCL2 protein | increases expression | 10426811 |
| D010656 | Phenylephrine | BCL2 protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein] | affects reaction|increases expression | 19910689 |
| D010656 | Phenylephrine | Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 11042672 |
| D010656 | Phenylephrine | Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 11042672 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of BCL2 mRNA | increases expression | 19910689 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of BCL2 protein | increases expression | 19910689 |
| D010656 | Phenylephrine | PTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 mRNA] | affects reaction|increases expression | 19910689 |
| D010656 | Phenylephrine | PTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 protein] | affects reaction|increases expression | 19910689 |
| D010672 | Phenytoin | Phenytoin results in increased expression of and affects the localization of BCL2 protein | affects localization|increases expression | 10695937 |
| D010672 | Phenytoin | Phenytoin results in decreased expression of BCL2 mRNA | decreases expression | 9118846 |
| C107448 | phthalocyanine Pc 4 | phthalocyanine Pc 4 results in decreased expression of BCL2 protein | decreases expression | 16007152 |
| C121565 | pifithrin | [pifithrin co-treated with Paclitaxel] results in increased phosphorylation of BCL2 protein | affects cotreatment|increases phosphorylation | 18516295 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 15547111 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15547111 |
| C121565 | pifithrin | pifithrin inhibits the reaction [arsenic trioxide results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 17487067 |
| C004479 | pimagedine | [pimagedine results in decreased activity of NOS2 protein] which results in decreased expression of BCL2 mRNA | decreases activity|decreases expression | 17135264 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of BCL2 protein | increases expression | 10426811 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of BCL2 protein | affects expression | 16912651 |
| C006253 | pirinixic acid | lactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] | decreases reaction|increases degradation|increases expression | 19361538 |
| C006253 | pirinixic acid | [[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide | decreases expression|increases expression|increases response to substance | 19361538 |
| C006253 | pirinixic acid | [[pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide] which results in decreased expression of BCL2 protein | decreases expression|increases abundance|increases expression | 19361538 |
| C006253 | pirinixic acid | [pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein | increases degradation|increases expression | 19361538 |
| C006253 | pirinixic acid | Potassium Cyanide promotes the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] | increases degradation|increases expression|increases reaction | 19361538 |
| C037850 | PK 11195 | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor] | decreases reaction|decreases response to substance | 12730627 |
| C037850 | PK 11195 | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A] | decreases reaction|decreases response to substance | 12730627 |
| C037850 | PK 11195 | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to mesoxalonitrile] | decreases reaction|decreases response to substance | 12730627 |
| C037850 | PK 11195 | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to pyridaben] | decreases reaction|decreases response to substance | 12730627 |
| C037850 | PK 11195 | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Rotenone] | decreases reaction|decreases response to substance | 12730627 |
| C037850 | PK 11195 | PK 11195 results in decreased expression of BCL2 protein | decreases expression | 15519653 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of BCL2 mRNA | increases expression | 16962711 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of BCL2 protein | increases expression | 16962711 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of BCL2 protein | decreases expression | 20869020 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of BCL2 protein | affects expression | 18097624 |
| D010938 | Plant Oils | Plant Oils results in decreased expression of BCL2 protein | decreases expression | 15961301 |
| C422648 | pluronic block copolymer p85 | pluronic block copolymer p85 inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 15939500 |
| C017645 | polyaspartate | [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18567086 |
| D011190 | Potassium Cyanide | BCL2 protein results in decreased susceptibility to Potassium Cyanide | decreases response to substance | 19361538 |
| D011190 | Potassium Cyanide | [[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide | decreases expression|increases expression|increases response to substance | 19361538 |
| D011190 | Potassium Cyanide | Potassium Cyanide promotes the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein] | increases degradation|increases expression|increases reaction | 19361538 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 15322087 |
| D044945 | Proanthocyanidins | Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 18611398 |
| D044945 | Proanthocyanidins | Proanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18611398 |
| D011374 | Progesterone | [Progesterone co-treated with Estrogens, Conjugated (USP)] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 15779298 |
| D011374 | Progesterone | Progesterone results in increased expression of BCL2 mRNA | increases expression | 15941375 |
| D011374 | Progesterone | Progesterone results in increased expression of BCL2 protein | increases expression | 15941375 |
| D011374 | Progesterone | Progesterone results in increased expression of BCL2 | increases expression | 17510236 |
| D015742 | Propofol | Propofol results in increased expression of BCL2 protein | increases expression | 16004787 |
| C009091 | protocatechuic acid | protocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18082360 |
| C107773 | pterostilbene | [pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18852136 |
| C107773 | pterostilbene | RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein] | affects cotreatment|affects reaction|decreases expression | 18852136 |
| C033607 | puerarin | arsenic trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 20416161 |
| C033607 | puerarin | puerarin results in decreased expression of BCL2 mRNA | decreases expression | 20416161 |
| C033607 | puerarin | puerarin results in decreased expression of BCL2 protein | decreases expression | 16055262 |
| C033607 | puerarin | puerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16426832 |
| C526689 | punarnavine | punarnavine results in decreased expression of BCL2 mRNA | decreases expression | 20192578 |
| C428725 | pyridaben | BCL2 protein results in decreased susceptibility to pyridaben | decreases response to substance | 12730627 |
| C428725 | pyridaben | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to pyridaben] | decreases reaction|decreases response to substance | 12730627 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16139439 |
| C071362 | pyrrolidino-4-iodotamoxifen | pyrrolidino-4-iodotamoxifen inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 14659978 |
| D011794 | Quercetin | [pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 18852136 |
| D011794 | Quercetin | Quercetin affects the expression of BCL2 protein | affects expression | 15975156 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12672908 |
| D011794 | Quercetin | Quercetin metabolite results in decreased expression of BCL2 protein | decreases expression | 16280456 |
| D011794 | Quercetin | Quercetin results in decreased expression of BCL2 protein | decreases expression | 16049707 15741050 18787224 |
| D011794 | Quercetin | Quercetin results in increased phosphorylation of BCL2 protein | increases phosphorylation | 16059641 |
| D011794 | Quercetin | [Quercetin results in increased susceptibility to Cisplatin] which results in decreased expression of BCL2 protein | decreases expression|increases response to substance | 16619537 |
| D011794 | Quercetin | RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein] | affects cotreatment|affects reaction|decreases expression | 18852136 |
| D011794 | Quercetin | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Quercetin results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 17135264 |
| D011794 | Quercetin | Quercetin results in decreased expression of BCL2 protein | decreases expression | 17039455 |
| D011794 | Quercetin | [Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA] | decreases expression|decreases reaction|increases expression | 17135264 |
| D011794 | Quercetin | [Quercetin results in decreased phosphorylation of CREB1 protein] which results in decreased expression of BCL2 mRNA | decreases expression|decreases phosphorylation | 17135264 |
| D011794 | Quercetin | [1-Methyl-4-phenylpyridinium co-treated with Quercetin] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 19466539 |
| D020849 | Raloxifene | Raloxifene affects the expression of BCL2 protein | affects expression | 16009171 |
| D020849 | Raloxifene | Raloxifene results in decreased expression of BCL2 mRNA | decreases expression | 16566921 |
| D020849 | Raloxifene | Raloxifene results in decreased expression of BCL2 protein | decreases expression | 16566921 17220163 |
| D020849 | Raloxifene | Raloxifene results in increased expression of BCL2 protein | increases expression | 16973256 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]] | affects binding|decreases reaction|increases reaction | 19631782 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to DAXX protein]] | affects binding|decreases reaction|increases reaction | 19631782 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SP100 protein]] | affects binding|decreases reaction|increases reaction | 19631782 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SUMO1 protein]] | affects binding|decreases reaction|increases reaction | 19631782 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to TP53 protein]] | affects binding|decreases reaction|increases reaction | 19631782 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein] | decreases reaction|increases activity|increases cleavage | 19631782 |
| C059514 | resveratrol | BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 19631782 |
| C059514 | resveratrol | BCL2 protein results in decreased susceptibility to resveratrol | decreases response to substance | 19631782 |
| C059514 | resveratrol | [resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 17690738 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17603292 |
| C059514 | resveratrol | resveratrol results in decreased expression of BCL2 | decreases expression | 16209266 |
| C059514 | resveratrol | resveratrol results in decreased expression of BCL2 protein | decreases expression | 17636462 16731767 17164350 17049120 16490592 15688415 19631782 |
| C059514 | resveratrol | resveratrol results in increased expression of BCL2 mRNA | increases expression | 17261084 |
| C059514 | resveratrol | resveratrol results in increased expression of BCL2 protein | increases expression | 19549761 |
| C059514 | resveratrol | vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]] | decreases reaction|increases activity|increases cleavage | 19631782 |
| C059514 | resveratrol | vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage | 19631782 |
| C059514 | resveratrol | vorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to resveratrol] | decreases reaction|decreases response to substance | 19631782 |
| C059514 | resveratrol | resveratrol results in decreased expression of BCL2 mRNA | decreases expression | 15637762 |
| C059514 | resveratrol | resveratrol results in decreased expression of BCL2 protein | decreases expression | 15637762 |
| C059514 | resveratrol | [1-Methyl-4-phenylpyridinium co-treated with resveratrol] results in increased expression of BCL2 mRNA | affects cotreatment|increases expression | 19466539 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] | decreases reaction|increases expression | 19073162 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of BCL2 | decreases expression | 16909596 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of BCL2 protein | decreases expression | 16109544 |
| C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17461445 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of BCL2 protein | decreases expression | 17461445 |
| D012402 | Rotenone | BCL2 protein results in decreased susceptibility to Rotenone | decreases response to substance | 12730627 |
| D012402 | Rotenone | PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Rotenone] | decreases reaction|decreases response to substance | 12730627 |
| D012402 | Rotenone | Rotenone results in increased expression of BCL2 mRNA | increases expression | 16815102 |
| D012402 | Rotenone | Rotenone results in increased expression of BCL2 protein | increases expression | 16815102 |
| D012402 | Rotenone | protocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 18082360 |
| D012402 | Rotenone | Rotenone results in decreased expression of BCL2 protein | decreases expression | 18082360 |
| C086511 | RU 58668 | RU 58668 affects the expression of BCL2 protein | affects expression | 15868441 |
| D012431 | Rutin | Rutin affects the expression of BCL2 protein | affects expression | 15975156 |
| D012431 | Rutin | Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] | decreases expression|decreases reaction|increases degradation | 19557821 |
| C039961 | S-(1,2-dichlorovinyl)cysteine | S-(1,2-dichlorovinyl)cysteine results in increased expression of BCL2 protein | increases expression | 15967204 |
| C065299 | S-allylcysteine | S-allylcysteine results in decreased expression of BCL2 protein | decreases expression | 17155983 |
| C065299 | S-allylcysteine | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| C065299 | S-allylcysteine | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| C057823 | salmeterol | salmeterol results in decreased expression of BCL2 mRNA | decreases expression | 14687023 |
| C057823 | salmeterol | salmeterol results in decreased expression of BCL2 protein | decreases expression | 14687023 |
| C093642 | SB 203580 | SB 203580 promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 16818652 |
| C417521 | SB 216763 | SB 216763 results in increased expression of BCL2 mRNA | increases expression | 16288908 |
| D012601 | Scopolamine | Scopolamine results in decreased expression of BCL2 protein | decreases expression | 17120751 |
| C524947 | Scutellaria barbata extract | Scutellaria barbata extract results in decreased expression of BCL2 protein | decreases expression | 15369734 |
| C090142 | secoisolariciresinol diglucoside | secoisolariciresinol diglucoside results in decreased expression of BCL2 mRNA | decreases expression | 19904759 |
| D012642 | Selegiline | Selegiline inhibits the reaction [3-morpholino-sydnonimine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12880480 |
| D012643 | Selenium | Selenium results in decreased expression of BCL2 protein | decreases expression | 17523932 |
| C028432 | selenium oxide | selenium oxide results in decreased expression of BCL2 | decreases expression | 15485790 |
| C028432 | selenium oxide | selenium oxide results in decreased expression of BCL2 protein | decreases expression | 11342237 |
| C002979 | selenomethylselenocysteine | selenomethylselenocysteine results in decreased expression of BCL2 mRNA | decreases expression | 19360359 |
| C002979 | selenomethylselenocysteine | [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein | decreases expression|increases activity | 19360359 |
| C002979 | selenomethylselenocysteine | selenomethylselenocysteine results in decreased expression of BCL2 protein | decreases expression | 11396176 |
| D020280 | Sertraline | Sertraline affects the expression of BCL2 protein | affects expression | 18403212 |
| C516024 | SH-6 compound | SH-6 compound results in decreased expression of BCL2 protein | decreases expression | 17289836 |
| C040115 | shogaol | shogaol results in decreased expression of BCL2 protein | decreases expression | 18384088 |
| C101426 | sildenafil | sildenafil inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15811867 |
| C101426 | sildenafil | sildenafil results in increased expression of BCL2 | increases expression | 18373738 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 15571967 |
| C025473 | sitosterol | sitosterol results in decreased expression of BCL2 mRNA | decreases expression | 14612938 |
| C025473 | sitosterol | sitosterol results in decreased expression of BCL2 protein | decreases expression | 14612938 |
| C118258 | SN50 peptide | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18508827 |
| C118258 | SN50 peptide | SN50 peptide results in decreased expression of BCL2 protein | decreases expression | 12466137 |
| C118258 | SN50 peptide | SN50 peptide results in decreased expression of BCL2 mRNA | decreases expression | 10567332 |
| C017947 | sodium arsenite | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein] | affects cotreatment|decreases expression|decreases reaction | 19082730 |
| C017947 | sodium arsenite | monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 19615344 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 19082730 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of BCL2 mRNA | decreases expression | 20339138 19615344 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of BCL2 mRNA | increases expression | 16966277 12679051 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of BCL2 protein | increases expression | 20390378 |
| C017947 | sodium arsenite | chelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]] | decreases expression|decreases reaction | 12690470 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12690470 |
| D012965 | Sodium Chloride | lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| D012965 | Sodium Chloride | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein | affects cotreatment|increases expression | 16030430 |
| D012965 | Sodium Chloride | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| D012965 | Sodium Chloride | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 16030430 |
| D018038 | Sodium Selenite | Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 17989939 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of BCL2 mRNA | decreases expression | 16542727 17989939 19363675 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16039982 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of BCL2 protein | increases expression | 18209489 |
| D013024 | Soybean Oil | Soybean Oil results in increased expression of BCL2 protein | increases expression | 15309441 |
| D013311 | Streptozocin | arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 19682444 |
| D013311 | Streptozocin | Streptozocin results in increased expression of BCL2 protein | increases expression | 15976052 19682444 |
| D020058 | Styrene | Styrene results in increased expression of BCL2 protein | increases expression | 15212811 |
| C013690 | styrene oxide | styrene oxide affects the expression of BCL2 mRNA | affects expression | 11230554 |
| C013690 | styrene oxide | styrene oxide results in decreased expression of BCL2 protein | decreases expression | 12663515 |
| C016766 | sulforafan | sulforafan results in decreased expression of BCL2 protein | decreases expression | 16033772 |
| D013467 | Sulindac | Sulindac results in decreased expression of BCL2 protein | decreases expression | 15793875 |
| D013467 | Sulindac | Sulindac results in decreased expression of BCL2 protein | decreases expression | 10223192 |
| D013467 | Sulindac | [olive oil co-treated with Sulindac] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15309441 |
| C025462 | sulindac sulfide | sulindac sulfide results in decreased expression of BCL2 protein | decreases expression | 18678619 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of BCL2 protein | increases expression | 16021636 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of BCL2 protein | increases expression | 16021636 |
| D013629 | Tamoxifen | ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] | decreases reaction|increases expression | 20305694 |
| D013629 | Tamoxifen | [[parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Tamoxifen | decreases activity|decreases expression|increases response to substance | 20154269 |
| D013629 | Tamoxifen | RELA protein inhibits the reaction [Tamoxifen results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 20154269 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16051634 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein] | decreases reaction|increases expression | 20305694 |
| D013629 | Tamoxifen | Tamoxifen promotes the reaction [BCAR1 protein mutant form results in decreased expression of BCL2 protein] | decreases expression|increases reaction | 19330798 |
| D013629 | Tamoxifen | Tamoxifen promotes the reaction [Doxorubicin results in increased expression of BCL2 mRNA] | increases expression|increases reaction | 19757172 |
| D013629 | Tamoxifen | Tamoxifen promotes the reaction [Mitomycin results in increased expression of BCL2 mRNA] | increases expression|increases reaction | 19757172 |
| D013629 | Tamoxifen | Tamoxifen promotes the reaction [Vindesine results in increased expression of BCL2 mRNA] | increases expression|increases reaction | 19757172 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of BCL2 mRNA | decreases expression | 20549698 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of BCL2 protein | decreases expression | 20154269 |
| D013629 | Tamoxifen | TP53 protein promotes the reaction [Tamoxifen results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 20549698 |
| D013629 | Tamoxifen | YC137 inhibits the reaction [ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]] | decreases reaction|increases expression | 20305694 |
| C021751 | tanshinone | tanshinone results in decreased expression of BCL2 protein | decreases expression | 20369472 16009009 19885617 |
| C031655 | tauroursodeoxycholic acid | tauroursodeoxycholic acid results in increased expression of BCL2 protein | increases expression | 15255934 |
| C086827 | tazarotene | tazarotene results in decreased expression of BCL2 protein | decreases expression | 16109552 16196285 |
| D013662 | Tea | Tea inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16480889 |
| D016593 | Terfenadine | Terfenadine analog results in decreased expression of BCL2 protein | decreases expression | 19289568 |
| D013739 | Testosterone | gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18030663 |
| D013739 | Testosterone | pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 16139439 |
| D013739 | Testosterone | Testosterone results in increased expression of BCL2 protein | increases expression | 18030663 |
| D013739 | Testosterone | gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18030663 |
| D013739 | Testosterone | Testosterone results in increased expression of BCL2 protein | increases expression | 18030663 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of BCL2 mRNA | increases expression | 20044593 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA | decreases expression | 20044593 19933214 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA | decreases expression | 15965093 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of BCL2 protein | decreases expression | 15965093 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of BCL2 mRNA | increases expression | 15965093 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of BCL2 protein | increases expression | 15965093 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene affects the expression of BCL2 protein | affects expression | 16010555 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in decreased expression of BCL2 protein | decreases expression | 12160929 |
| C117155 | tetracycline CMT-3 | tetracycline CMT-3 results in decreased expression of BCL2 protein | decreases expression | 16039551 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15748703 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19631781 |
| D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA | affects cotreatment|affects expression | 16979875 |
| D013755 | Tetradecanoylphorbol Acetate | 2-methoxyacetaldehyde promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] | increases expression|increases reaction | 10221278 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein | increases expression | 10221278 |
| C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex affects the expression of BCL2 protein | affects expression | 16002045 |
| C009438 | tetrandrine | BCL2 protein affects the susceptibility to tetrandrine | affects response to substance | 18495333 |
| C009438 | tetrandrine | tetrandrine results in decreased expression of BCL2 mRNA | decreases expression | 18495333 |
| D013792 | Thalidomide | [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 15867202 |
| D013792 | Thalidomide | [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 15867202 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of BCL2 protein | decreases expression | 15982930 |
| C026995 | thallium acetate | thallium acetate results in decreased expression of BCL2 protein | decreases expression | 15965099 |
| C056068 | theaflavin | theaflavin results in decreased expression of BCL2 protein | decreases expression | 17499812 |
| C056068 | theaflavin | theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] | decreases reaction|increases expression | 18973830 |
| D013806 | Theophylline | Theophylline results in decreased expression of BCL2 protein | decreases expression | 10877050 |
| D008063 | Thioctic Acid | BCL2 protein results in decreased susceptibility to Thioctic Acid | decreases response to substance | 16990509 |
| D008063 | Thioctic Acid | Thioctic Acid results in increased degradation of and results in decreased expression of BCL2 protein | decreases expression|increases degradation | 16990509 |
| D013852 | Thiotepa | Thiotepa results in decreased expression of BCL2 protein | decreases expression | 10822281 |
| D013852 | Thiotepa | Thiotepa results in increased cleavage of BCL2 protein | increases cleavage | 10822281 |
| D013852 | Thiotepa | Thiotepa results in increased expression of BCL2 protein | increases expression | 10822281 |
| D013893 | Thiram | Thiram results in decreased expression of BCL2 mRNA | decreases expression | 17954590 |
| D024505 | Tocopherols | BCL2 protein results in decreased susceptibility to Tocopherols | decreases response to substance | 16001965 |
| D024505 | Tocopherols | Tocopherols results in increased expression of BCL2 mRNA | increases expression | 8970189 |
| D024505 | Tocopherols | Tocopherols results in increased expression of BCL2 protein | increases expression | 8970189 |
| C496197 | trans-10,cis-12-conjugated linoleic acid | trans-10,cis-12-conjugated linoleic acid results in decreased expression of BCL2 mRNA | decreases expression | 15888570 |
| D014212 | Tretinoin | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 20349282 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of BCL2 | decreases expression | 16909596 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of BCL2 mRNA | decreases expression | 12644474 15770638 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of BCL2 protein | decreases expression | 17077328 16778211 16109544 15770638 16109552 12644474 16242776 16517207 16196285 16572199 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of BCL2 protein | decreases expression | 16712891 |
| D014236 | Trichlorfon | Tetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19631781 |
| D014236 | Trichlorfon | Trichlorfon results in decreased expression of BCL2 protein | decreases expression | 19631781 |
| D014241 | Trichloroethylene | Trichloroethylene results in decreased expression of BCL2 protein | decreases expression | 12160929 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased activity of BCL2 protein | increases activity | 12160929 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of BCL2 protein | decreases expression | 16010430 |
| D014266 | Trientine | Trientine results in decreased expression of BCL2 protein | decreases expression | 11369509 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of BCL2 mRNA | decreases expression | 17127020 |
| D014415 | Tunicamycin | Tunicamycin results in increased expression of BCL2 mRNA | increases expression | 17127020 |
| C113580 | U 0126 | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein] | decreases reaction|increases expression | 18508827 |
| C005460 | uranyl acetate | uranyl acetate inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 12690470 |
| C005460 | uranyl acetate | uranyl acetate results in increased expression of BCL2 protein | increases expression | 12690470 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 11091364 |
| D014520 | Urethane | Urethane results in decreased expression of BCL2 mRNA | decreases expression | 11091364 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in decreased expression of BCL2 protein | decreases expression | 15970352 |
| C005466 | ursolic acid | ursolic acid results in decreased expression of BCL2 protein | decreases expression | 16012738 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of BCL2 mRNA | increases expression | 19101580 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of BCL2 protein | affects expression | 15379904 |
| D014635 | Valproic Acid | Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19149911 |
| D014751 | Vindesine | Tamoxifen promotes the reaction [Vindesine results in increased expression of BCL2 mRNA] | increases expression|increases reaction | 19757172 |
| D014751 | Vindesine | Vindesine results in increased expression of BCL2 mRNA | increases expression | 19757172 |
| D014801 | Vitamin A | Vitamin A results in decreased expression of BCL2 protein | decreases expression | 16216918 |
| D014810 | Vitamin E | Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 15566391 |
| D014810 | Vitamin E | [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein | affects cotreatment|affects expression | 16933212 |
| D024483 | Vitamin K 3 | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein] | affects cotreatment|decreases expression|decreases reaction | 19082730 |
| D024483 | Vitamin K 3 | [sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 19082730 |
| D024483 | Vitamin K 3 | Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 19265712 |
| D024483 | Vitamin K 3 | Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 19265712 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in decreased expression of BCL2 mRNA | decreases expression | 19265712 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in decreased expression of BCL2 protein | decreases expression | 19265712 |
| C111237 | vorinostat | BCL2 protein results in decreased susceptibility to vorinostat | decreases response to substance | 15897598 |
| C111237 | vorinostat | vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]] | decreases reaction|increases activity|increases cleavage | 19631782 |
| C111237 | vorinostat | vorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]] | decreases reaction|increases cleavage | 19631782 |
| C111237 | vorinostat | vorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to resveratrol] | decreases reaction|decreases response to substance | 19631782 |
| C111237 | vorinostat | vorinostat results in decreased expression of BCL2 protein | decreases expression | 16144943 15897598 19631782 |
| C528002 | Weichang'an | Weichang'an results in decreased expression of BCL2 mRNA | decreases expression | 18205257 17498489 18161298 |
| C528002 | Weichang'an | Weichang'an results in decreased expression of BCL2 protein | decreases expression | 18205257 18161298 |
| D054358 | Withanolides | Withanolides inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein] | decreases reaction|increases expression | 17520333 |
| C104536 | xanthohumol | xanthohumol results in decreased expression of BCL2 protein | decreases expression | 15995977 |
| D014978 | Xenon | Xenon results in increased expression of BCL2 protein | increases expression | 16034370 |
| C493272 | YC137 | YC137 inhibits the reaction [ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]] | decreases reaction|increases expression | 20305694 |
| C493272 | YC137 | YC137 inhibits the reaction [ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]] | decreases reaction|increases expression | 20305694 |
| C493272 | YC137 | YC137 results in decreased activity of BCL2 protein | decreases activity | 20305694 |
| D015018 | Ytterbium | Ytterbium analog results in decreased expression of BCL2 protein | decreases expression | 19632212 |
| D015029 | Zeranol | Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 16757814 |
| C403304 | zerumbone | zerumbone results in decreased expression of BCL2 mRNA | decreases expression | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 20452335 |
| D015215 | Zidovudine | BCL2 protein affects the susceptibility to Zidovudine | affects response to substance | 9850737 |
| D015215 | Zidovudine | Drugs, Chinese Herbal promotes the reaction [Zidovudine results in decreased expression of BCL2 mRNA] | decreases expression|increases reaction | 17696246 |
| D015215 | Zidovudine | Zidovudine results in decreased expression of BCL2 mRNA | decreases expression | 17696246 |
| D015215 | Zidovudine | Zidovudine results in increased expression of BCL2 mRNA | increases expression | 9850737 |
| D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA | affects cotreatment|decreases expression | 18313992 |
| D015032 | Zinc | Zinc affects the expression of BCL2 mRNA | affects expression | 16979875 |
| D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA | affects cotreatment|affects expression | 16979875 |
| D015032 | Zinc | Zinc results in decreased expression of BCL2 protein | decreases expression | 16472982 |
| D015032 | Zinc | [Zinc results in increased localization of [IKBKB protein binds to NFKBIA protein]] which results in increased expression of BCL2 protein | affects binding|increases expression|increases localization | 17029595 |
| D015032 | Zinc | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| D015032 | Zinc | Metipranolol inhibits the reaction [Zinc results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| D015032 | Zinc | Zinc results in increased expression of BCL2 protein | increases expression | 16799065 |
| C016837 | zinc chloride | [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 16624386 |
| D019287 | Zinc Sulfate | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| D019287 | Zinc Sulfate | Metipranolol inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein] | decreases reaction|increases expression | 16799065 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased expression of BCL2 protein | increases expression | 16799065 |
| C088658 | zoledronic acid | BCL2 protein results in decreased susceptibility to zoledronic acid | decreases response to substance | 11986784 |
| C088658 | zoledronic acid | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 20349282 |
| C088658 | zoledronic acid | zoledronic acid affects the expression of BCL2 mRNA | affects expression | 19036117 |
| C088658 | zoledronic acid | [zoledronic acid co-treated with docetaxel] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 19103299 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of BCL2 mRNA | increases expression | 18225567 |
| C088658 | zoledronic acid | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein | affects cotreatment|decreases expression | 19789217 |
| D015054 | Zymosan | TNFRSF1A gene mutant form inhibits the reaction [Zymosan results in decreased expression of BCL2 protein] | decreases expression|decreases reaction | 17724436 |
| D015054 | Zymosan | Zymosan results in decreased expression of BCL2 protein | decreases expression | 17724436 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 7.76 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 7.76 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 31.43 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Carbamazepine | 31.43 | 8986270 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Diethylhexyl Phthalate | 31.43 | 6734493 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 31.43 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 31.43 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | mancozeb | 31.43 | 982313 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 31.43 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 31.43 | 9677735 3425630 6195326 10563481 9118846 8986270 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 31.43 | 11752688 15322242 14514962 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 31.43 | 8333272 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 31.43 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 8.78 | 18769834 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 8.78 | 19490988 | |
| MESH:D000015 | Abnormalities, Multiple | Vitamin A | 8.78 | 10992263 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.71 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 8.92 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 8.92 | 11192467 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 8.92 | 7265320 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 4.68 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 6.75 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 6.75 | 16185265 18769834 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 3.29 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 3.94 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 3.83 | 17202136 17190629 16889938 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 22.11 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 22.11 | 12690470 17670903 15814532 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 22.11 | 16316344 16595132 17003819 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 22.11 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 22.11 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 22.11 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 22.11 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 22.11 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 7.06 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | Particulate Matter | 7.06 | 12396868 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 7.06 | 18653653 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 3.91 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | marker/mechanism | 21472143 | ||
| MESH:D000230 | Adenocarcinoma | 1,2-Dimethylhydrazine | 33.48 | 1933837 1113308 | |
| MESH:D000230 | Adenocarcinoma | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 33.48 | 15831436 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 33.48 | 11798837 19825857 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 33.48 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 33.48 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 33.48 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 33.48 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | dracorhodin | 33.48 | 15215653 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 33.48 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 33.48 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 33.48 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 33.48 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 33.48 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 33.48 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 33.48 | 15688392 15113128 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 33.48 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 33.48 | 18316556 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.12 | 15814487 | |
| MESH:D000236 | Adenoma | marker/mechanism | 10223192 10426811 | ||
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 26.23 | 10737359 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 26.23 | 16176798 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 26.23 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 26.23 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 26.23 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 26.23 | 19555203 | |
| MESH:D000236 | Adenoma | Folic Acid | 26.23 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 26.23 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 26.23 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 26.23 | 10223192 | |
| MESH:D000236 | Adenoma | Urethane | 26.23 | 6695378 10530776 10822126 17195641 11497255 17093202 16926031 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.41 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | 2-aminofluorene | 16.55 | 19052882 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 16.55 | 17162532 19061943 17620307 19052882 18056438 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 16.55 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 16.55 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 16.55 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | dibenzoylmethane | 8.37 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 8.37 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 8.37 | 17611924 19003578 15623613 12394442 11874996 16460482 11535846 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.11 | 15276417 | |
| MESH:D000309 | Adrenal Insufficiency | Dehydroepiandrosterone | 4.21 | 17302879 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 8.52 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 8.52 | 17306315 16712894 | |
| MESH:D000380 | Agranulocytosis | Clozapine | 3.51 | 12649775 14617031 16160616 | |
| MESH:D000382 | Agricultural Workers' Diseases | alachlor | 10.85 | 11874814 14769641 | |
| MESH:D000382 | Agricultural Workers' Diseases | Heptachlor | 10.85 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Lindane | 10.85 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | mancozeb | 10.85 | 8807224 16132792 15864902 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 10.85 | 11874814 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 6.43 | 21441931 | |
| MESH:D000419 | Albuminuria | Raloxifene | 6.43 | 17451421 17308373 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.72 | 15451039 15451040 | |
| MESH:D000437 | Alcoholism | Mecamylamine | 4.32 | 20201817 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 8.35 | 17887948 | |
| MESH:D019973 | Alcohol-Related Disorders | puerarin | 8.35 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | Etodolac | 6.51 | 16979129 | |
| OMIM:607154 | ALLERGIC RHINITIS | Terfenadine | 6.51 | 16037679 | |
| MESH:D000505 | Alopecia | Capsaicin | 7.85 | 17569567 | |
| MESH:D000505 | Alopecia | Isoflavones | 7.85 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 7.85 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.07 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 3.78 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | marker/mechanism | 18077176 | ||
| MESH:D000544 | Alzheimer Disease | Copper | 30.94 | 16886094 16325427 16962711 17119284 16866297 16410023 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 30.94 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 30.94 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | Goserelin | 30.94 | 16050439 | |
| MESH:D000544 | Alzheimer Disease | huperzine A | 30.94 | 12586202 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 30.94 | 17627676 15579461 | |
| MESH:D000544 | Alzheimer Disease | Iron | 30.94 | 16563566 16640825 | |
| MESH:D000544 | Alzheimer Disease | Lithium | 30.94 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 30.94 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Particulate Matter | 30.94 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 30.94 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 30.94 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 30.94 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | rosiglitazone | 30.94 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 30.94 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Trichlorfon | 30.94 | 11419566 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 30.94 | 16410023 16580781 17119284 16325427 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 3.63 | 17688650 | |
| MESH:D000647 | Amnesia | Scopolamine | 5.29 | 16946593 | |
| MESH:D019969 | Amphetamine-Related Disorders | Amphetamine | 4.48 | 16916582 15010207 18475255 16459022 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 2.97 | 15469931 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 4.60 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 4.60 | 16510725 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 20.13 | 17963324 15504547 | |
| MESH:D000740 | Anemia | ferric-sorbitol-citrate | 20.13 | 17257079 | |
| MESH:D000740 | Anemia | Fluorouracil | 20.13 | 17963324 15504547 16511603 | |
| MESH:D000740 | Anemia | Iron | 20.13 | 16434484 16566752 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 20.13 | 11748828 | |
| MESH:D000740 | Anemia | Vitamin A | 20.13 | 16960172 | |
| MESH:D000740 | Anemia | Zymosan | 20.13 | 18664788 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.02 | 14761424 17661222 11369114 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 2.79 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 8.61 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 8.61 | 17163184 16569441 17375513 17147795 17162259 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Vitamin A | 8.61 | 16960172 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.38 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 3.36 | 16910769 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 3.84 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 11.43 | 10982225 | |
| MESH:D000799 | Angioedema | Astemizole | 11.43 | 2883202 | |
| MESH:D000799 | Angioedema | salmeterol | 11.43 | 10982225 | |
| MESH:D000853 | Anophthalmos | Benomyl | 7.31 | 15907663 | |
| MESH:D000853 | Anophthalmos | Ethanol | 7.31 | 15513904 | |
| MESH:D000855 | Anorexia | Amphetamine | 3.60 | 12183048 16084549 16101753 12005258 | |
| MESH:D000860 | Anoxia | Oxygen | 6.36 | 20872349 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 6.36 | 7265320 | |
| MESH:D000881 | Anthrax | Ciprofloxacin | 5.11 | 20385868 | |
| MESH:D016736 | Antiphospholipid Syndrome | Ciprofloxacin | 5.11 | 9485080 | |
| MESH:D000987 | Antisocial Personality Disorder | Testosterone | 4.26 | 7506515 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.37 | 15043669 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 13.42 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Fluoxetine | 13.42 | 18083778 | |
| MESH:D001008 | Anxiety Disorders | Pentobarbital | 13.42 | 18313124 11141031 | |
| MESH:D001008 | Anxiety Disorders | Sertraline | 13.42 | 18822694 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 13.42 | 17497229 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.33 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 6.60 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 6.60 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 4.66 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 4.66 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.22 | 12569548 16835338 16251483 18414634 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 5.12 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 5.12 | 11256880 | |
| MESH:D018771 | Arthralgia | Amlodipine | 8.53 | 9825082 | |
| MESH:D018771 | Arthralgia | Indomethacin | 8.53 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 16.26 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 16.26 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 16.26 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 16.26 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 16.26 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 16.26 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 16.26 | 16872482 17659584 15944321 15188379 15142272 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.17 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 4.48 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 4.48 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Minocycline | 4.48 | 14528503 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 4.48 | 16292516 | |
| MESH:D053627 | Asthenozoospermia | 2,5-hexanedione | 5.19 | 10689203 | |
| MESH:D001249 | Asthma | marker/mechanism | 18357729 | ||
| MESH:D001249 | Asthma | Acetaldehyde | 13.99 | 9600491 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 13.99 | 16516891 | |
| MESH:D001249 | Asthma | formoterol | 13.99 | 12113382 10967152 | |
| MESH:D001249 | Asthma | Mustard Gas | 13.99 | 10378619 | |
| MESH:D001249 | Asthma | salmeterol | 13.99 | 11694805 10359889 | |
| MESH:D001249 | Asthma | Theophylline | 13.99 | 12113382 9701106 | |
| MESH:D001249 | Asthma | Tretinoin | 13.99 | 16456186 | |
| MESH:D001249 | Asthma | Vitamin A | 13.99 | 16732791 | |
| MESH:D001249 | Asthma | Zinc | 13.99 | 17085522 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 3.32 | 12372130 20485159 | |
| MESH:D001250 | Asthma, Exercise-Induced | salmeterol | 4.56 | 10984370 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 7.91 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 7.91 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 18.71 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Cholesterol | 18.71 | 16632123 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 18.71 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 18.71 | 16640825 16632123 | |
| MESH:D050197 | Atherosclerosis | olive oil | 18.71 | 16216721 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 18.71 | 16391483 | |
| MESH:D050197 | Atherosclerosis | Phenytoin | 18.71 | 15136057 | |
| MESH:D050197 | Atherosclerosis | Plant Oils | 18.71 | 16216721 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 18.71 | 16873680 17967414 | |
| MESH:D001284 | Atrophy | fulvestrant | 3.35 | 11514358 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Oxidopamine | 3.45 | 14699433 | |
| MESH:D001321 | Autistic Disorder | marker/mechanism | 11814262 20375269 | ||
| MESH:D001321 | Autistic Disorder | Acetaminophen | 5.65 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Dehydroepiandrosterone Sulfate | 5.65 | 15820420 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 5.65 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Fluoxetine | 5.65 | 18775368 19232924 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 5.65 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 5.65 | 16917939 19056591 19267885 18929414 | |
| MESH:D001321 | Autistic Disorder | Homocysteine | 5.65 | 20468076 16297937 | |
| MESH:D001321 | Autistic Disorder | Iron | 5.65 | 17352947 | |
| MESH:D001321 | Autistic Disorder | olanzapine | 5.65 | 18685284 17069543 | |
| MESH:D001321 | Autistic Disorder | Sertraline | 5.65 | 18775368 | |
| MESH:D001321 | Autistic Disorder | Sirolimus | 5.65 | 21115397 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 5.65 | 19232924 17157402 19460635 18985861 15238991 18558336 20603192 17688650 18177632 18316065 18396377 17507914 18940202 18775368 16609825 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 13.41 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 13.41 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 13.41 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 13.41 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Ciprofloxacin | 7.37 | 11505790 | |
| MESH:D001424 | Bacterial Infections | Iron | 7.37 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 2.88 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.44 | 10684365 | |
| MESH:D001714 | Bipolar Disorder | Carbamazepine | 5.75 | 17594078 20046352 | |
| MESH:D001714 | Bipolar Disorder | Lithium | 5.75 | 19153942 20338123 20046352 17594078 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 5.75 | 17594078 20046352 | |
| MESH:D001768 | Blister | Mustard Gas | 3.58 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 10.15 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 10.15 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 10.15 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 10.15 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.21 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 3.91 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 3.91 | 8888407 | |
| MESH:D001851 | Bone Diseases, Metabolic | Ginkgo biloba extract 761 | 4.77 | 19356626 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.64 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 11.29 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 11.29 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 11.29 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 5.91 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 5.91 | 16121404 19442620 11697798 15867366 16778634 17312309 | |
| MESH:D001862 | Bone Resorption | Berberine | 14.43 | 9881647 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 14.43 | 11985600 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 14.43 | 9881647 | |
| MESH:D001862 | Bone Resorption | pamidronate | 14.43 | 15845617 8053405 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 14.43 | 16769263 15845617 8053405 11869084 18496637 18404659 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 3.77 | 11207687 | |
| MESH:D001919 | Bradycardia | Capsaicin | 8.90 | 18207255 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 8.90 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 8.90 | 15306635 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.44 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.74 | 17868700 | |
| MESH:D001930 | Brain Injuries | Nitroprusside | 13.94 | 14637104 | |
| MESH:D001930 | Brain Injuries | Progesterone | 13.94 | 15845082 15665606 15380490 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 13.94 | 16580743 | |
| MESH:D001930 | Brain Injuries | Zinc | 13.94 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 24.33 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 24.33 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 24.33 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Morphine | 24.33 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 24.33 | 16041641 | |
| MESH:D002545 | Brain Ischemia | puerarin | 24.33 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 24.33 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Acrylonitrile | 19.40 | 12562636 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 19.40 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Carmustine | 19.40 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | Copper | 19.40 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 19.40 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 19.40 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 19.40 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 16954440 12517783 | ||
| MESH:D001943 | Breast Neoplasms | 2-methoxyestradiol | 81.73 | 15219808 18223236 | |
| MESH:D001943 | Breast Neoplasms | 4-(1H-imidazol-1-yl)retinoic acid | 81.73 | 17145897 17387344 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 81.73 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 81.73 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 81.73 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 81.73 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 81.73 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 81.73 | 17162533 11921183 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 81.73 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 81.73 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Calcitriol | 81.73 | 11237771 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 81.73 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Copper | 81.73 | 15986119 17079463 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 81.73 | 16243823 18593918 18462866 19250217 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 81.73 | 18323546 17388661 15136595 12006526 16978400 18234424 17020986 11325840 15093573 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 81.73 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 81.73 | 17035597 18593368 | |
| MESH:D001943 | Breast Neoplasms | Dieldrin | 81.73 | 15770527 11859874 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 81.73 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 81.73 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | docetaxel | 81.73 | 16264153 18628466 19526202 17369602 15567936 16495393 15692762 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 81.73 | 16595493 11325840 15634643 17369602 16264153 18234424 16826403 16115903 18695136 19526202 17426702 15668708 18382427 17983394 16322301 15136595 15567936 16096432 15994142 18628466 15993339 15692762 16935488 15939500 | |
| MESH:D001943 | Breast Neoplasms | Epirubicin | 81.73 | 15093573 16642371 12006526 17388661 18511948 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 81.73 | 12948864 19861407 17289903 16675129 17018787 17261762 14630087 18497071 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 81.73 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 81.73 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | flavopiridol | 81.73 | 12517783 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 81.73 | 18357371 16557594 15136595 19217205 16595493 16110121 18608205 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 81.73 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 81.73 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | gemcitabine | 81.73 | 18382427 17039268 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 81.73 | 16541309 16873071 17200150 | |
| MESH:D001943 | Breast Neoplasms | gingerol | 81.73 | 17683926 | |
| MESH:D001943 | Breast Neoplasms | Goserelin | 81.73 | 15668708 | |
| MESH:D001943 | Breast Neoplasms | Grape Seed Proanthocyanidins | 81.73 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | Heptachlor | 81.73 | 8738476 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 81.73 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 81.73 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | Lindane | 81.73 | 14688026 | |
| MESH:D001943 | Breast Neoplasms | Linseed Oil | 81.73 | 21138602 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 81.73 | 16253758 11306469 14633655 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 81.73 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 81.73 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 81.73 | 18323546 16244791 18223236 16273361 16115903 15136595 18234424 11325840 | |
| MESH:D001943 | Breast Neoplasms | parthenolide | 81.73 | 16873071 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 81.73 | 17614352 16175315 15562024 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 81.73 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 81.73 | 17440819 16912660 15572757 15758505 15775269 17242785 17261762 17595753 17952589 16837676 17893378 17049068 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 81.73 | 16393696 17651959 17534123 | |
| MESH:D001943 | Breast Neoplasms | selenomethylselenocysteine | 81.73 | 18855134 | |
| MESH:D001943 | Breast Neoplasms | Styrene | 81.73 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 81.73 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 81.73 | 20390343 18629630 18815881 20135344 19011961 20005174 19487384 18984771 19084267 16202921 17049068 19289846 19221464 15668708 17893378 19155303 19288272 19103187 19189212 18351453 19189210 18855134 17261762 19142967 20544844 11161223 19066611 19115204 16873071 15565566 17242785 19059307 21138602 16273361 19200415 18425577 19410462 21152245 20065188 17440819 20859285 18821012 18997820 16818667 19244106 | |
| MESH:D001943 | Breast Neoplasms | tanshinone | 81.73 | 15849732 19885617 | |
| MESH:D001943 | Breast Neoplasms | Testosterone | 81.73 | 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 81.73 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tetrachloroethylene | 81.73 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 81.73 | 16166294 16443354 16873071 | |
| MESH:D001943 | Breast Neoplasms | Trichloroethylene | 81.73 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | vorinostat | 81.73 | 16144943 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 81.73 | 18695136 16096432 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.58 | 15286001 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 8.30 | 17687719 10378619 | |
| MESH:D029481 | Bronchitis, Chronic | salmeterol | 8.30 | 17687719 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 7.82 | 16813970 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Vitamin A | 7.82 | 17377406 17426644 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 2.83 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 6.28 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 6.28 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Mechlorethamine | 7.87 | 9625245 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 7.87 | 9625245 | |
| MESH:D002100 | Cachexia | Indomethacin | 3.44 | 11239499 15625704 16537180 15141370 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 3.94 | 16962696 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 2.89 | 16111702 | |
| MESH:D019559 | Capillary Leak Syndrome | Acitretin | 4.88 | 17097361 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 4.89 | 16011737 18705752 16124888 16192424 16097048 3786805 16227642 16050911 15721981 15700767 10355542 15673190 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 4.89 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 12.13 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 12.13 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 12.13 | 16051944 | |
| MESH:D002277 | Carcinoma | marker/mechanism | 10426811 | ||
| MESH:D002277 | Carcinoma | Curcumin | 8.89 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 8.89 | 19555203 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 8.89 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 8.89 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.48 | 15504454 17687452 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 2.95 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.56 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone | 57.78 | 16096431 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 57.78 | 17761372 10737359 3084413 6705139 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-aminofluorene | 57.78 | 19052882 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 57.78 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 57.78 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 57.78 | 16217749 14691202 11135700 15073043 15553829 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 57.78 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 57.78 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 57.78 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 57.78 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 57.78 | 18056438 10737359 19107877 18978308 21159647 16830150 20007298 16698587 20935162 20514400 20432363 16878318 16681979 18971187 18785209 16502159 19418558 16328049 3581430 20727157 19052882 16540662 11831363 16935385 17428255 16288022 20101231 17173139 3084413 18788625 18691550 19701751 20084675 19919837 19394651 19208518 20524982 18506893 17761372 17055752 19519916 16569478 18393292 19539802 16779866 17978847 17162532 10672840 20512989 19171122 16807293 17138121 19383236 20214788 18665156 19335982 18210153 19822196 18494052 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 57.78 | 15948411 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 57.78 | 16234567 18059187 17876044 16023760 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 57.78 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 57.78 | 15341023 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 57.78 | 15763234 18788625 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 57.78 | 17159502 16270382 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 57.78 | 17088986 17971768 17045692 18930000 16332177 16799960 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 57.78 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 57.78 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | malachite green | 57.78 | 12616621 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 57.78 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 57.78 | 1701930 6705139 17173139 20935162 20007298 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 57.78 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 57.78 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 57.78 | 16227395 19321006 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Sirolimus | 57.78 | 19335982 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 57.78 | 17306315 15276417 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 57.78 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 57.78 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 57.78 | 1917145 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.41 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 10.14 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 10.14 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 10.14 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.77 | 18791128 14736730 11352223 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 13.84 | 16179969 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 13.84 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 13.84 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 13.84 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 13.84 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 13.84 | 11894018 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 13.84 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 13.84 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.40 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.28 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 8.96 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 8.96 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 8.96 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 8.96 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 8.96 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.67 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 46.79 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acitretin | 46.79 | 16196285 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 46.79 | 18922899 15504454 17687452 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 46.79 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 46.79 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 46.79 | 17066447 18337622 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 46.79 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 46.79 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 46.79 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 46.79 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 46.79 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 46.79 | 17066447 18986760 16757204 16280240 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 46.79 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 46.79 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 46.79 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 46.79 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Sirolimus | 46.79 | 19435901 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 46.79 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 46.79 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 46.79 | 16051514 16096774 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 46.79 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 11.06 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Ciprofloxacin | 11.06 | 15028437 10741713 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 11.06 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 11.06 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 14.85 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 14.85 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 14.85 | 7544033 11179087 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 14.85 | 16170337 11754973 17287366 17124262 11179087 15728586 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 14.85 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 14.85 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 14.85 | 18670907 18850075 16120746 | |
| MESH:D009202 | Cardiomyopathies | carvedilol | 11.20 | 15476868 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 11.20 | 16242529 16731534 15476868 15811867 17329180 15792986 18627295 16651473 16455267 17928571 17007740 16612575 17131338 16278810 16364871 17974986 17308081 16952015 17351982 17924179 16109756 17382496 17519947 15505089 16269455 | |
| MESH:D009202 | Cardiomyopathies | Iron | 11.20 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 11.20 | 16612575 | |
| MESH:D009202 | Cardiomyopathies | sildenafil | 11.20 | 15811867 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 4.88 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | carvedilol | 4.60 | 19477965 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 4.60 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 4.60 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 24.55 | 17938729 15738583 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 24.55 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 24.55 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 24.55 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | Isoflavones | 24.55 | 17689850 | |
| MESH:D002318 | Cardiovascular Diseases | olive oil | 24.55 | 16216721 | |
| MESH:D002318 | Cardiovascular Diseases | Particulate Matter | 24.55 | 12396868 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 24.55 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 24.55 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 24.55 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 2.89 | 16973168 18022660 | |
| MESH:D020212 | Carotid Artery Injuries | tetracycline CMT-3 | 4.98 | 14507662 | |
| MESH:D002386 | Cataract | Acetaminophen | 8.05 | 10977129 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 8.05 | 12484553 | |
| MESH:D002386 | Cataract | pimagedine | 8.05 | 15003327 17936468 | |
| MESH:D002386 | Cataract | Tretinoin | 8.05 | 17460283 | |
| MESH:D002389 | Catatonia | olanzapine | 4.65 | 16772815 18071103 | |
| MESH:D002418 | Cattle Diseases | Citric Acid | 7.20 | 1108409 | |
| MESH:D002418 | Cattle Diseases | Trichlorfon | 7.20 | 14651886 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 15.48 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 15.48 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 15.48 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 15.48 | 17174075 21159647 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 15.48 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitronitrosoguanidine | 15.48 | 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 15.48 | 7505956 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 15.48 | 20056578 19524636 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 6.56 | 4080065 | |
| MESH:D002493 | Central Nervous System Diseases | Phenytoin | 6.56 | 4080065 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 7.77 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 7.77 | 16129372 | |
| MESH:D002637 | Chest Pain | Theophylline | 4.29 | 15238202 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 3.26 | 20678186 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 3.26 | 20734317 | |
| MESH:D015362 | Child Nutrition Disorders | Vitamin A | 3.89 | 16153327 | |
| MESH:D018281 | Cholangiocarcinoma | 2-aminofluorene | 11.67 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 11.67 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 11.67 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 11.67 | 18291259 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.60 | 12912871 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.58 | 11181007 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 25.41 | 15913567 18164287 18590720 15500046 19486331 7624871 16629650 12927374 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 25.41 | 19486331 | |
| MESH:D002779 | Cholestasis | Diosgenin | 25.41 | 16105132 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 25.41 | 11677210 15861022 16919318 17110522 17681005 17333356 16105132 | |
| MESH:D002779 | Cholestasis | Levonorgestrel | 25.41 | 15861022 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 25.41 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 25.41 | 19176532 | |
| MESH:D002779 | Cholestasis | Ursodeoxycholic Acid | 25.41 | 16487557 | |
| MESH:D002779 | Cholestasis | Vitamin A | 25.41 | 16175620 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 9.39 | 10220858 19407337 | |
| MESH:D002780 | Cholestasis, Intrahepatic | Ursodeoxycholic Acid | 9.39 | 14728856 | |
| MESH:D018211 | Chondrosarcoma, Mesenchymal | marker/mechanism | 12817616 | ||
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 4.29 | 11748493 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.56 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.20 | 15894690 | |
| MESH:D016770 | Ciliophora Infections | malachite green | 6.27 | 16175963 15900690 | |
| MESH:D016770 | Ciliophora Infections | Niclosamide | 6.27 | 12113305 | |
| MESH:D002971 | Cleft Lip | Ethanol | 6.09 | 15513904 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 6.09 | 21254359 | |
| MESH:D002971 | Cleft Lip | Phenytoin | 6.09 | 2227380 | |
| MESH:D002972 | Cleft Palate | Ethanol | 12.76 | 15513904 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 12.76 | 8946559 21254359 | |
| MESH:D002972 | Cleft Palate | Phenytoin | 12.76 | 3877104 2227380 10789828 6856622 1687470 6862529 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 12.76 | 15340226 8697196 12621046 15668235 16354765 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 12.76 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 12.76 | 12810352 | |
| MESH:D002972 | Cleft Palate | Vitamin A | 12.76 | 16054864 | |
| MESH:D019970 | Cocaine-Related Disorders | Cocaine | 4.15 | 19606084 | |
| MESH:D003072 | Cognition Disorders | Clozapine | 10.85 | 17123785 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 10.85 | 15800139 | |
| MESH:D003072 | Cognition Disorders | Scopolamine | 10.85 | 19527754 | |
| MESH:D003092 | Colitis | Curcumin | 17.87 | 16782535 16804969 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 17.87 | 16474422 | |
| MESH:D003092 | Colitis | Rutin | 17.87 | 15652231 | |
| MESH:D003092 | Colitis | Selenium | 17.87 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 17.87 | 16680017 | |
| MESH:D003092 | Colitis | Tretinoin | 17.87 | 17035595 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 2.89 | 20423518 | |
| MESH:D003103 | Coloboma | Curcumin | 6.45 | 18809619 | |
| MESH:D003103 | Coloboma | Phenytoin | 6.45 | 9212184 | |
| MESH:D003110 | Colonic Neoplasms | marker/mechanism | 19147571 10223192 | ||
| MESH:D003110 | Colonic Neoplasms | 1,2-Dimethylhydrazine | 36.07 | 18155637 16338953 1113308 1933837 16293270 | |
| MESH:D003110 | Colonic Neoplasms | 2'-benzoyloxycinnamaldehyde | 36.07 | 14660655 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 36.07 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 36.07 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 36.07 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 36.07 | 16340194 19359593 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 36.07 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Deoxycholic Acid | 36.07 | 16213893 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 36.07 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Etodolac | 36.07 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 36.07 | 18772588 17018589 17725105 17169374 15001691 16340194 16510598 17016597 17172411 17287894 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 36.07 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 36.07 | 15625704 15786552 15637740 15963497 15936596 11260862 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 36.07 | 17725105 17287894 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 36.07 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 36.07 | 16510598 16024531 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 36.07 | 17148506 19056647 19440933 15741050 11134977 16640504 17191121 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 36.07 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 36.07 | 12458338 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Vitamin A | 36.07 | 17219422 16267017 | |
| MESH:D015179 | Colorectal Neoplasms | marker/mechanism | 18949393 | ||
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 22.72 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 22.72 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 22.72 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 22.72 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 22.72 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 22.72 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Etodolac | 22.72 | 11076880 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 22.72 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 22.72 | 17454858 18802399 17094418 18448328 18288408 20501625 16303861 16391804 15289873 16282729 17255274 15148649 17594712 16524972 14970324 16331619 18509181 17695437 17016601 17401013 18383874 18949393 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 22.72 | 17087956 16985020 17245555 16963246 17116713 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 22.72 | 11197048 17054584 18059344 12606626 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 22.72 | 16391804 17159606 16303861 15273666 17454858 18509181 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Isoflavones | 22.72 | 17116718 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 22.72 | 17695437 17594712 17401013 18448328 17255274 18509181 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 22.72 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | pterostilbene | 22.72 | 18852136 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 22.72 | 18095365 18852136 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 22.72 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 22.72 | 18059344 10666051 11076880 11197048 | |
| MESH:D003128 | Coma | Ginkgo biloba extract 761 | 4.63 | 10836866 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 3.88 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | Phenytoin | 4.72 | 10627286 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 4.72 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 7.48 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 7.48 | 9301478 | |
| MESH:D003324 | Coronary Artery Disease | Homocysteine | 2.97 | 16379339 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.55 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.68 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.12 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 6.67 | 10350223 | |
| MESH:D003371 | Cough | Citric Acid | 6.67 | 9413022 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.70 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Acitretin | 20.79 | 8838291 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 20.79 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 20.79 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Carbamazepine | 20.79 | 9014606 | |
| MESH:D019465 | Craniofacial Abnormalities | decamethrin | 20.79 | 19861644 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 20.79 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 20.79 | 11198716 15451039 10194807 19302082 11873399 15451040 15513904 | |
| MESH:D019465 | Craniofacial Abnormalities | Glucocorticoids | 20.79 | 18281261 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 20.79 | 9879862 18769834 | |
| MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 20.79 | 19952982 8986270 9212184 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 20.79 | 10048152 20055451 15322242 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 20.79 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 20.79 | 16925845 14991402 10589399 8800419 17551590 9664655 9125849 9224671 9211117 9142499 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 20.79 | 17688650 16575769 8888407 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin A | 20.79 | 10992263 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 20.79 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 20.79 | 19302082 | |
| MESH:D016638 | Critical Illness | Estrogens | 4.37 | 16670151 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.15 | 16078585 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.04 | 16002989 12952375 | |
| MESH:D003490 | Cyanosis | Endosulfan | 4.01 | 7900959 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 11.85 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Ciprofloxacin | 11.85 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 11.85 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 11.85 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | sildenafil | 11.85 | 19747007 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 3.41 | 12388444 16614059 18433785 15276878 17979934 16989017 16413132 18093676 10700343 10498854 18483878 18710439 15643279 12161096 18295254 11948286 12913760 17010015 18372110 16651033 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 8.01 | 16733453 | |
| MESH:D007644 | Darier Disease | Lithium | 8.01 | 20338123 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.61 | 15213294 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.38 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.82 | 19031437 | |
| MESH:D003715 | Dengue | Doxycycline | 4.51 | 17502914 | |
| MESH:D003866 | Depressive Disorder | Fluoxetine | 4.57 | 15014590 | |
| MESH:D003866 | Depressive Disorder | Sertraline | 4.57 | 18822694 20305041 15014590 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 5.72 | 17474826 | |
| MESH:D003865 | Depressive Disorder, Major | Sertraline | 5.72 | 16968574 | |
| MESH:D003872 | Dermatitis | Benzene | 3.24 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | alachlor | 8.52 | 8428444 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 8.52 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 8.52 | 16823706 15059100 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 8.52 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | mancozeb | 8.52 | 8807224 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Trientine | 8.52 | 8970840 | |
| MESH:D003876 | Dermatitis, Atopic | Diethylhexyl Phthalate | 3.51 | 16882537 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 3.51 | 18249437 | |
| MESH:D009783 | Dermatitis, Occupational | mancozeb | 4.32 | 8807224 | |
| MESH:D003882 | Dermatomyositis | Methylprednisolone | 4.87 | 20191521 | |
| MESH:D002658 | Developmental Disabilities | olanzapine | 3.49 | 17069543 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | Lithium | 4.20 | 19244398 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 17.81 | 16640825 16604332 | |
| MESH:D003920 | Diabetes Mellitus | rosiglitazone | 17.81 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 17.81 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 17.81 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Trientine | 17.81 | 16973718 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 17.81 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 8.70 | 15331540 10990075 11751995 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 8.70 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 8.70 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 8.70 | 2177838 19496084 17442507 15862027 19960420 18603373 1374869 16286809 12093613 11260395 16684804 12446591 7637645 11055810 17874149 8740154 15298345 12083368 18715473 19298542 6379147 15831366 12644472 19586609 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 7.53 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Dehydroepiandrosterone | 7.53 | 16616286 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 7.53 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 7.53 | 18603373 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Vitamin A | 7.53 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 22.95 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 22.95 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Clozapine | 22.95 | 16402076 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 22.95 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 22.95 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 22.95 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 22.95 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 22.95 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 22.95 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 22.95 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 22.95 | 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 22.95 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 22.95 | 17107852 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.15 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | arjunolic acid | 25.02 | 19682444 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 25.02 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 25.02 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 25.02 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 25.02 | 17308373 17451421 15920148 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 25.02 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 25.02 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 25.02 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 2.95 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 7.22 | 17662242 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 7.22 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 7.14 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 7.14 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | Morphine | 7.14 | 2540324 | |
| MESH:D003967 | Diarrhea | vorinostat | 7.14 | 20479100 | |
| MESH:D006970 | Disorders of Excessive Somnolence | Clozapine | 3.96 | 15331141 | |
| MESH:D004244 | Dizziness | Astemizole | 4.86 | 3105558 | |
| OMIM:607208 | DRAVET SYNDROME | Carbamazepine | 7.29 | 11748493 | |
| OMIM:607208 | DRAVET SYNDROME | Phenytoin | 7.29 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Phenytoin | 3.95 | 15024534 | |
| MESH:D004342 | Drug Hypersensitivity | Carbamazepine | 3.24 | 16538175 16538176 15057820 20216337 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 30.53 | 7624871 17522070 18289764 20133375 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 30.53 | 16081117 11739529 14986274 11743745 17522070 11529661 15968718 14550746 14725611 12540782 12392966 19739265 16781746 11287661 12958197 17906064 11461765 10915739 12705907 19420014 16177239 19923254 16227642 2444490 19416960 15619225 16393943 10663392 11421492 19164858 11834606 12153990 16109766 12594235 10774834 18713872 19370779 17562736 19085960 18071297 16485898 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 30.53 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbamazepine | 30.53 | 17465707 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 30.53 | 21278145 15998439 7440962 7179309 19085960 6623471 2869522 10092053 10915739 6884620 16177239 11566570 15968718 15027814 7120509 3786805 4309450 3732212 9327722 17522070 16227642 19336974 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 30.53 | 17851650 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 30.53 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 30.53 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 30.53 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 30.53 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Erythromycin Estolate | 30.53 | 14998559 17522070 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 30.53 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate | 30.53 | 12540782 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 30.53 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 30.53 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tea | 30.53 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 30.53 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Trichloroethylene | 30.53 | 7120509 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 30.53 | 19641884 1733752 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.51 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Carbamazepine | 18.67 | 20216337 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 18.67 | 15033597 12649298 19839026 12231392 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 18.67 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 18.67 | 15033597 11033412 | |
| MESH:D004362 | Drug Toxicity | Lamivudine | 18.67 | 15040536 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 18.67 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 18.67 | 15040536 | |
| MESH:D015352 | Dry Eye Syndromes | Vitamin A | 4.22 | 16146918 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.58 | 18446180 17190690 18043480 12774134 16326151 16133044 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 6.94 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 6.94 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 6.94 | 11535926 17351913 17151854 11595431 17045617 10671773 11595415 17202747 17329845 11991626 16699067 | |
| MESH:D050171 | Dyslipidemias | Clozapine | 2.91 | 16402076 | |
| MESH:D004417 | Dyspnea | Endosulfan | 8.48 | 3388749 7900959 | |
| MESH:D004417 | Dyspnea | Furosemide | 8.48 | 16935035 | |
| MESH:D004417 | Dyspnea | Oxygen | 8.48 | 20016425 | |
| MESH:D004421 | Dystonia | Phenobarbital | 5.50 | 1851702 | |
| MESH:D004421 | Dystonia | Valproic Acid | 5.50 | 1851702 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 13.46 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin A | 13.46 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin E | 13.46 | 9068938 | |
| MESH:D004480 | Ectromelia | Vitamin A | 4.23 | 16054864 | |
| MESH:D004485 | Eczema | Dexamethasone | 2.96 | 12438553 | |
| MESH:D004487 | Edema | Aspirin | 31.10 | 17259670 | |
| MESH:D004487 | Edema | Dexamethasone | 31.10 | 19703484 | |
| MESH:D004487 | Edema | Fluoxetine | 31.10 | 12798668 | |
| MESH:D004487 | Edema | Furosemide | 31.10 | 11834646 | |
| MESH:D004487 | Edema | Indomethacin | 31.10 | 19703484 7907874 8273558 16100529 8985016 7990266 10653021 | |
| MESH:D004487 | Edema | Mustard Gas | 31.10 | 11428647 9260866 11402378 11428631 | |
| MESH:D004487 | Edema | pirinixic acid | 31.10 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 31.10 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 31.10 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 31.10 | 8985016 | |
| MESH:D004487 | Edema | rosiglitazone | 31.10 | 12083418 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 31.10 | 11000095 12711302 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 31.10 | 9599246 11698051 7812673 16716910 8113982 15177302 8273558 | |
| MESH:D004487 | Edema | Zymosan | 31.10 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 6.69 | 15322242 16714409 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 6.69 | 18230668 | |
| MESH:D004646 | Emphysema | Endosulfan | 4.95 | 7900959 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 28.83 | 15138306 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Carbamazepine | 28.83 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 28.83 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Minocycline | 28.83 | 11835378 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 28.83 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 28.83 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 28.83 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 28.83 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 28.83 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 8.76 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 8.76 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 6.71 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 6.71 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | 4-hydroxytamoxifen | 19.56 | 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 19.56 | 15700306 16804899 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 19.56 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 19.56 | 19148513 11473722 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 19.56 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 19.56 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 19.56 | 16202921 17893378 20544844 19155303 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 19.56 | 16569247 | |
| MESH:D004715 | Endometriosis | Indomethacin | 13.69 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 13.69 | 16134523 | |
| MESH:D004715 | Endometriosis | Progesterone | 13.69 | 16134523 | |
| MESH:D004715 | Endometriosis | Sulindac | 13.69 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 13.69 | 10568697 9294722 | |
| MESH:D004716 | Endometritis | Citric Acid | 5.15 | 1108409 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 8.79 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 8.79 | 15268973 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 2.97 | 18509659 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.18 | 16328016 17763956 10567023 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.25 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.25 | 17923197 | |
| MESH:D004802 | Eosinophilia | Astemizole | 6.43 | 1355641 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 6.43 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 6.43 | 11298111 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Carbamazepine | 10.47 | 20485159 16415921 16538176 18855540 19915237 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | lamotrigine | 10.47 | 20235791 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 10.47 | 20235791 | |
| MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 4.63 | 1399206 6251365 | |
| MESH:D004831 | Epilepsies, Myoclonic | Carbamazepine | 13.96 | 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | lamotrigine | 13.96 | 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 13.96 | 3659116 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 13.96 | 17275665 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Carbamazepine | 15.20 | 16628512 15008574 17116037 | |
| MESH:D004828 | Epilepsies, Partial | lamotrigine | 15.20 | 17116037 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 15.20 | 3922381 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Phenytoin | 15.20 | 11558140 17116037 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 15.20 | 16628512 3922381 | |
| MESH:D004827 | Epilepsy | Carbamazepine | 11.56 | 821787 17178248 17465707 19620853 18234410 19439326 20417680 19700373 7988514 9014606 | |
| MESH:D004827 | Epilepsy | lamotrigine | 11.56 | 19668019 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 11.56 | 20417680 | |
| MESH:D004827 | Epilepsy | Phenytoin | 11.56 | 821787 20417680 11434505 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 11.56 | 19439326 19700373 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 11.56 | 18234410 20417680 | |
| MESH:D004832 | Epilepsy, Absence | Naloxone | 7.00 | 6254150 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 7.00 | 6401628 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 7.00 | 6254150 7562514 6426943 | |
| MESH:D017029 | Epilepsy, Complex Partial | Carbamazepine | 15.40 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 15.40 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 15.40 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 15.40 | 7750514 | |
| MESH:D004833 | Epilepsy, Temporal Lobe | lamotrigine | 5.24 | 16499746 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Carbamazepine | 12.88 | 15276670 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 12.88 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 12.88 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 12.88 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | marker/mechanism | 12394778 | ||
| MESH:D007172 | Erectile Dysfunction | sildenafil | 4.32 | 16368379 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.58 | 9357497 | |
| MESH:D004892 | Erythema Multiforme | Thiram | 5.05 | 16750123 | |
| MESH:D004916 | Erythromelalgia | Carbamazepine | 4.15 | 19549232 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.52 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 4.13 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | marker/mechanism | 21472143 | ||
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 17.92 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 17.92 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 17.92 | 17638652 15173087 16785472 15464296 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 17.92 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | docetaxel | 17.92 | 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 17.92 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 17.92 | 17638652 16337965 16481741 16785472 15173087 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 17.92 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 17.92 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 17.92 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 17.92 | 16543248 | |
| MESH:D005076 | Exanthema | Carbamazepine | 3.90 | 20485159 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 8.19 | 16504073 | |
| MESH:D017889 | Exfoliation Syndrome | Homocysteine | 8.19 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Benomyl | 7.69 | 1914497 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 7.69 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 7.69 | 16938888 9664655 | |
| MESH:D005198 | Fanconi Syndrome | Ifosfamide | 5.02 | 17481685 | |
| MESH:D005221 | Fatigue | Amphetamine | 7.41 | 19890266 | |
| MESH:D005221 | Fatigue | vorinostat | 7.41 | 20479100 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 48.39 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 48.39 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 48.39 | 16239168 16045604 61145 12631006 19224547 15959796 17595544 12795759 | |
| MESH:D005234 | Fatty Liver | Curcumin | 48.39 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 48.39 | 19224547 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 48.39 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethanol | 48.39 | 19236843 16409862 18620774 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 48.39 | 15345470 | |
| MESH:D005234 | Fatty Liver | Iron | 48.39 | 16640825 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 48.39 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 48.39 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 48.39 | 17473493 | |
| MESH:D005234 | Fatty Liver | rosiglitazone | 48.39 | 19196556 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 48.39 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 48.39 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 48.39 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.06 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.19 | 15751030 16513791 16534752 16611131 16002989 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.19 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.25 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.72 | 15513904 10194807 15451040 16946407 | |
| MESH:D005313 | Fetal Death | Phenytoin | 5.66 | 10627286 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 5.66 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.29 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 2.63 | 18558336 8888407 | |
| MESH:D005327 | Fetal Resorption | Vitamin A | 3.78 | 16054864 | |
| MESH:D005334 | Fever | Indomethacin | 2.74 | 11852909 17627676 10431976 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 7.75 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 7.75 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 10.58 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 10.58 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 10.58 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 7.02 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 7.02 | 11555667 | |
| MESH:D005355 | Fibrosis | arsenite | 22.52 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 22.52 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 22.52 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 22.52 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Indomethacin | 22.52 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 22.52 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 22.52 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 22.52 | 17994277 | |
| MESH:D005391 | Firesetting Behavior | Testosterone | 4.26 | 7506515 | |
| MESH:D005393 | Fish Diseases | malachite green | 6.15 | 15900690 16175963 | |
| MESH:D005393 | Fish Diseases | Niclosamide | 6.15 | 12113305 | |
| MESH:D005499 | Folliculitis | Astemizole | 8.14 | 1671328 | |
| MESH:D005499 | Folliculitis | Indomethacin | 8.14 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 3.96 | 6392382 | |
| MESH:D005600 | Fragile X Syndrome | Minocycline | 5.17 | 18835858 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 3.88 | 16640825 16604332 | |
| MESH:D005706 | Gallbladder Neoplasms | therapeutic | 16904648 | ||
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.75 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 3.64 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 19.60 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 19.60 | 15046732 | |
| MESH:D005756 | Gastritis | Folic Acid | 19.60 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 19.60 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 19.60 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.50 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.16 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 7.61 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 7.61 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.70 | 12701121 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 7.71 | 8708960 | |
| MESH:D005885 | Gingival Hyperplasia | Phenytoin | 7.71 | 9029455 | |
| MESH:D019214 | Gingival Overgrowth | Phenytoin | 4.63 | 16390469 14659971 | |
| MESH:D005901 | Glaucoma | Folic Acid | 6.89 | 16504073 | |
| MESH:D005901 | Glaucoma | Homocysteine | 6.89 | 16504073 | |
| MESH:D005909 | Glioblastoma | Aspirin | 34.90 | 12870263 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 34.90 | 18405923 | |
| MESH:D005909 | Glioblastoma | Carmustine | 34.90 | 16187019 | |
| MESH:D005909 | Glioblastoma | Curcumin | 34.90 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 34.90 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 34.90 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 34.90 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 34.90 | 12870263 | |
| MESH:D005909 | Glioblastoma | myricetin | 34.90 | 19804834 | |
| MESH:D005909 | Glioblastoma | Quercetin | 34.90 | 19804834 | |
| MESH:D005909 | Glioblastoma | Testosterone | 34.90 | 17162496 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 34.90 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 34.90 | 18801729 | |
| MESH:D005910 | Glioma | Fluorouracil | 10.55 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 10.55 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 10.55 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 10.55 | 17643826 | |
| MESH:D005910 | Glioma | tanshinone | 10.55 | 16955220 | |
| MESH:D005910 | Glioma | Thalidomide | 10.55 | 16327979 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 3.94 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.57 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.66 | 16524712 15173396 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 2.92 | 11849393 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 2.99 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.77 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 3.49 | 11014644 16376943 15172196 | |
| MESH:D006130 | Growth Disorders | Zinc | 2.76 | 17217573 | |
| MESH:D006261 | Headache | Aspirin | 13.04 | 15240983 | |
| MESH:D006261 | Headache | Nitric Oxide | 13.04 | 11554966 11284996 | |
| MESH:D006261 | Headache | Nitroglycerin | 13.04 | 11554966 11284996 | |
| MESH:D006261 | Headache | Plant Oils | 13.04 | 19121572 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 24.27 | 15102660 15464296 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 24.27 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 24.27 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 24.27 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 24.27 | 18337622 15102660 15162350 | |
| MESH:D006258 | Head and Neck Neoplasms | IDN 5109 | 24.27 | 16391850 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 24.27 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Sirolimus | 24.27 | 19435901 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 24.27 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 12.11 | 19898482 | |
| MESH:D034381 | Hearing Loss | Furosemide | 12.11 | 17868369 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 12.11 | 15968427 17868369 18024279 19130971 | |
| MESH:D034381 | Hearing Loss | Styrene | 12.11 | 17420221 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.56 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.02 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 4.13 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | Acitretin | 24.07 | 8838291 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 24.07 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 24.07 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 24.07 | 17286298 16524890 | |
| MESH:D006330 | Heart Defects, Congenital | Homocysteine | 24.07 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Lithium | 24.07 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 24.07 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 24.07 | 9664655 14991402 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin A | 24.07 | 16080930 10992263 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 24.07 | 16080930 | |
| MESH:D006331 | Heart Diseases | Ciprofloxacin | 16.33 | 11505790 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 16.33 | 16495754 16330681 18006777 18674790 12587719 16707910 16244371 17875725 16879835 16244372 16144979 17888722 14766674 | |
| MESH:D006331 | Heart Diseases | Grape Seed Proanthocyanidins | 16.33 | 12587719 | |
| MESH:D006331 | Heart Diseases | pifithrin | 16.33 | 14766674 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 16.33 | 11110106 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 16.33 | 12093613 | |
| MESH:D006331 | Heart Diseases | Urethane | 16.33 | 16046796 | |
| MESH:D006333 | Heart Failure | Dobutamine | 18.15 | 17440445 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 18.15 | 17481944 | |
| MESH:D006333 | Heart Failure | Furosemide | 18.15 | 16845234 12660669 16011733 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 18.15 | 18097624 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 18.15 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 18.15 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 18.15 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 18.15 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.17 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Ciprofloxacin | 6.09 | 17643012 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 6.09 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 3.73 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 4.64 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 4.64 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 6.14 | 16183116 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 6.14 | 12579204 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.19 | 17053826 17255318 16574947 17236123 16640825 16604332 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 2.84 | 15720958 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.74 | 11918545 | |
| MESH:D006470 | Hemorrhage | Endosulfan | 5.59 | 7900959 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 5.59 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.63 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.11 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 3.94 | 14986274 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 10.37 | 18590720 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 10.37 | 19900420 19110552 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 10.37 | 18339527 | |
| MESH:D006505 | Hepatitis | Zymosan | 10.37 | 19110552 | |
| MESH:D006509 | Hepatitis B | Lamivudine | 3.63 | 17703166 | |
| MESH:D019694 | Hepatitis B, Chronic | Lamivudine | 3.63 | 16476009 15631357 15274664 15309715 12044531 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.17 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 7.02 | 17338147 | |
| MESH:D006521 | Hepatitis, Chronic | Minocycline | 7.02 | 14986274 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 3.88 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 18.68 | 17109627 17276780 16607473 19888908 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 18.68 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Trientine | 18.68 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 18.68 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 18.68 | 17063115 | |
| MESH:D006529 | Hepatomegaly | Iron | 8.47 | 16890145 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 8.47 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 8.47 | 16221962 19176532 19772884 18467677 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 8.47 | 15340226 12621046 16120746 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.49 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 6.09 | 16490937 16863852 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 6.09 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin A | 6.09 | 16490937 15707848 17436238 16863852 16292552 16877224 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 6.09 | 16490937 16863852 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.43 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Amsacrine | 10.92 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 10.92 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 10.92 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 10.92 | 16876885 | |
| MESH:D006628 | Hirsutism | Testosterone | 4.06 | 17019078 | |
| MESH:D015658 | HIV Infections | Iron | 8.45 | 16597321 | |
| MESH:D015658 | HIV Infections | Lamivudine | 8.45 | 11141242 20032539 17530837 9296927 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 8.45 | 12878215 | |
| MESH:D015658 | HIV Infections | Vitamin A | 8.45 | 16960176 | |
| MESH:D015658 | HIV Infections | Zidovudine | 8.45 | 11698656 17358032 11363243 11141242 20032539 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 8.15 | 17209195 | |
| MESH:D006679 | HIV Seropositivity | Vitamin A | 8.15 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 13.68 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 13.68 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 13.68 | 18501091 15147373 17606976 | |
| MESH:D006689 | Hodgkin Disease | Epirubicin | 13.68 | 18180244 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 13.68 | 16135485 15147373 16200630 17606976 18180244 | |
| MESH:D006689 | Hodgkin Disease | Ifosfamide | 13.68 | 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 13.68 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 15.61 | 17088409 | |
| MESH:D019584 | Hot Flashes | Fluoxetine | 15.61 | 14716179 | |
| MESH:D019584 | Hot Flashes | Isoflavones | 15.61 | 14716179 17290160 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 15.61 | 17454163 16566672 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 15.61 | 14716179 | |
| MESH:D006816 | Huntington Disease | Sertraline | 4.48 | 18403212 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.29 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Lithium Chloride | 7.76 | 19797860 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 7.76 | 16354765 8697196 15340226 16959395 18606429 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.17 | 15240983 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 19.67 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 19.67 | 17434803 17043245 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 19.67 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 19.67 | 12727271 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 19.67 | 17418472 | |
| MESH:D006930 | Hyperalgesia | rosiglitazone | 19.67 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 19.67 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 19.67 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.12 | 17883296 | |
| MESH:D017588 | Hyperandrogenism | Dehydroepiandrosterone Sulfate | 7.38 | 17392600 | |
| MESH:D017588 | Hyperandrogenism | Testosterone | 7.38 | 17019078 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 2.96 | 16899240 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 9.93 | 18089816 | |
| MESH:D006934 | Hypercalcemia | Furosemide | 9.93 | 17652376 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 9.93 | 19622757 18089816 | |
| MESH:D053565 | Hypercalciuria | Furosemide | 8.25 | 17652376 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 8.25 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | Cholesterol | 7.22 | 16933029 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 7.22 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 7.22 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 7.53 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 7.53 | 11156591 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.02 | 16778211 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 4.51 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 4.51 | 18262572 11834736 | |
| MESH:D020138 | Hyperhomocysteinemia | Carbamazepine | 17.82 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 17.82 | 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 17.82 | 16755160 16395265 16397167 16433478 16865747 | |
| MESH:D020138 | Hyperhomocysteinemia | Homocysteine | 17.82 | 17369066 18234410 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 17.82 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 17.82 | 16484555 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.01 | 17050553 | |
| MESH:D006948 | Hyperkinesis | Amphetamine | 10.36 | 14960337 1977408 | |
| MESH:D006948 | Hyperkinesis | Clozapine | 10.36 | 16046005 | |
| MESH:D006948 | Hyperkinesis | Methamphetamine | 10.36 | 17658665 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 10.19 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 10.19 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 10.19 | 16873680 | |
| MESH:D006949 | Hyperlipidemias | ursolic acid | 10.19 | 8847885 | |
| MESH:D006962 | Hyperparathyroidism, Secondary | Furosemide | 4.28 | 15086907 | |
| MESH:D006963 | Hyperphagia | olanzapine | 4.65 | 17933447 | |
| MESH:D006965 | Hyperplasia | Carbamazepine | 6.21 | 18773962 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 6.21 | 12960047 14722030 | |
| MESH:D006967 | Hypersensitivity | Terfenadine | 3.88 | 2570798 | |
| MESH:D006973 | Hypertension | Amlodipine | 22.94 | 9825082 12850387 | |
| MESH:D006973 | Hypertension | Arsenic | 22.94 | 16076760 11953799 9931084 | |
| MESH:D006973 | Hypertension | Benzene | 22.94 | 17940673 | |
| MESH:D006973 | Hypertension | carvedilol | 22.94 | 16640825 | |
| MESH:D006973 | Hypertension | Cyclosporine | 22.94 | 10903974 | |
| MESH:D006973 | Hypertension | Dexamethasone | 22.94 | 17042910 | |
| MESH:D006973 | Hypertension | Nifedipine | 22.94 | 20102058 | |
| MESH:D006973 | Hypertension | Phenylephrine | 22.94 | 8949925 12717712 | |
| MESH:D006973 | Hypertension | Quercetin | 22.94 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 22.94 | 17577099 15787275 | |
| MESH:D006973 | Hypertension | Sodium Chloride | 22.94 | 11507004 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 22.94 | 18670907 18850075 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.56 | 15338365 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Furosemide | 3.75 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 3.19 | 15838368 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 9.51 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 9.51 | 18502941 12791704 | |
| MESH:D006984 | Hypertrophy | Sirolimus | 9.51 | 19211884 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 5.94 | 17488730 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | tanshinone | 5.94 | 19662366 | |
| MESH:D006986 | Hypervitaminosis A | Vitamin A | 4.57 | 16054864 | |
| MESH:D006987 | Hypesthesia | Arsenic | 3.96 | 16093927 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.59 | 12669777 | |
| MESH:D007006 | Hypogonadism | Iron | 5.31 | 16640825 | |
| MESH:D007006 | Hypogonadism | Testosterone | 5.31 | 12002444 | |
| MESH:C537153 | Hypomagnesemia primary | Furosemide | 4.08 | 11041285 | |
| MESH:D007018 | Hypopituitarism | Testosterone | 4.60 | 17426086 | |
| MESH:D007019 | Hypoproteinemia | Furosemide | 4.28 | 16096441 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.14 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.14 | 16569931 16945680 | |
| MESH:D007022 | Hypotension | Dopamine | 9.82 | 6740701 | |
| MESH:D007022 | Hypotension | Furosemide | 9.82 | 11041285 | |
| MESH:D007022 | Hypotension | Isoproterenol | 9.82 | 6740701 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 9.82 | 7265320 | |
| MESH:D007024 | Hypotension, Orthostatic | Furosemide | 3.84 | 15811171 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.55 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.44 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.77 | 16133968 10651667 10647630 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 3.74 | 16076520 | |
| MESH:D007174 | Impulse Control Disorders | Testosterone | 4.26 | 7506515 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 3.78 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 10.69 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 10.69 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 10.69 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 6.27 | 15036965 | |
| MESH:D007246 | Infertility | Thiram | 6.27 | 6420938 | |
| MESH:D007247 | Infertility, Female | Dieldrin | 5.37 | 10630421 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 5.37 | 12013081 | |
| MESH:D007248 | Infertility, Male | 3-dinitrobenzene | 31.29 | 16988215 | |
| MESH:D007248 | Infertility, Male | alachlor | 31.29 | 17049205 12948887 16466525 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 31.29 | 7193160 16517039 | |
| MESH:D007248 | Infertility, Male | decitabine | 31.29 | 17581917 | |
| MESH:D007248 | Infertility, Male | Endosulfan | 31.29 | 9432128 8588293 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 31.29 | 17937319 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 31.29 | 11514358 | |
| MESH:D007248 | Infertility, Male | Gossypol | 31.29 | 11202417 9639145 | |
| MESH:D007248 | Infertility, Male | Methoxychlor | 31.29 | 11955947 16467254 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 31.29 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 31.29 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 31.29 | 15346721 12646999 | |
| MESH:D007248 | Infertility, Male | Theophylline | 31.29 | 16988215 | |
| MESH:D007249 | Inflammation | Capsaicin | 36.38 | 16956363 | |
| MESH:D007249 | Inflammation | Curcumin | 36.38 | 16956363 17151092 18403477 | |
| MESH:D007249 | Inflammation | Dexamethasone | 36.38 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 36.38 | 18785209 | |
| MESH:D007249 | Inflammation | Fluoxetine | 36.38 | 12798668 | |
| MESH:D007249 | Inflammation | Indomethacin | 36.38 | 3291741 7812673 12568917 | |
| MESH:D007249 | Inflammation | Mustard Gas | 36.38 | 11402378 8975870 11428647 11428620 16001271 9260866 9357497 17524151 11428631 | |
| MESH:D007249 | Inflammation | Plant Extracts | 36.38 | 16366677 15997105 19332304 12787963 | |
| MESH:D007249 | Inflammation | Plant Oils | 36.38 | 10432208 | |
| MESH:D007249 | Inflammation | Progesterone | 36.38 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 36.38 | 16366677 | |
| MESH:D007249 | Inflammation | rosiglitazone | 36.38 | 12083418 | |
| MESH:D007249 | Inflammation | Sulindac | 36.38 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 36.38 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 36.38 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 36.38 | 7562506 7812673 11698051 8273558 15177302 | |
| MESH:D007249 | Inflammation | Thalidomide | 36.38 | 16134734 | |
| MESH:D007249 | Inflammation | ursolic acid | 36.38 | 8847885 | |
| MESH:D007249 | Inflammation | Zymosan | 36.38 | 11289658 8014878 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 3.90 | 18596194 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Rutin | 3.90 | 15652231 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 18.65 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 18.65 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 18.65 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 18.65 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 18.65 | 16624496 | |
| MESH:D007299 | Insect Bites and Stings | decamethrin | 4.21 | 15189238 | |
| MESH:D007333 | Insulin Resistance | Berberine | 13.02 | 18563319 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 13.02 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 13.02 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 13.02 | 16306350 | |
| MESH:D007333 | Insulin Resistance | rosiglitazone | 13.02 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 13.02 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 11.15 | 18236018 15831440 17329856 11713966 17994277 11855677 11686837 15610444 10210152 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 11.15 | 11713966 11574821 10210152 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 11.15 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 11.15 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | marker/mechanism | 10223192 | ||
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 8.28 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 8.28 | 12628509 12584176 12351151 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 8.28 | 10213222 12663524 12628509 12351151 12584176 10223192 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.50 | 11245490 12394442 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 8.92 | 15241188 | |
| MESH:D019586 | Intracranial Hypertension | Vitamin A | 8.92 | 15955940 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 3.54 | 17163184 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.26 | 17553498 | |
| MESH:D007511 | Ischemia | Zinc | 3.11 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 8.76 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 8.76 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 8.76 | 15992940 17551590 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.44 | 16133968 10574470 18306037 | |
| MESH:D007627 | Keloid | Quercetin | 3.40 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 8.97 | 15604871 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Scopolamine | 8.97 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 3.42 | 16930632 12749816 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.06 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 8.06 | 15464296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 8.06 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 34.07 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 34.07 | 15190930 19839026 12231392 12649298 18289764 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 34.07 | 18776723 10903974 8314463 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 34.07 | 15369732 15699352 16775033 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 34.07 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Furosemide | 34.07 | 11041285 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 34.07 | 17934191 18289764 19349640 | |
| MESH:D007674 | Kidney Diseases | Grape Seed Proanthocyanidins | 34.07 | 12587719 | |
| MESH:D007674 | Kidney Diseases | Ifosfamide | 34.07 | 16221203 17035713 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 34.07 | 17190690 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 34.07 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 34.07 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 34.07 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 34.07 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 34.07 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 16.01 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 16.01 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 16.01 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 16.01 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 16.01 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 11.74 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 11.74 | 15003126 14681315 16762066 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 11.74 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 11.74 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 11.74 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 11.74 | 12579204 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 6.77 | 11231351 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 6.77 | 11231351 | |
| MESH:D007859 | Learning Disorders | Cholesterol | 17.89 | 17134702 | |
| MESH:D007859 | Learning Disorders | Copper | 17.89 | 17134702 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 17.89 | 17184923 | |
| MESH:D007859 | Learning Disorders | Endosulfan | 17.89 | 8157075 | |
| MESH:D007859 | Learning Disorders | Ethanol | 17.89 | 15451040 | |
| MESH:D007859 | Learning Disorders | Scopolamine | 17.89 | 19182383 19426756 | |
| MESH:D007889 | Leiomyoma | Curcumin | 10.33 | 18555241 | |
| MESH:D007889 | Leiomyoma | Goserelin | 10.33 | 16973256 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 10.33 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 3.30 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 8.77 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 8.77 | 10320625 12228301 11703811 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Sodium Chloride | 8.77 | 9499605 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 8.77 | 15237267 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 3.11 | 16514283 | |
| MESH:D007938 | Leukemia | marker/mechanism | |||
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 34.97 | 12970779 | |
| MESH:D007938 | Leukemia | (2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide | 34.97 | 17352252 | |
| MESH:D007938 | Leukemia | alachlor | 34.97 | 14769641 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 34.97 | 15070760 | |
| MESH:D007938 | Leukemia | Azacitidine | 34.97 | 19148494 | |
| MESH:D007938 | Leukemia | Benzene | 34.97 | 17119257 14694614 15935818 18335105 | |
| MESH:D007938 | Leukemia | Curcumin | 34.97 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 34.97 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 34.97 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | Genistein | 34.97 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | LAQ824 | 34.97 | 16275999 | |
| MESH:D007938 | Leukemia | Quercetin | 34.97 | 17468513 | |
| MESH:D007938 | Leukemia | SN50 peptide | 34.97 | 12970779 | |
| MESH:D007938 | Leukemia | Tretinoin | 34.97 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.56 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 6.96 | 18172266 18587576 17658394 17802794 17008537 17296974 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 6.96 | 15802533 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Methylprednisolone | 6.96 | 14551737 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | oblimersen | 6.96 | 17296974 | |
| MESH:D007945 | Leukemia, Lymphoid | mancozeb | 8.25 | 16132792 | |
| MESH:D007945 | Leukemia, Lymphoid | Thiotepa | 8.25 | 10069464 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 19.22 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 19.22 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 19.22 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 19.22 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 19.22 | 20370541 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 19.22 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 10.71 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 10.71 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 10.71 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 9.32 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 9.32 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 9.32 | 16572323 10785260 15631656 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Thiotepa | 9.32 | 10373061 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 18.71 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 18.71 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 18.71 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 18.71 | 17236224 19117987 18454857 | |
| MESH:D007951 | Leukemia, Myeloid | Thiotepa | 18.71 | 10069464 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 18.71 | 16932348 16482212 19285840 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | ABT-737 | 18.11 | 17097560 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Amsacrine | 18.11 | 18043129 15148258 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 18.11 | 16467208 19850784 20471514 17050201 16968895 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 18.11 | 17596541 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 18.11 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 18.11 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 18.11 | 19010910 18206229 18460780 19387464 17679729 18704418 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 18.11 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 18.11 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 18.11 | 19850784 16294345 17596541 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 18.11 | 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 18.11 | 16294345 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 3.86 | 18055864 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 3.69 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 10.79 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 10.79 | 19225113 17869043 16891316 17217047 15213294 12018890 11161223 15622746 12679006 12712474 16823087 19642359 17649720 15336539 16966277 16112521 11468182 16330433 19035177 16331271 19075265 9834237 15748426 17712046 17107899 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | dracorhodin | 10.79 | 16864444 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 10.79 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 10.79 | 16331271 17506722 17368321 16823087 17301526 17294898 16935935 16788101 16766008 19075265 15748426 12679006 17217047 19225113 17361223 19029980 16140955 17339181 9834237 17107899 17649720 19035177 19642359 17712046 16891316 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 6.67 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 6.67 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 3.78 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.12 | 17980183 | |
| MESH:D007970 | Leukopenia | Ciprofloxacin | 7.00 | 17846019 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 7.00 | 11830472 10052129 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.44 | 16707609 | |
| MESH:D020961 | Lewy Body Disease | Iron | 3.88 | 16563566 | |
| MESH:D017513 | Lichen Nitidus | Astemizole | 4.86 | 2563723 | |
| MESH:D017880 | Limb Deformities, Congenital | Acitretin | 15.18 | 8838291 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 15.18 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 15.18 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 15.18 | 10473037 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 15.18 | 9224671 | |
| MESH:D017880 | Limb Deformities, Congenital | Vitamin A | 15.18 | 16054864 | |
| MESH:D008064 | Lipidoses | Clozapine | 8.31 | 17567588 | |
| MESH:D008064 | Lipidoses | Fluoxetine | 8.31 | 17567588 15342952 | |
| MESH:D008064 | Lipidoses | Sertraline | 8.31 | 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 8.31 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.33 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.12 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 26.18 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 26.18 | 17334410 16943688 16239168 17157831 17174718 11408273 21278145 16221502 11903743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 26.18 | 20032147 18407596 19638242 18522880 18665156 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 26.18 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 26.18 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 26.18 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 26.18 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 26.18 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | puerarin | 26.18 | 16426832 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 26.18 | 16943688 17174718 | |
| MESH:D008103 | Liver Cirrhosis | Vitamin A | 26.18 | 16256175 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.52 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 5.15 | 12468960 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Ursodeoxycholic Acid | 5.15 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | 1,3-dimethylthiourea | 40.33 | 11682029 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Bee Venoms | 40.33 | 20821823 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 40.33 | 15362042 16011737 18251166 15959796 12586293 14620537 18156304 20821823 16192424 15876570 17766677 18279442 17557913 12609069 18187930 11481614 18339082 14724832 15123356 17976157 12667390 10355542 12898905 16015684 17631135 16097048 15818738 15052691 17714472 18166357 12958196 12445421 12546737 18006644 12741479 18263696 18376398 12389079 18429990 17944888 15996030 13678700 12632512 18205269 16027843 17565644 17525996 15650968 18472094 18420326 18395914 14716833 16248980 12666154 15931870 15370692 18210741 15057751 17922224 18481824 16638106 18418968 12632514 17823541 17805973 18395095 18412020 14512876 15338365 17721639 14748882 18705752 15673190 18054572 16136751 16116963 18472332 17900296 17869086 14716496 17761835 16033810 15730626 17640975 17481882 15925388 12649538 15893842 17708605 17698563 18277467 18317297 12445418 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 40.33 | 17355460 18006644 18705752 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 40.33 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 40.33 | 15571005 15504291 15479170 16570917 16169303 15591649 14726149 17881167 17724770 15744066 15383259 18637143 16009107 15723089 14568256 14659978 14643895 17198567 17201889 18629640 17465448 15161499 15369754 18210741 18237412 16544323 15942678 18239293 18095165 15798949 14709902 15793283 18371158 17534399 17719030 16627068 15366600 17203207 18672772 18567088 17348192 12925901 15099470 15298665 16042886 15577212 15733078 15138612 15842777 16603200 12918455 17666798 17196135 15492853 17036385 17432682 15763062 15086199 15081153 18364076 17640959 15864749 15067225 16270385 15339415 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 40.33 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 40.33 | 15818738 12632512 17629604 18567088 15641146 15744066 15383259 15754396 17666798 16610055 15849816 18371158 18237412 18606216 15864749 17881167 15339415 17036385 17348192 15763062 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 40.33 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 40.33 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 40.33 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | fasudil | 40.33 | 17761835 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 40.33 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 40.33 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 40.33 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 40.33 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 40.33 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidino-4-iodotamoxifen | 40.33 | 15842777 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 40.33 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 40.33 | 17347453 15980055 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Sirolimus | 40.33 | 17050028 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 40.33 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 40.33 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | tetrandrine | 40.33 | 17201889 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 40.33 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 40.33 | 18397230 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin A | 40.33 | 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 40.33 | 16169303 | |
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 31.96 | 17184895 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 31.96 | 16611625 19460945 11587558 12969438 16610002 19784758 12587719 19014921 | |
| MESH:D008107 | Liver Diseases | Arsenic | 31.96 | 11134558 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 31.96 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 31.96 | 16964402 15720792 17285989 15830285 16246199 | |
| MESH:D008107 | Liver Diseases | Curcumin | 31.96 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 31.96 | 17034775 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 31.96 | 17056761 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 31.96 | 17207593 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 31.96 | 16877991 | |
| MESH:D008107 | Liver Diseases | Grape Seed Proanthocyanidins | 31.96 | 12587719 | |
| MESH:D008107 | Liver Diseases | Lindane | 31.96 | 1715830 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 31.96 | 19363144 | |
| MESH:D008107 | Liver Diseases | Phenytoin | 31.96 | 14986274 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 31.96 | 17034775 | |
| MESH:D008107 | Liver Diseases | Sulindac | 31.96 | 16867024 14986274 | |
| MESH:D008107 | Liver Diseases | Tetrachloroethylene | 31.96 | 17267091 | |
| MESH:D008107 | Liver Diseases | Vitamin A | 31.96 | 16175620 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 10.22 | 17347304 17207112 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 10.22 | 17207112 16737972 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Vitamin A | 10.22 | 16762690 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.63 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 7.99 | 16871587 17185352 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 7.99 | 16899240 14706259 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 7.99 | 17457977 | |
| MESH:D008113 | Liver Neoplasms | 10-hydroxycamptothecin | 73.38 | 16603448 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 73.38 | 10737359 10672840 14678523 16273603 18001218 11376686 | |
| MESH:D008113 | Liver Neoplasms | 2-aminofluorene | 73.38 | 20452335 19499222 20492335 19850985 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 73.38 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 73.38 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 73.38 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 73.38 | 20195826 21137059 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 73.38 | 21295105 19389873 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 73.38 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Copper | 73.38 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | Dehydroepiandrosterone | 73.38 | 18709148 | |
| MESH:D008113 | Liver Neoplasms | Dieldrin | 73.38 | 8742319 9539021 | |
| MESH:D008113 | Liver Neoplasms | Diethylhexyl Phthalate | 73.38 | 11940454 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 73.38 | 18977376 16942905 15175105 19833225 19638242 10737359 19499222 18644402 19254457 18754104 21278145 20118626 19426721 18978307 20101389 19551842 12112319 20492335 19690152 19073162 18648771 20452335 12771043 21047994 20137499 15885732 19255062 20501860 20583210 20405173 21071580 20434301 19850985 19427195 21167192 9163691 19294768 19256749 19996281 19812893 19642983 2862719 2422723 19090486 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 73.38 | 15890375 16712894 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 73.38 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 73.38 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 73.38 | 15113037 17045692 18383874 16603448 | |
| MESH:D008113 | Liver Neoplasms | Heptachlor | 73.38 | 2422723 9544696 | |
| MESH:D008113 | Liver Neoplasms | Iron | 73.38 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | Mitomycin | 73.38 | 15113037 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 73.38 | 8742319 19812893 19482888 19073162 15975961 21047994 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 73.38 | 16377806 20007298 15890375 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 73.38 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 73.38 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 73.38 | 19321006 19073162 20405173 19812893 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 73.38 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 73.38 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 73.38 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 73.38 | 17093202 17559639 16391232 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 73.38 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | marker/mechanism | 10426811 | ||
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 40.91 | 6150874 1399818 534488 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 40.91 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 40.91 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 40.91 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 40.91 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 40.91 | 15583823 12014681 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dehydroepiandrosterone | 40.91 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Deoxycholic Acid | 40.91 | 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 40.91 | 2563599 16842330 19004024 18282651 17174075 19519916 18775883 17854601 18544905 9362446 17942915 18308698 18093689 19539802 19126423 16267830 18164116 19009564 18079962 21159647 3124819 18253720 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 40.91 | 6150874 1848544 15603536 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 40.91 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 40.91 | 2563599 18308698 6150874 17172636 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 40.91 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | styrene oxide | 40.91 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 40.91 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachloroethylene | 40.91 | 7955063 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Trichloroethylene | 40.91 | 7955063 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vitamin A | 40.91 | 17113696 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 11.41 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Astemizole | 11.41 | 18472280 11989578 | |
| MESH:D008133 | Long QT Syndrome | Dobutamine | 11.41 | 19353679 | |
| MESH:D008133 | Long QT Syndrome | olanzapine | 11.41 | 20210726 | |
| MESH:D008133 | Long QT Syndrome | Terfenadine | 11.41 | 8772706 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 3.91 | 16080182 | |
| MESH:D008171 | Lung Diseases | 2-chloroethyl ethyl sulfide | 22.19 | 18675330 16252256 12815614 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 22.19 | 12815614 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 22.19 | 16863852 | |
| MESH:D008171 | Lung Diseases | Dobutamine | 22.19 | 16638327 | |
| MESH:D008171 | Lung Diseases | Grape Seed Proanthocyanidins | 22.19 | 12587719 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 22.19 | 18702808 18161513 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 22.19 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin A | 22.19 | 16863852 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 22.19 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 6.16 | 14698565 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 6.16 | 17228818 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 15.87 | 17365036 | |
| MESH:D055370 | Lung Injury | Ciprofloxacin | 15.87 | 18197910 | |
| MESH:D055370 | Lung Injury | naphthalene | 15.87 | 6834280 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 15.87 | 11395602 | |
| MESH:D055370 | Lung Injury | Oxygen | 15.87 | 18339021 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 15.87 | 16129981 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 70.16 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 70.16 | 17139156 12438228 16401635 18508827 15172992 15893417 14755239 9255578 19931552 18813816 16061637 | |
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 70.16 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | Acrylonitrile | 70.16 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 70.16 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 70.16 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 70.16 | 17306315 19168569 17976673 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 70.16 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 70.16 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 70.16 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 70.16 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 70.16 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 70.16 | 18816296 20464547 18569708 17053015 20869020 20135361 6695378 18520028 20064080 | |
| MESH:D008175 | Lung Neoplasms | Cantharidin | 70.16 | 16117893 | |
| MESH:D008175 | Lung Neoplasms | Ciprofloxacin | 70.16 | 20211752 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 70.16 | 17225452 11798837 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 70.16 | 19359593 16243823 18462866 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 70.16 | 19336726 16288123 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 70.16 | 11195469 15824018 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 70.16 | 20970405 20512841 6695378 21163286 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 70.16 | 16061637 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 70.16 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 70.16 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 70.16 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 70.16 | 11497255 11053908 16537180 | |
| MESH:D008175 | Lung Neoplasms | Iron | 70.16 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 70.16 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 70.16 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 70.16 | 3148597 8781369 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 70.16 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 70.16 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 70.16 | 16712894 15276417 19931552 17077188 17306315 | |
| MESH:D008175 | Lung Neoplasms | Styrene | 70.16 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 70.16 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 70.16 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 70.16 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 70.16 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 70.16 | 16391232 12765245 11893704 16007126 16289808 17093202 15166089 15136453 11246140 17195641 12957351 11552296 16337739 11497255 7750092 10779650 16926031 11074608 11323394 11992545 11544531 10530776 6695378 16788158 10997738 14587096 10822126 12117781 15902970 11062179 11807781 11307925 16204055 17255336 12466968 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 70.16 | 11062179 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 70.16 | 18800350 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.22 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Carbamazepine | 3.33 | 16628512 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 3.33 | 17718048 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.57 | 15166399 | |
| MESH:D008223 | Lymphoma | Benzene | 36.91 | 17119257 17584886 | |
| MESH:D008223 | Lymphoma | bortezomib | 36.91 | 16098063 | |
| MESH:D008223 | Lymphoma | Chlorambucil | 36.91 | 10745627 | |
| MESH:D008223 | Lymphoma | Curcumin | 36.91 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 36.91 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 36.91 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 36.91 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 36.91 | 16098063 | |
| MESH:D008223 | Lymphoma | Doxycycline | 36.91 | 20133848 | |
| MESH:D008223 | Lymphoma | Etoposide | 36.91 | 12556972 12854902 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 36.91 | 11418001 16257854 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 36.91 | 16166326 | |
| MESH:D008223 | Lymphoma | Thiotepa | 36.91 | 10069464 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 21.07 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 21.07 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 21.07 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | oblimersen | 21.07 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 21.07 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 21.07 | 14737004 | |
| MESH:D008224 | Lymphoma, Follicular | marker/mechanism | 12855623 | ||
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 9.47 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 9.47 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 9.47 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 9.47 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 6.46 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 6.46 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.14 | 20479100 | |
| MESH:D008268 | Macular Degeneration | Iron | 2.89 | 16640825 | |
| MESH:D008288 | Malaria | Astemizole | 3.50 | 16816845 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 3.91 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Acrylonitrile | 15.20 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 15.20 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 15.20 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Styrene | 15.20 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 15.20 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 40.95 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Dehydroepiandrosterone | 40.95 | 16457693 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 40.95 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 40.95 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 40.95 | 16891317 11408345 17203775 11807958 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 40.95 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 40.95 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 40.95 | 10767621 17020996 16619500 17131329 15688392 10838139 14999141 14633655 16944150 15313902 16051031 11751437 19196723 12931682 11807958 15113128 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 40.95 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 40.95 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 40.95 | 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 40.95 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | selenomethylselenocysteine | 40.95 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 40.95 | 16827153 11731420 19196723 14580682 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 40.95 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tocopherols | 40.95 | 17927505 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 40.95 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 40.95 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 7.38 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 7.38 | 19453300 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 4.12 | 16832597 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 3.70 | 19213072 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 3.70 | 17453147 | |
| MESH:D008545 | Melanoma | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 52.75 | 17992120 | |
| MESH:D008545 | Melanoma | Acitretin | 52.75 | 16109552 | |
| MESH:D008545 | Melanoma | Carboplatin | 52.75 | 16342250 11712820 16225601 12040289 | |
| MESH:D008545 | Melanoma | Carmustine | 52.75 | 12393984 | |
| MESH:D008545 | Melanoma | Cisplatin | 52.75 | 16248763 12374674 18332650 12393984 12883367 18176117 15577323 18505091 17761969 16432458 17023156 16809738 11135225 | |
| MESH:D008545 | Melanoma | Curcumin | 52.75 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | decitabine | 52.75 | 17785578 16505122 | |
| MESH:D008545 | Melanoma | docetaxel | 52.75 | 12417787 | |
| MESH:D008545 | Melanoma | Doxorubicin | 52.75 | 16827129 | |
| MESH:D008545 | Melanoma | dracorhodin | 52.75 | 15684474 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 52.75 | 17992120 11746506 | |
| MESH:D008545 | Melanoma | Epirubicin | 52.75 | 16642371 | |
| MESH:D008545 | Melanoma | Fenretinide | 52.75 | 16270382 | |
| MESH:D008545 | Melanoma | Glucose | 52.75 | 14993021 | |
| MESH:D008545 | Melanoma | Isotretinoin | 52.75 | 17237267 | |
| MESH:D008545 | Melanoma | LAQ824 | 52.75 | 17237267 | |
| MESH:D008545 | Melanoma | oblimersen | 52.75 | 16966688 11095261 | |
| MESH:D008545 | Melanoma | Paclitaxel | 52.75 | 16342250 12025231 12040289 | |
| MESH:D008545 | Melanoma | resveratrol | 52.75 | 17992120 | |
| MESH:D008545 | Melanoma | Sirolimus | 52.75 | 19282848 | |
| MESH:D008545 | Melanoma | sodium arsenite | 52.75 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Sulindac | 52.75 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 52.75 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 52.75 | 16098027 12829675 17089043 | |
| MESH:D008545 | Melanoma | Tretinoin | 52.75 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 52.75 | 16505122 | |
| MESH:D008545 | Melanoma | Vindesine | 52.75 | 16225601 | |
| MESH:D008545 | Melanoma | Vitamin K 3 | 52.75 | 19082730 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 6.33 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 6.33 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 5.74 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 5.74 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 10.70 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 10.70 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | Scopolamine | 10.70 | 19527754 15957009 19182383 19426756 | |
| MESH:D008569 | Memory Disorders | Trichlorfon | 10.70 | 15957009 | |
| MESH:D008591 | Meningomyelocele | Homocysteine | 7.30 | 16602021 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 7.30 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.30 | 17109627 17268249 | |
| MESH:D001523 | Mental Disorders | Clozapine | 6.69 | 16856516 | |
| MESH:D001523 | Mental Disorders | Fluoxetine | 6.69 | 16856516 | |
| MESH:D001523 | Mental Disorders | olanzapine | 6.69 | 16856516 | |
| MESH:D001523 | Mental Disorders | Sertraline | 6.69 | 16856516 | |
| MESH:D008607 | Mental Retardation | Carbamazepine | 3.63 | 9014606 | |
| MESH:D008607 | Mental Retardation | Phenytoin | 3.63 | 9212184 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 13.82 | 18303189 16966607 16166281 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 13.82 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 13.82 | 17638057 | |
| MESH:D008654 | Mesothelioma | hexamethylene bisacetamide | 13.82 | 15543656 | |
| MESH:D008654 | Mesothelioma | Selenium | 13.82 | 15107826 | |
| MESH:D008654 | Mesothelioma | Tocopherols | 13.82 | 15878867 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 13.82 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | olanzapine | 6.14 | 19142110 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 6.14 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | Clozapine | 5.27 | 19142101 | |
| MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 5.27 | 17261469 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.19 | 16801185 | |
| MESH:D008708 | Methemoglobinemia | malachite green | 5.27 | 18363129 | |
| MESH:D008708 | Methemoglobinemia | Nitroglycerin | 5.27 | 3537620 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.24 | 17358032 | |
| MESH:D053842 | Microsatellite Instability | Methylnitronitrosoguanidine | 4.31 | 17671175 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 7.48 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 7.48 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 7.48 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 7.48 | 18765137 18803445 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 6.16 | 14659530 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitroglycerin | 6.16 | 14659530 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.03 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 3.95 | 15863610 | |
| MESH:D009006 | Monosomy | Azacitidine | 4.48 | 19299654 | |
| MESH:D009041 | Motion Sickness | Scopolamine | 4.95 | 1613127 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 12.84 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 12.84 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 12.84 | 18986760 16757204 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 12.84 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Sirolimus | 12.84 | 19435901 | |
| MESH:D052016 | Mucositis | Doxorubicin | 7.23 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 7.23 | 17159606 | |
| MESH:D009101 | Multiple Myeloma | alachlor | 54.43 | 14769641 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 54.43 | 19549372 19417148 14977855 15949261 11468182 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 54.43 | 19549372 18443271 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 54.43 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 54.43 | 19372569 19112201 19112817 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 54.43 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 54.43 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 54.43 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 54.43 | 15867202 16118317 15744524 | |
| MESH:D009101 | Multiple Myeloma | lonafarnib | 54.43 | 16996129 | |
| MESH:D009101 | Multiple Myeloma | oblimersen | 54.43 | 15867202 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 54.43 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 54.43 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 54.43 | 17164350 16267019 14749477 17049120 16490592 17935668 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 54.43 | 17168659 16445831 15867202 15939924 19112817 15744524 19112201 19372569 15741222 15920492 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 54.43 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Vitamin A | 54.43 | 16374440 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 54.43 | 18089719 16996129 19621390 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.73 | 18160304 12879239 15259001 15241586 17724436 10890648 15834315 12130978 15213630 10479408 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.08 | 17086897 | |
| MESH:D020529 | Multiple Sclerosis, Relapsing-Remitting | Minocycline | 5.18 | 11835378 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 12.16 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 12.16 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 12.16 | 17962980 | |
| MESH:D009135 | Muscular Diseases | Glucocorticoids | 5.84 | 15946989 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 5.84 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 4.67 | 18694830 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 2.57 | 8888407 | |
| MESH:D009164 | Mycobacterium Infections | Ciprofloxacin | 4.01 | 10063276 | |
| MESH:D009181 | Mycoses | Iron | 3.88 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.08 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 20.27 | 16882451 16105982 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 20.27 | 19805378 17596541 18720364 17611569 | |
| MESH:D009190 | Myelodysplastic Syndromes | Ciprofloxacin | 20.27 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 20.27 | 19010910 16882708 19157545 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 20.27 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 20.27 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 20.27 | 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 20.27 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | marker/mechanism | 19027736 | ||
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 28.82 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 28.82 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Cocaine | 28.82 | 18072171 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 28.82 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 28.82 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Homocysteine | 28.82 | 17412321 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 28.82 | 16538859 19595682 16697266 17052832 16584858 19172585 15740881 | |
| MESH:D009203 | Myocardial Infarction | Lithium | 28.82 | 16288908 | |
| MESH:D009203 | Myocardial Infarction | Nitroglycerin | 28.82 | 14729435 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 28.82 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 28.82 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 28.82 | 16317513 16525036 16456233 17125593 17188708 17015251 | |
| MESH:D009203 | Myocardial Infarction | SB 216763 | 28.82 | 16288908 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 14.32 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Dobutamine | 14.32 | 12447174 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 14.32 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 14.32 | 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 14.32 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 12.56 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 12.56 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 12.56 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 12.56 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 12.56 | 19207477 | |
| MESH:D009205 | Myocarditis | Particulate Matter | 7.24 | 12563109 | |
| MESH:D009205 | Myocarditis | resveratrol | 7.24 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 7.30 | 17484760 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 7.30 | 17484760 | |
| MESH:D009207 | Myoclonus | Fluoxetine | 4.31 | 8041377 | |
| MESH:D009224 | Myotonia Congenita | Carbamazepine | 7.30 | 20399394 | |
| MESH:D009224 | Myotonia Congenita | Phenytoin | 7.30 | 1896199 | |
| MESH:D009232 | Myxoma | Raloxifene | 3.95 | 16343187 | |
| MESH:D009325 | Nausea | Aspirin | 6.98 | 15240983 | |
| MESH:D009325 | Nausea | vorinostat | 6.98 | 20479100 | |
| MESH:D016870 | Neisseriaceae Infections | Ciprofloxacin | 4.77 | 20378725 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 8.83 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 8.83 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | tetracycline CMT-3 | 8.83 | 11172680 11172682 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 17.41 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 17.41 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 17.41 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 17.41 | 11053908 16537180 11239499 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 17.41 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 17.41 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | punarnavine | 17.41 | 19171408 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 17.41 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 17.41 | 17312309 15867366 19139120 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.78 | 19410462 | |
| MESH:D009369 | Neoplasms | 2'-benzoyloxycinnamaldehyde | 58.38 | 17855188 | |
| MESH:D009369 | Neoplasms | alitretinoin | 58.38 | 16946489 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 58.38 | 11141357 | |
| MESH:D009369 | Neoplasms | Berberine | 58.38 | 12415430 | |
| MESH:D009369 | Neoplasms | Carboplatin | 58.38 | 17925555 18854779 | |
| MESH:D009369 | Neoplasms | Cisplatin | 58.38 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 58.38 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 58.38 | 19116145 19470736 17925555 | |
| MESH:D009369 | Neoplasms | deguelin | 58.38 | 17764071 | |
| MESH:D009369 | Neoplasms | Dieldrin | 58.38 | 8820588 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 58.38 | 15313581 | |
| MESH:D009369 | Neoplasms | Fenretinide | 58.38 | 15958647 17353921 | |
| MESH:D009369 | Neoplasms | ferric-sorbitol-citrate | 58.38 | 17257079 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 58.38 | 18600527 16928823 18239605 | |
| MESH:D009369 | Neoplasms | Lindane | 58.38 | 16818664 12807735 | |
| MESH:D009369 | Neoplasms | lycopene | 58.38 | 17051425 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 58.38 | 15533788 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 58.38 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 58.38 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 58.38 | 11559025 | |
| MESH:D009369 | Neoplasms | Tetrachloroethylene | 58.38 | 11911487 | |
| MESH:D009369 | Neoplasms | Thiotepa | 58.38 | 18854779 | |
| MESH:D009369 | Neoplasms | Tretinoin | 58.38 | 16946489 16594593 | |
| MESH:D009369 | Neoplasms | Trichloroethylene | 58.38 | 11911487 | |
| MESH:D009369 | Neoplasms | Urethane | 58.38 | 15625555 | |
| MESH:D009369 | Neoplasms | ursolic acid | 58.38 | 8847885 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 12.69 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 12.69 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 12.69 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 12.69 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 12.69 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 5.63 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 5.63 | 19200415 19196722 19189210 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 11.76 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 11.76 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 11.76 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | parthenolide | 11.76 | 16921510 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 6.07 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Minocycline | 6.07 | 435818 444868 | |
| MESH:D009397 | Nephrocalcinosis | Furosemide | 4.28 | 15086907 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.22 | 16636307 16899518 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 2.85 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 7.67 | 19348381 18481113 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 7.67 | 16889571 15640375 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 7.67 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | 1-Methyl-4-phenylpyridinium | 12.21 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | 3-dinitrobenzene | 12.21 | 11301198 | |
| MESH:D009410 | Nerve Degeneration | mancozeb | 12.21 | 15350641 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 12.21 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 12.21 | 15790535 18619942 17356569 | |
| MESH:D009422 | Nervous System Diseases | 2,5-hexanedione | 4.69 | 12164553 | |
| MESH:D009421 | Nervous System Malformations | Benomyl | 33.20 | 14502586 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 33.20 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Carbamazepine | 33.20 | 16990009 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 33.20 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 33.20 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 33.20 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 33.20 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 33.20 | 16859833 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 33.20 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.03 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 28.90 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 28.90 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 28.90 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 28.90 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 28.90 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | mancozeb | 28.90 | 15864902 | |
| MESH:D009436 | Neural Tube Defects | Phenytoin | 28.90 | 9118846 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 28.90 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 28.90 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 28.90 | 16359493 8888407 | |
| MESH:D009436 | Neural Tube Defects | Vitamin A | 28.90 | 17400914 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 3.91 | 11555667 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.64 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 12.27 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 12.27 | 8761367 15176712 16115947 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 12.27 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 12.27 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 12.27 | 17368321 | |
| MESH:D009447 | Neuroblastoma | Thiotepa | 12.27 | 8761367 | |
| MESH:D019636 | Neurodegenerative Diseases | 1-Methyl-4-phenylpyridinium | 30.33 | 16353238 | |
| MESH:D019636 | Neurodegenerative Diseases | 2,5-hexanedione | 30.33 | 17492505 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 30.33 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Amphetamine | 30.33 | 15183010 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 30.33 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 30.33 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 30.33 | 17296847 16604332 | |
| MESH:D019636 | Neurodegenerative Diseases | Oxidopamine | 30.33 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 30.33 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 30.33 | 16850258 17266991 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 19.65 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 19.65 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 19.65 | 12837982 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 19.65 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Thiotepa | 19.65 | 12837982 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 13.34 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 13.34 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 13.34 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 13.34 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.52 | 20387270 | |
| MESH:D009468 | Neuromuscular Diseases | Amlodipine | 5.38 | 9825082 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.10 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 2.24 | 16436463 | |
| MESH:D009503 | Neutropenia | Ciprofloxacin | 10.16 | 17846019 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 10.16 | 8291058 | |
| MESH:D009503 | Neutropenia | Folic Acid | 10.16 | 16322990 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 10.16 | 16761898 7688884 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Cholesterol | 4.16 | 9802331 20557099 | |
| MESH:D053206 | Nocturnal Enuresis | Furosemide | 4.28 | 17945291 | |
| MESH:D009669 | Nose Neoplasms | alachlor | 3.35 | 14563481 16178123 15580706 16698726 11127290 | |
| MESH:D009759 | Nystagmus, Pathologic | Astemizole | 4.86 | 6135121 | |
| MESH:D009765 | Obesity | 2-chloroethyl ethyl sulfide | 11.78 | 16289378 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 11.78 | 17217161 | |
| MESH:D009765 | Obesity | Capsaicin | 11.78 | 19056576 | |
| MESH:D009765 | Obesity | Clozapine | 11.78 | 19142110 18515891 | |
| MESH:D009765 | Obesity | Curcumin | 11.78 | 19297423 | |
| MESH:D009765 | Obesity | olanzapine | 11.78 | 18515891 | |
| MESH:D009765 | Obesity | pirinixic acid | 11.78 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 11.78 | 19056576 20132043 | |
| MESH:D009771 | Obsessive-Compulsive Disorder | Fluoxetine | 3.98 | 20418887 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.58 | 6374098 | |
| MESH:D009784 | Occupational Diseases | Benzene | 2.80 | 15612468 15935809 17119257 17479406 16737584 17178637 15913788 15576619 15727169 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.18 | 16517039 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 8.17 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Doxycycline | 8.17 | 17267227 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 8.17 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 8.17 | 16640825 | |
| MESH:D010009 | Osteochondrodysplasias | marker/mechanism | 17954590 | ||
| MESH:D010009 | Osteochondrodysplasias | Thiram | 4.20 | 15518828 17954590 15899490 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 7.10 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 7.10 | 15867366 | |
| MESH:D010018 | Osteomalacia | Carbamazepine | 11.36 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 11.36 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenytoin | 11.36 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 15.09 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 15.09 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 15.09 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | Isoflavones | 15.09 | 16562857 | |
| MESH:D010024 | Osteoporosis | Levonorgestrel | 15.09 | 12665316 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 15.09 | 15775268 17882678 19059307 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 15.09 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Dehydroepiandrosterone | 20.37 | 16397352 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 20.37 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 20.37 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 20.37 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 20.37 | 15579764 17823083 17893378 15758505 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 20.37 | 17513867 | |
| MESH:C536063 | Osteoporosis-pseudoglioma syndrome | pamidronate | 5.45 | 18825883 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.75 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.41 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 51.87 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 51.87 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 51.87 | 19769630 12452020 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 51.87 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 51.87 | 19769630 17225452 6897625 15464296 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 51.87 | 19020741 18462866 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 51.87 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 51.87 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 51.87 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 51.87 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 51.87 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 51.87 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate | 51.87 | 16749867 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 51.87 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 51.87 | 17393432 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 51.87 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 51.87 | 17306315 15276417 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 51.87 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 51.87 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 51.87 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 51.87 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 51.87 | 16391232 | |
| MESH:D010146 | Pain | Acetaminophen | 25.40 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 25.40 | 6995502 6363464 | |
| MESH:D010146 | Pain | Capsaicin | 25.40 | 17084039 19081190 17043245 18987195 16996476 17434803 | |
| MESH:D010146 | Pain | Carbamazepine | 25.40 | 15215642 | |
| MESH:D010146 | Pain | Cyclophosphamide | 25.40 | 12161096 18093676 | |
| MESH:D010146 | Pain | Fluoxetine | 25.40 | 12798668 | |
| MESH:D010146 | Pain | Indomethacin | 25.40 | 3291741 17440234 17627676 13679232 | |
| MESH:D010146 | Pain | Morphine | 25.40 | 15275824 15215642 6776300 16273134 20225289 18699797 | |
| MESH:D010146 | Pain | Phenytoin | 25.40 | 15215642 | |
| MESH:D010146 | Pain | Sulindac | 25.40 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 25.40 | 16870215 | |
| MESH:D010146 | Pain | zoledronic acid | 25.40 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 6.65 | 18702446 12538197 | |
| MESH:D010149 | Pain, Postoperative | Methylprednisolone | 6.65 | 12538197 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 52.31 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 52.31 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 52.31 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 52.31 | 17440100 19401701 19196508 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 52.31 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 52.31 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 52.31 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 52.31 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 52.31 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 52.31 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 52.31 | 19003803 16929163 15113037 16500647 | |
| MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 52.31 | 17440100 18383843 11504793 18992248 16929163 | |
| MESH:D010190 | Pancreatic Neoplasms | mancozeb | 52.31 | 8603375 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 52.31 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 52.31 | 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 52.31 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 52.31 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 52.31 | 11504793 16820089 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 52.31 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 52.31 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 52.31 | 19294695 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 2.56 | 15028970 17883296 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.20 | 11578682 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 9.94 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 9.94 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 9.94 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 9.94 | 18922899 12065085 18404319 8330346 | |
| MESH:D010214 | Papillon-Lefevre Disease | Acitretin | 5.32 | 16008657 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.67 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.12 | 16537180 | |
| MESH:D010267 | Parapsoriasis | Carbamazepine | 4.15 | 16538176 | |
| MESH:D020447 | Parasomnias | Iron | 4.42 | 17352947 | |
| MESH:D010291 | Paresis | Thalidomide | 4.70 | 9200351 | |
| MESH:D010300 | Parkinson Disease | 1-Methyl-4-phenylpyridinium | 12.61 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Dieldrin | 12.61 | 16809432 17291500 16112328 11181820 11445065 | |
| MESH:D010300 | Parkinson Disease | Homocysteine | 12.61 | 16275827 | |
| MESH:D010300 | Parkinson Disease | Iron | 12.61 | 16640825 16563566 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 12.61 | 11124998 15451049 11445065 12911755 11181820 16140633 16510128 15824117 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 12.61 | 18619942 18191903 19232380 16140633 11445065 15451049 11535288 19114014 16412576 | |
| MESH:D010300 | Parkinson Disease | Selegiline | 12.61 | 18328768 | |
| MESH:D010300 | Parkinson Disease | Sirolimus | 12.61 | 19682553 | |
| MESH:D010302 | Parkinson Disease, Secondary | Oxidopamine | 6.30 | 11771942 15893579 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 6.30 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 4.67 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 4.67 | 18197244 15927086 15574749 15795934 | |
| OMIM:167400 | PAROXYSMAL EXTREME PAIN DISORDER | Carbamazepine | 4.35 | 17679678 17145499 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.12 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 8.52 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 8.52 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Doxycycline | 4.98 | 11026799 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.58 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 3.97 | 11156591 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.33 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 8.23 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 8.23 | 15464296 | |
| MESH:D010523 | Peripheral Nervous System Diseases | n-hexane | 8.23 | 16484137 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 3.42 | 6392382 16905509 15371236 | |
| MESH:D010538 | Peritonitis | Zymosan | 3.38 | 15979727 18760300 11985352 14761945 15259001 18977430 19088179 17371808 18557954 17826846 19641140 | |
| MESH:D020795 | Photophobia | Aspirin | 4.17 | 15240983 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.56 | 17983394 | |
| MESH:D020774 | Pick Disease of the Brain | Fluoxetine | 4.45 | 8041377 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 8.79 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 8.79 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 7.02 | 16977796 15687265 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 7.02 | 16391232 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.29 | 15087411 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 3.35 | 10923243 | |
| MESH:D016066 | Pleural Effusion, Malignant | tetrandrine | 5.79 | 18495333 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 8.66 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 8.66 | 17638057 | |
| MESH:D011000 | Pleurodynia, Epidemic | Amlodipine | 5.92 | 9825082 | |
| MESH:D011014 | Pneumonia | Paraquat | 2.91 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 3.78 | 18573544 | |
| MESH:D011041 | Poisoning | Iron | 4.22 | 16604332 | |
| MESH:D011041 | Poisoning | Mustard Gas | 4.22 | 15727166 | |
| MESH:D017689 | Polydactyly | Phenytoin | 3.62 | 9212184 | |
| MESH:D011141 | Polyuria | Furosemide | 8.36 | 17945291 | |
| MESH:D011141 | Polyuria | Lithium Chloride | 8.36 | 19692487 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.40 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 6.00 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 6.00 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 10.41 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 10.41 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 10.41 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 10.41 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 5.91 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 5.91 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 5.91 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 5.06 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 5.06 | 17114810 | |
| MESH:D011248 | Pregnancy Complications | Carbamazepine | 3.63 | 9014606 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.58 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 22.46 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Carbamazepine | 22.46 | 9014606 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 22.46 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 22.46 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 22.46 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 22.46 | 11222880 11118676 11399792 11896295 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 22.46 | 20603192 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 7.30 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 7.30 | 17616702 | |
| MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.21 | 15572423 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 9.60 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 9.60 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 9.60 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 16733517 | ||
| MESH:D011471 | Prostatic Neoplasms | 2-methoxyestradiol | 47.67 | 16356831 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 47.67 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 47.67 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 47.67 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 47.67 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 47.67 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Berberine | 47.67 | 16505103 | |
| MESH:D011471 | Prostatic Neoplasms | bicalutamide | 47.67 | 15638997 18487222 17914592 19011039 19240160 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 47.67 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | brassinolide | 47.67 | 17557751 | |
| MESH:D011471 | Prostatic Neoplasms | Calcitriol | 47.67 | 18247401 16644109 15754350 12479363 16289102 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 47.67 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 47.67 | 18226269 10851300 11398177 12497104 18156803 15129424 18769126 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 47.67 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | diallyl disulfide | 47.67 | 16691315 | |
| MESH:D011471 | Prostatic Neoplasms | diallyl trisulfide | 47.67 | 17513609 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 47.67 | 15046698 17136230 15846301 | |
| MESH:D011471 | Prostatic Neoplasms | docetaxel | 47.67 | 18824434 19103299 16644109 16520278 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 47.67 | 16888761 16729912 18437689 15897917 15749863 16868541 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 47.67 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Estramustine | 47.67 | 18824434 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 47.67 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 47.67 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 47.67 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 47.67 | 15256057 16925846 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Heptachlor | 47.67 | 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | Isoflavones | 47.67 | 16365062 17571952 17219775 17374662 | |
| MESH:D011471 | Prostatic Neoplasms | Lindane | 47.67 | 14688026 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | lycopene | 47.67 | 17337101 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 47.67 | 12376480 15682402 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 47.67 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 47.67 | 16729912 16356831 17136230 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | panduratin A | 47.67 | 16497706 | |
| MESH:D011471 | Prostatic Neoplasms | parthenolide | 47.67 | 16921510 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 47.67 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 47.67 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 47.67 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 47.67 | 16536755 16220300 15731164 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 47.67 | 17804756 17675339 17718901 16731767 15767336 17636462 | |
| MESH:D011471 | Prostatic Neoplasms | S-allylcysteine | 47.67 | 17155983 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 47.67 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 47.67 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 47.67 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | tetracycline CMT-3 | 47.67 | 11857423 11172682 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 47.67 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | theaflavin | 47.67 | 17499812 | |
| MESH:D011471 | Prostatic Neoplasms | Thiram | 47.67 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Tocopherols | 47.67 | 12504091 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 47.67 | 18798265 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 47.67 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | vorinostat | 47.67 | 17218635 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 47.67 | 16700911 16606632 12429649 16517595 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 47.67 | 12438248 19103299 | |
| MESH:D011507 | Proteinuria | Arsenic | 10.09 | 21343184 | |
| MESH:D011507 | Proteinuria | Gentamicins | 10.09 | 15033597 | |
| MESH:D011507 | Proteinuria | Indomethacin | 10.09 | 11849393 | |
| MESH:D011507 | Proteinuria | Tretinoin | 10.09 | 16636307 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.42 | 16640825 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.70 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 10.63 | 15861022 16919318 | |
| MESH:D011537 | Pruritus | Levonorgestrel | 10.63 | 15861022 | |
| MESH:D011537 | Pruritus | Mustard Gas | 10.63 | 18058305 | |
| MESH:D011537 | Pruritus | Naloxone | 10.63 | 15861022 | |
| MESH:D019310 | Pseudolymphoma | Carbamazepine | 18.04 | 12752131 9591791 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 18.04 | 12752131 | |
| MESH:D019310 | Pseudolymphoma | Phenytoin | 18.04 | 8603615 12752131 1419762 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 18.04 | 12752131 11422049 | |
| MESH:D011565 | Psoriasis | Acitretin | 4.70 | 16924049 16385345 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 4.70 | 16882103 | |
| MESH:D011565 | Psoriasis | tazarotene | 4.70 | 16605289 15989518 | |
| MESH:D011595 | Psychomotor Agitation | olanzapine | 4.05 | 18685284 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.34 | 18769834 | |
| MESH:D011618 | Psychotic Disorders | Clozapine | 5.03 | 15331141 | |
| MESH:D011618 | Psychotic Disorders | Cocaine | 5.03 | 16134406 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.22 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.21 | 10548101 | |
| MESH:D011645 | Puerperal Infection | Citric Acid | 5.15 | 1108409 | |
| MESH:D029424 | Pulmonary Disease, Chronic Obstructive | Theophylline | 3.81 | 18983928 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 3.70 | 10903255 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.08 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 7.77 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 7.77 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 11.68 | 17365031 17975199 17322281 15814490 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 11.68 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 11.68 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 11.68 | 17720292 17894541 10334151 17266442 17620002 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 11.68 | 16324872 17997886 | |
| MESH:D011658 | Pulmonary Fibrosis | Particulate Matter | 11.68 | 12475806 | |
| MESH:D011658 | Pulmonary Fibrosis | S-allylcysteine | 11.68 | 16614485 | |
| MESH:D011693 | Purpura | Raloxifene | 3.95 | 15770314 | |
| MESH:D012003 | Rectal Fistula | Ciprofloxacin | 9.34 | 18371140 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 9.34 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.61 | 16160472 15538739 18286688 18722050 | |
| MESH:D012021 | Reflex, Abnormal | Pentobarbital | 4.44 | 10930210 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 12.08 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 12.08 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 12.08 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 12.08 | 17132701 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 3.98 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 9.10 | 19211983 18460982 | |
| MESH:D015427 | Reperfusion Injury | Furosemide | 9.10 | 16526316 | |
| MESH:D015427 | Reperfusion Injury | Morphine | 9.10 | 19211983 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 9.10 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 9.10 | 17058453 16314181 15827377 17520802 16317513 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | 2-chloroethyl ethyl sulfide | 24.11 | 16292752 12210543 18257742 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 24.11 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 24.11 | 18379247 10666014 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 24.11 | 18379247 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Furosemide | 24.11 | 15912074 16096441 12394941 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 24.11 | 18339021 17627322 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 24.11 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 24.11 | 16129981 | |
| MESH:D012127 | Respiratory Distress Syndrome, Newborn | Vitamin A | 4.22 | 16877224 | |
| MESH:D012135 | Respiratory Sounds | alachlor | 5.04 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 5.04 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.31 | 18990726 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.22 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | marker/mechanism | |||
| MESH:D012162 | Retinal Degeneration | Fenretinide | 10.52 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 10.52 | 18172121 18155124 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 10.52 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 10.52 | 16584753 | |
| MESH:D012173 | Retinitis | Gentamicins | 4.67 | 18644591 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 4.36 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 4.36 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | Thioctic Acid | 4.36 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 8.48 | 11555667 | |
| MESH:D012175 | Retinoblastoma | SN50 peptide | 8.48 | 12466137 | |
| MESH:D012206 | Rhabdomyolysis | Lamivudine | 3.96 | 9296927 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 9.94 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 9.94 | 16116481 16283617 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 9.94 | 19155313 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 4.70 | 17050345 | |
| MESH:D012220 | Rhinitis | Aspirin | 4.70 | 12372130 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Astemizole | 10.06 | 10822083 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 10.06 | 15015336 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Terfenadine | 10.06 | 8201490 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.05 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 7.76 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 7.76 | 18313854 17203757 15675481 17710206 15625365 16767912 | |
| MESH:D012509 | Sarcoma | Ifosfamide | 7.76 | 15625365 18313854 17710206 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 16.56 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 16.56 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 16.56 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 16.56 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 16.56 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.22 | 17846226 | |
| MESH:D013584 | Sarcoma, Synovial | therapeutic | 16450387 | ||
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 3.94 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 3.94 | 9673227 | |
| MESH:D012559 | Schizophrenia | Clozapine | 5.65 | 17667964 19369910 20168265 11151749 18855531 20521326 20107430 20580759 17726453 20452607 16141801 20521320 17123785 11763009 18806925 | |
| MESH:D012559 | Schizophrenia | Copper | 5.65 | 16842975 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 5.65 | 16641680 | |
| MESH:D012559 | Schizophrenia | Homocysteine | 5.65 | 16641680 | |
| MESH:D012559 | Schizophrenia | olanzapine | 5.65 | 17726453 20107430 20521326 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 5.65 | 15737665 19110320 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.36 | 16096327 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.33 | 16636934 | |
| MESH:D012640 | Seizures | Acrylonitrile | 26.91 | 20127315 | |
| MESH:D012640 | Seizures | Carbamazepine | 26.91 | 16938433 16180713 19414003 16876388 15946322 9844417 9046859 | |
| MESH:D012640 | Seizures | Cocaine | 26.91 | 10454489 | |
| MESH:D012640 | Seizures | Endosulfan | 26.91 | 10698677 7539098 | |
| MESH:D012640 | Seizures | Ethanol | 26.91 | 9754883 | |
| MESH:D012640 | Seizures | lamotrigine | 26.91 | 9844417 16499746 | |
| MESH:D012640 | Seizures | Lindane | 26.91 | 7539098 15475178 12842176 | |
| MESH:D012640 | Seizures | Lithium | 26.91 | 19660546 | |
| MESH:D012640 | Seizures | Mecamylamine | 26.91 | 12660363 | |
| MESH:D012640 | Seizures | Midazolam | 26.91 | 10087439 | |
| MESH:D012640 | Seizures | Pentobarbital | 26.91 | 10087439 9754883 | |
| MESH:D012640 | Seizures | Phenobarbital | 26.91 | 3137016 11442880 16876388 4039156 | |
| MESH:D012640 | Seizures | Phenytoin | 26.91 | 9844417 3691417 10029267 15946322 19919933 11044598 16876388 3137016 | |
| MESH:D012640 | Seizures | Valproic Acid | 26.91 | 11044598 17978042 1511512 16876388 3137016 14763951 11738929 15475178 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.24 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 7.84 | 18389075 | |
| MESH:D018805 | Sepsis | tetracycline CMT-3 | 7.84 | 16003065 15489642 | |
| MESH:D018805 | Sepsis | Zymosan | 7.84 | 11441115 | |
| MESH:D020230 | Serotonin Syndrome | Fluoxetine | 4.31 | 8704074 | |
| OMIM:608579 | SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO | lamotrigine | 5.04 | 20485159 19668019 | |
| MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 4.60 | 16631401 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 3.16 | 7327846 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 3.72 | 12269725 | |
| MESH:D012871 | Skin Diseases | Arsenic | 8.45 | 17050553 19834688 17453740 18709164 17938729 6392382 15952646 16702368 17548696 16353154 16759981 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 8.45 | 18709164 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 8.45 | 18709164 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 8.45 | 15451306 12880345 16961503 | |
| MESH:D012871 | Skin Diseases | Vitamin A | 8.45 | 18709164 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 8.45 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 43.57 | 17029826 16251483 19538983 17976673 17050553 15504454 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 43.57 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 43.57 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 43.57 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 43.57 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | gingerol | 43.57 | 19481070 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 43.57 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 43.57 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 43.57 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | mancozeb | 43.57 | 1733566 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 43.57 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 43.57 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 43.57 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 43.57 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 43.57 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 43.57 | 8985016 12065085 11807781 18404319 8330346 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 43.57 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 43.57 | 11807781 | |
| MESH:D012893 | Sleep Disorders | Carbamazepine | 6.46 | 19414003 | |
| MESH:D012893 | Sleep Disorders | Midazolam | 6.46 | 6138072 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Midazolam | 4.28 | 6138071 | |
| MESH:D055752 | Small Cell Lung Carcinoma | ABT-737 | 9.39 | 19010845 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 9.39 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | therapeutic | 16450387 | ||
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 7.02 | 16767912 15625365 17203757 | |
| MESH:D012983 | Soft Tissue Neoplasms | Ifosfamide | 7.02 | 15625365 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 11.05 | 16002989 16709447 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 11.05 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 11.05 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 3.94 | 16517039 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 3.92 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 5.71 | 15862959 16503802 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 5.71 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 5.03 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 5.03 | 19490988 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 8.39 | 12587719 | |
| MESH:D013158 | Splenic Diseases | Grape Seed Proanthocyanidins | 8.39 | 12587719 | |
| MESH:D013226 | Status Epilepticus | Lithium | 7.41 | 19430551 19951488 19570321 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 7.41 | 12833885 | |
| MESH:D019956 | Stereotypic Movement Disorder | Amphetamine | 4.82 | 1977408 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Carbamazepine | 10.05 | 18855540 16538176 16415921 19694795 15057820 19915237 20485159 | |
| MESH:D013262 | Stevens-Johnson Syndrome | lamotrigine | 10.05 | 20235791 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 10.05 | 20235791 | |
| MESH:D013272 | Stomach Diseases | Amifostine | 11.88 | 17160473 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 11.88 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 11.88 | 17160473 15038085 16113693 17207306 10192188 17638125 18209964 15472012 18545984 10486359 16184426 16280098 10215738 | |
| MESH:D013272 | Stomach Diseases | sildenafil | 11.88 | 16113693 | |
| MESH:D013274 | Stomach Neoplasms | Acrylonitrile | 39.17 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 39.17 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 39.17 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 39.17 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 39.17 | 17522103 18396642 15958060 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 39.17 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 39.17 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 39.17 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | docetaxel | 39.17 | 16557585 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 39.17 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 39.17 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 39.17 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 39.17 | 18396642 19015929 16424979 16951190 17172411 17522103 18567086 17498489 15786421 19084572 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 39.17 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | Furosemide | 39.17 | 17052386 | |
| MESH:D013274 | Stomach Neoplasms | gambogic acid | 39.17 | 19084572 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 39.17 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 39.17 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Linoleic Acids, Conjugated | 39.17 | 20155912 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 39.17 | 15930296 16257854 18593901 | |
| MESH:D013274 | Stomach Neoplasms | N'-nitrosonornicotine | 39.17 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 39.17 | 18396642 18506536 | |
| MESH:D013274 | Stomach Neoplasms | Sodium Chloride | 39.17 | 16646055 | |
| MESH:D013274 | Stomach Neoplasms | styrene oxide | 39.17 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 39.17 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | Weichang'an | 39.17 | 17498489 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 39.17 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 30.32 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 30.32 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 30.32 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 30.32 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 30.32 | 11906479 17189318 17918041 16755016 9562338 9211565 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 30.32 | 18181030 16252198 16631530 11729361 17657623 11595415 17654042 15255614 18726076 18237397 16934674 15104355 10423059 11523592 17895592 12500499 12787963 12077510 16169175 16755016 18193104 18299717 17977527 18431645 17135157 12498302 18543354 18087811 11906479 11145282 17918041 18209962 10878458 14567935 1323529 16397915 16150113 11595431 10750652 15138204 17627676 12467913 | |
| MESH:D013276 | Stomach Ulcer | Nifedipine | 30.32 | 14653237 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 30.32 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | olive oil | 30.32 | 12498302 16252198 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 30.32 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 30.32 | 12787963 17135157 18237397 15255614 18193104 | |
| MESH:D013276 | Stomach Ulcer | Plant Oils | 30.32 | 16252198 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 30.32 | 15138204 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 12.61 | 16403987 16517955 | |
| MESH:D020521 | Stroke | Aspirin | 12.61 | 16403987 | |
| MESH:D020521 | Stroke | Folic Acid | 12.61 | 16517955 | |
| MESH:D020521 | Stroke | Raloxifene | 12.61 | 16837676 | |
| MESH:D020521 | Stroke | Vitamin E | 12.61 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.03 | 16321402 | |
| MESH:D013322 | Strongyloidiasis | Trichlorfon | 5.04 | 14651886 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 8.41 | 17634840 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 8.41 | 18364113 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.47 | 16684133 16045194 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 5.50 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 5.50 | 11529278 9754883 | |
| MESH:D013398 | Sudden Infant Death | Iron | 8.12 | 16640825 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 8.12 | 12563064 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 11.60 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 11.60 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Thiotepa | 11.60 | 12837982 | |
| MESH:D013610 | Tachycardia | Nitroprusside | 4.11 | 15306635 | |
| MESH:D017180 | Tachycardia, Ventricular | olanzapine | 3.85 | 20210726 | |
| MESH:D024801 | Tauopathies | Camptothecin | 6.67 | 16930453 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 6.67 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 8.18 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 8.18 | 17997062 | |
| MESH:D013733 | Testicular Diseases | 2,5-hexanedione | 6.28 | 17725299 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 6.28 | 15864552 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.14 | 17225452 15464296 | |
| MESH:D013742 | Tetanus | Midazolam | 8.87 | 2903605 | |
| MESH:D013742 | Tetanus | Propofol | 8.87 | 2903605 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 5.59 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | vorinostat | 5.59 | 20479100 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.14 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 4.55 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 4.55 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 7.04 | 10850423 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 7.04 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.32 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | alachlor | 19.78 | 8812207 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 19.78 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 19.78 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 19.78 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 19.78 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 19.78 | 18791128 11352223 14736730 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 19.78 | 3078959 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 19.78 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 19.78 | 16026305 17045167 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 8.44 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 8.44 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | Acitretin | 16.01 | 16196285 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 16.01 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 16.01 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 16.01 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 16.01 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 12.18 | 15213294 | |
| MESH:D016171 | Torsades de Pointes | Astemizole | 12.18 | 8256756 9583453 | |
| MESH:D016171 | Torsades de Pointes | Dobutamine | 12.18 | 19353679 | |
| MESH:D016171 | Torsades de Pointes | Terfenadine | 12.18 | 8256756 | |
| MESH:D014123 | Toxoplasmosis | Ciprofloxacin | 4.44 | 20186551 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 3.63 | 17262798 | |
| MESH:D014376 | Tuberculosis | Iron | 4.15 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.15 | 16040207 | |
| MESH:D014402 | Tuberous Sclerosis | Sirolimus | 4.05 | 21115397 18495876 | |
| MESH:D014456 | Ulcer | gypenoside | 7.66 | 17380554 | |
| MESH:D014456 | Ulcer | Indomethacin | 7.66 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 2.95 | 3119515 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 32.32 | 1399818 15867355 15289314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 32.32 | 17306315 15987713 19322015 19429237 17976673 18640142 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 32.32 | 11780464 12845720 20435036 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 32.32 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Ciprofloxacin | 32.32 | 15028437 10741713 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 32.32 | 12973940 15464296 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 32.32 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 32.32 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 32.32 | 19087683 17616700 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 32.32 | 17306315 16452187 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 32.32 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 32.32 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 32.32 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 32.32 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 32.32 | 11723127 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 32.32 | 8653321 17572228 16712894 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.09 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.69 | 18462866 | |
| MESH:D014581 | Urticaria | Acetaminophen | 12.26 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 12.26 | 20485159 10982225 | |
| MESH:D014581 | Urticaria | Astemizole | 12.26 | 1976298 3080510 2859714 2565098 2885854 2147912 2568013 1683191 2883202 3097109 3134034 2568189 | |
| MESH:D014581 | Urticaria | salmeterol | 12.26 | 10982225 | |
| MESH:D014581 | Urticaria | Terfenadine | 12.26 | 2569995 2885854 2565098 2859714 2568013 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 27.46 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 27.46 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 27.46 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 27.46 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 27.46 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 27.46 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 27.46 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 27.46 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 8.54 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 8.54 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 18.27 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 18.27 | 16690809 15809267 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 18.27 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 18.27 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 18.27 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 18.27 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 7.56 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 7.56 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 16.48 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 16.48 | 1336536 | |
| MESH:D014605 | Uveitis | Sirolimus | 16.48 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 16.48 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 9.69 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 9.69 | 16513791 16002989 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 9.69 | 12579204 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 11.28 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 11.28 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 11.28 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 2.99 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.32 | 10620525 | |
| MESH:D020301 | Vasospasm, Intracranial | fasudil | 7.37 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 7.37 | 18364113 | |
| MESH:D014689 | Venous Insufficiency | coumarin | 4.18 | 12708602 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.61 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 5.92 | 14671159 15869587 | |
| MESH:D020246 | Venous Thrombosis | Levonorgestrel | 5.92 | 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 12.08 | 17334414 17638931 17678736 16364871 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 12.08 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 12.08 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 12.08 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 7.67 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 7.67 | 18097624 | |
| MESH:D014717 | Vertigo | Astemizole | 4.86 | 3105558 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 3.99 | 18776599 | |
| MESH:D014802 | Vitamin A Deficiency | Vitamin A | 3.78 | 16146918 16175781 16960172 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.55 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 6.30 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 6.30 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 3.95 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.65 | 15886252 | |
| MESH:D015430 | Weight Gain | Clozapine | 5.66 | 17502770 20107430 20564506 16141801 16402076 20521320 | |
| MESH:D015430 | Weight Gain | olanzapine | 5.66 | 19434072 20107430 17933447 | |
| MESH:D015431 | Weight Loss | Clozapine | 3.52 | 17933447 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.55 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 9.14 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | Estrogens | 9.14 | 11172683 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 9.14 | 20213670 19894650 | |
| MESH:D014947 | Wounds and Injuries | Plant Oils | 9.14 | 16313111 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 8.97 | 17120751 | |
| MESH:D014985 | Xerophthalmia | Scopolamine | 8.97 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05014 | Amyotrophic lateral sclerosis (ALS) |
| KEGG:04210 | Apoptosis |
| REACT:578 | Apoptosis |
| KEGG:05210 | Colorectal cancer |
| KEGG:04510 | Focal adhesion |
| KEGG:04722 | Neurotrophin signaling pathway |
| KEGG:05200 | Pathways in cancer |
| KEGG:05215 | Prostate cancer |
| KEGG:04141 | Protein processing in endoplasmic reticulum |
| KEGG:05222 | Small cell lung cancer |
| KEGG:05145 | Toxoplasmosis |
| KEGG:05152 | Tuberculosis |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA443622 | Carcinoma, Non-Small-Cell Lung |
| PA446654 | Cholangiocarcinoma |
| PA444818 | Lung Neoplasms |
| PA445204 | Ovarian Neoplasms |
| PA443560 | Breast Neoplasms |
| PA446108 | Colorectal Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA448691 | busulfan |
| PA451581 | tamoxifen |
| PA451746 | tretinoin |
| PA451578 | tacrolimus |
| PA449780 | glutathione |
| PA10804 | imatinib |
| PA449165 | cyclophosphamide |
| PA449383 | docetaxel |
| PA449412 | doxorubicin |
| PA449552 | etoposide |
| PA128406956 | fluorouracil |
| PA450761 | paclitaxel |
| PA451729 | topotecan |
| PA449167 | cyclosporine |
| PA452627 | flavopiridol |
| PA451620 | teriparatide |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB01229 | antagonist | Paclitaxel | Antineoplastic Agents;Antineoplastic Agents, Phytogenic;Tubulin Modulators |
| DB01248 | - | Docetaxel | Antineoplastic Agents;Radiation-Sensitizing Agents;Antimalarials;Antineoplastic Agents, Phytogenic |
| DB01367 | activator | Rasagiline | Neuroprotective Agents;Monoamine Oxidase Inhibitors |
| No data |
| No data |
| No data |